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SUMMARY 
 
 The Electrical Impedance Mammography (EIM) device is an imaging system 
developed at the University of Sussex for the detection of breast lesions in vivo using 
quadrature detection of impedance. 
The work describes a novel technique to integrate Ultrasound-guided Focused 
Ultrasound Surgery (USgFUS) with the existing EIM system. The benefits that such a 
system could provide include the possibility of non-invasive detection, diagnosis and 
treatment of breast cancer all within a single device and involving no radiation. 
Furthermore the timescales involved would allow the process to be considered an 
outpatient procedure such that a patient can be diagnosed and treated on the same day 
using the same device. 
Various geometries of transducer were investigated for physical compatibility as 
well as the ability to target the entire specified volume, based on the dimensions of the 
existing system. Simulations were performed using a custom written code based on 
Huygen’s principle, allowing minimum surface area and power requirements to be 
determined and feasibility of designs to be evaluated.  
The use of phase differences in the excitation signals applied to individual 
elements was also investigated, thus the effect of steering the simulated focus could be 
observed, an important factor to consider when attempting to incorporate a transducer 
into a device with restricted dimensions. 
Resulting simulated pressure fields were used to obtain acoustic intensity fields, 
which could then be used as inputs in the Pennes Bio-Heat Transfer Equation (BHTE) 
allowing temperature distributions to be observed. 
Preliminary studies proved the feasibility of using the suggested transducer design 
in conjunction with the existing EIM system. Pressure fields and heating patterns were 
all within acceptable limits, confirming the ability of the device to effectively ablate 
cancerous tissue. Additionally the capability to steer the resultant focal point was 
validated, and a thermal dose model was implemented allowing different heating patterns 
to be quantitatively compared. 
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Chapter 1:        
           
             
Introduction & Background 
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1.1: Chapter Introduction 
This chapter provides an introduction and general background to the investigation 
undertaken for this thesis. Numerous ablative cancer treatments will be discussed and 
High Intensity Focused Ultrasound (HIFU) will be introduced, with a focus on the 
application of these methods for the ablation of cancerous tissue. A brief history of 
HIFU will also be presented along with examples of HIFU devices that are currently on 
the market for the surgical treatment of various cancer types. Additionally, following 
the conclusion an outline of each chapter is provided for reference. 
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1.2: Thesis Introduction 
In the chapters that follow relevant background information on acoustics and 
specifically on HIFU will be given, including a comprehensive review of relevant 
literature. In addition a brief account of the underlying theory of transducer design will 
be given and numerous types of transducer will be presented, with examples, along 
with a summary of the attributes of each. The problem at hand will then be defined, 
and the design specification(s) will be listed. From this a suitability study of transducer 
designs will be given, and decisions made will be presented as to which transducer(s) 
will be the most practical for the intended application. The design parameters for the 
intended application will subsequently be investigated and selected, followed by a 
report of simulations performed to optimise a number of these parameters using a 
custom code written in MATLAB [1] thus providing a feasibility and optimisation study 
simultaneously. The pressure fields from these (simulated) transducers will be used to 
calculate acoustic intensity fields which will subsequently be set as inputs in the 
Pennes Bio-Heat Transfer Equation (BHTE) [2] allowing the resulting temperature rise 
in a simulated target tissue (modelled using varying attenuation coefficients) to be 
calculated using the COMSOL Multiphysics software package [3]. This will additionally 
include results of a custom model, designed to allow different transducers to be 
quantitatively compared using a measure called the ‘equivalent thermal dose’ [4]. 
Following this the outcome of the simulations will be summarised thus allowing the 
results to be presented in a concise form. Finally the transducer manufacture, 
including additional equipment to facilitate operation (such as driving circuitry) will be 
briefly outlined. For reference there will also be appendices included at the end of the 
thesis. These contain the original project proposal & a sample of the MATLAB code 
written for the simulation of the various acoustic intensity fields. 
To summarise the results of this thesis it has been shown that the incorporation of a 
surgical HIFU device into the existing EIM system developed at the University of Sussex 
is both possible and practical. The design of such a device has been outlined up to the 
point of plausible manufacture. 
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Once completed this single device system potentially offers detection, diagnosis and 
treatment of breast cancer all within the timescale of an out-patient procedure, with 
the possibility of expanding the system to treat cancers other than that of the breast. 
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1.3: Cancer Treatment via Ablation: The Options 
Advances in medical technologies over the last number of decades have allowed for 
the development and growth of new and exciting treatment methodologies. Included 
in this list are a number of treatments capable of destroying tissue via ablation, some 
of which require direct access to the target tissues, while others can be performed 
non-invasively. 
Radiofrequency ablation (RFA) makes use of an electric current applied directly to the 
target tissue via contact electrodes. The electric current causes resistive heating within 
the tissue, and generally devices of this type have integral sensors installed in the 
treatment ‘tip’ to allow temperature rises to be monitored and controlled [5]. 
Commonly used for suppression of atrial fibrillation, this treatment methodology has 
recently found an increased use for the treatment of cancers, using small diameter 
probes from which retractable electrodes can be used to make contact with the 
malignant target tissue. Treatments of this kind generally last for up to 25 mins [6]. 
Patient comfort during the procedure is questionable due to the need for electrodes to 
make direct contact with the tissue for effective treatment. For this reason anaesthesia 
is generally recommended during treatments of this nature. 
Laser ablation is a feasible treatment capable of destroying pathogenic tissue although 
this too requires the penetration of the skin to effectively reach the target tissue 
area(s). This is generally achieved using very small needles containing thin fibres 
capable of transmitting suitable frequencies of light, generally in the near-infrared end 
of the spectrum. The mechanism of tissue destruction utilised here can be referred to 
as photocoagulation [7] and generally takes a few minutes of exposure to effectively 
destroy the target tissue. 
Microwave ablation (MWA) can be utilised as a percutaneous and as an open-surgical 
procedure. In general, a thin microwave antenna is inserted directly into the target 
tissue and electromagnetic microwaves are used to agitate the tissue to frequencies as 
high as 2.45 GHz [6]. This causes agitation of the water molecules present which 
causes the production of heat leading to cell death via coagulative necrosis [8]. 
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Although research into MWA continues, advantages can be readily seen in the ability 
to ablate larger tumour masses within comparatively short treatment durations 
compared with those of alternative thermal ablation methods. Having said this MWA 
does require contact with the tissue to be treated and so cannot be called a non-
invasive procedure as some other treatment methodologies claim. 
Cryoablation generally uses argon gas or liquid nitrogen delivered through a small 
probe directly into the target tissue. The tissue is subsequently frozen, thawed and 
frozen again a number of times until cell death occurs [9]. As with many of the 
treatment methodologies mentioned so far, cryoablation can be guided using 
diagnostic ultrasound to facilitate the accurate placement of the probe, 
laparoscopically or percutaneously and therefore can be referred to as a ‘minimally-
invasive’ treatment procedure. 
Numerous therapies based on radiation have also been researched and used in 
practice as early as the 1960s. These include brachytherapy, involving the insertion of a 
radioactive source into the tumour site, hadron therapy, involving the use of a beam of 
‘heavy protons’ to deliver energy to the target tissue and the ‘Gamma Knife’ which 
utilises a bowl-shaped array of gamma ray sources causing a natural focus at the 
geometric centre of the sphere, of which the bowl forms a section of, delivering 
sufficient energy to destroy unwanted tissue. For more information on these 
technologies the reader is directed toward the review paper [6]. 
High Intensity Focused Ultrasound Surgery (HIFUS) or Focused Ultrasound Surgery 
(FUS) offers a truly non-invasive surgical option. The following sections describe the 
theory and application of HIFU as a surgical tool. 
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1.4: Introduction to HIFU 
High-Intensity focused ultrasound surgery otherwise referred to as FUS or HIFUS uses a 
focused ultrasound machine to destroy pathogenic tissue, such as that of a cancerous 
tumour. This is achieved by the coherent focusing of ultrasonic waves leading to 
precise heating of a localized area to a temperature of above 56°C (for one second) 
thus destroying the target cells by thermal ablation [10]. This process of heating and 
destruction can be compared to the focusing of sunlight using a magnifying glass (see 
Figure 1). 
 
Figure 1 - HIFU analogous to focusing sunlight using a magnifying glass 
HIFU has been widely used to treat prostate cancer with promising results and is an 
approved therapy in many parts of the world, including Australia, Canada, China, South 
Korea and some parts of Europe. At present investigations are under way to determine 
the feasibility of HIFU treatments for other types of cancers such as those that affect 
the brain, breast, liver, pancreas, rectum, kidney, testes and bones. 
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1.5: HIFU, A Brief History 
Investigations into the use of HIFU for non-invasive tissue ablation have been carried 
out as early as the 1940s. In the 1950s and 1960s Francis and William Fry, amongst 
others, performed work that led to treatments of neurological disorders using the 
combination of ultrasound and a high precision milling machine to accurately destroy 
tumours of the brain [11]. This type of clinical trial however has until recently been 
difficult to perform due to the problems and complexity associated with the targeting 
of the ultrasound beams. As both ultrasound technology and general medical imaging 
have advanced the use of HIFU for the treatment of tumours has once again become 
an area of interest. 
In 1994 the first CE (mandatory conformity marking for products sold in Europe) 
approved commercial HIFU machine was launched by Focus Surgery of America. In 
depth studies at the time showed that the machine developed, the Sonablate 200 [12] 
was able to destroy prostate tissue without long term side effects and with no 
bleeding or blood loss. Later a French company EDAP-Technomed, developed a similar 
technology called Ablatherm [13] of which a 2006 study showed that non-recurring 
survival rates were in the region of 50 % and 70 % for intermediate and low risk 
patients respectively. 
Magnetic resonance imaging (MRI) guided procedures using HIFU (MRgFUS or 
MRIgFUS) were first developed in the early 1990s and were patented in the US in 1992. 
In 2000 the technology was further developed by an Israeli company, Insightec, who 
went on to produce the ExAblate 2000 [14] the first MRI guided HIFU system to obtain 
market approval from the Food and Drug Administration (FDA) and to sell 
commercially in the U.S. The company Chongqing Haifu of China developed a similar 
system in 2001, using ultrasound in place of magnetic resonance to guide the HIFU 
ablation and the process was certified for use on benign and malignant tumours. 
Sumo Corporation developed a treatment called HIFU-2001 [15] which is capable of 
treating tumours related to many internal organs such as the liver and kidneys. This 
treatment is well known, perhaps mostly for the fact that the procedure does not 
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require any use of anaesthetics, although these could be recommended in certain 
cases. 
This concludes the brief history of the organisations that appear as the major players in 
the development of HIFU for surgery. It is worth noting here that although the above 
companies have made significant progress in the field of HIFU development there are 
also many other highly influential groups working on various HIFU applications, and 
the list of organisations discussed should not be taken as absolute. In the next chapter 
a number of the publications produced by these other groups will be reviewed, 
alongside the groups mentioned specifically above. 
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1.6: Research Aims, Objectives & Achievements 
1.6.1: Aims 
The research project described is the integration of a therapeutic High Intensity 
Focused Ultrasound (HIFU) transducer array into an existing Electrical Impedance 
Mammography (EIM) non-invasive medical imaging device. The resulting system 
therefore would allow dual modalities of diagnosis and treatment to be available using 
a single device. The aim of this research is to show that this integration is feasible, and 
to develop the design of a suitably compatible therapeutic device. 
1.6.2: Objectives 
The objectives of this project are to answer the following questions. 
• Can EIM be used in conjunction with HIFU to provide both diagnosis and 
targeted treatment? 
• How can a HIFU transducer be integrated into the existing EIM system designed 
by the Biomedical Engineering (BMEng) group at the University of Sussex? 
• What factors must be considered when designing and manufacturing a HIFU 
transducer? (Including, but not limited to the phasing of array elements and 
electronic steering)  
Given satisfactory answers to these questions the design of a suitable device will be 
progressed to a stage at which manufacturing is plausible. 
1.6.3: Achievements 
To summarise, the research work performed has shown that the incorporation of a 
surgical HIFU device into the existing EIM system developed at the University of Sussex 
is indeed feasible. It has been proven that modification of the existing electrode plate 
would allow sufficient space to position a suitably powerful HIFU transducer, capable 
of targeted tissue ablation within a known volume, namely that of human breast 
tissue. The proposed design allows for steering a surgical focal point within the target 
volume while avoiding permanent tissue damage to non-targeted areas. 
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1.7: Chapter Conclusion 
In this chapter a brief introduction has been presented and several ablation techniques 
have been discussed with a focus on the advantages and disadvantages they provide in 
comparison to HIFU, as a surgical instrument. This overview suggests that, at least for 
the current undertaking, HIFU presents the most practical choice. 
A brief history on HIFU has also been given, along with some examples of surgical HIFU 
devices that have gained approval from the respective legislative bodies in countries 
around the world. HIFU and HIFU transducers will be discussed in detail later in this 
thesis (see Chapter 3). 
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1.8: Thesis Structure 
For reference the contents of each of the subsequent chapters will be summarised. 
1.8.1: Chapter 2 
This chapter presents a comprehensive literature review of relevant publications. 
Available at the time of writing. To facilitate relevance to the reader a short 
chronological review is given to set the scene. An in-depth review follows, with 
sections dedicated to transducer design and theory as well as medical trials and 
accounts to allow for project perspective. 
1.8.2: Chapter 3 
Here principles of acoustics and interaction with matter are laid out. HIFU is 
introduced in more detail, with examples of currently available devices given. Types of 
transducer are presented with various geometries and methods of focusing being 
described 
1.8.3: Chapter 4 
In this chapter the ‘problem’ is defined. A design specification is created based on 
transducer and acoustics theory with many of the necessary properties and 
construction restrictions being introduced, explained and chosen. 
1.8.4: Chapter 5 
The first sets of simulations are presented here. Initially the theory will be explained 
and parameters used will be listed, followed by the results and findings from the 
simulations performed. The work presented includes calibration of the parameters 
used to allow accurate and obtainable results. All the results relate to the computed 
acoustic pressure and intensity fields, with simulated focal intensities of the proposed 
HIFU transducer presented.  
1.8.5: Chapter 6 
In this chapter theory relevant to the time-dependent tissue temperature rise, 
resulting from the acoustic intensities presented in the previous chapter will be 
described. A thermal dose model will also be introduced. 
1.8.6: Chapter 7 
Here project conclusions will be discussed. In later sections proposals for future work 
to further the goals of this project will be laid out. It is hoped that one or more of these 
directions will be taken up by another research project at some point, following the 
submission of this thesis. 
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Chapter 2:        
           
            
Literature Review 
14 
 
2.1: Chapter Introduction 
Presented in this chapter is a comprehensive literature review split into numerous 
sections. The first section provides a short chronological review of the larger groups 
working on similar areas in HIFU devices and research since 2003. Following this an in-
depth review of over thirty published papers will be presented. This in-depth review 
will be further divided between reports on medical trials and those focusing on 
transducer design and acoustic field simulation. 
Much of the inspiration for the transducer design described in later chapters came 
from the publications included in this section. Where appropriate, references to these 
papers will be made in the subsequent chapters of this thesis. 
For reference & prior to the literature review, please refer to the image below (see 
Figure 2, [15]) showing a typical, simplified HIFU arrangement for surgery. 
 
 
Figure 2 - Simplified HIFU process applied to a liver tumour 
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2.2: Brief Chronological Review of Recent Literature 
The brief history already presented (see Section 1.5) is an overview of the work 
performed by large commercial groups, who can be described as leaders in the field of 
using HIFU for ablation of tumours. These groups have published many scientific 
papers on the subject of HIFU, as have other, non-commercial groups from around the 
world. This section will briefly summarize these more recent findings in chronological 
order beginning from 2003, and where applicable summarise the results of 
experiments and trials that have been performed. More detailed reviews of the 
technology and its medical application follows later in this thesis (see Section 2.3). 
From the available literature the Chongqing Haifu (HIFU) Technology Company of 
China appear to have the greatest experience with ultrasound guided HIFU treatments 
(USgFUS) of all the groups researched. In 2003, 28 women with biopsy proven breast 
cancer were randomized into a HIFU treatment group and a control group [16]. All 
patients had a single tumour, no larger than 6 cm in diameter, at a location at least 0.5 
cm away from skin and lung tissue and 2 cm away from the nipple. Twenty-five 
patients in the control group underwent modified radical mastectomy, while the 
remaining twenty-three received HIFU treatment 1-2 weeks prior to modified radical 
mastectomy. The HIFU treatment encompassed the tumour volume and a portion of 
healthy tissue, measuring 1.5-2 cm around the tumour. Following HIFU treatment 14 of 
the 23 patients experienced mild local pain, and one experienced minimal skin burn, 
but these patients had entirely recovered after 10 days following the treatment. 
Pathological examination showed the tumours in the HIFU group patients underwent 
complete coagulative necrosis in the defined tumour volume, showing HIFU as a 
promising surgical tool, given a suitably located tumour. One after-effect of the 
treatment that some patients found distressing was the presence of a firm, palpable 
lump in the area of ablation. This lump was predicted to reduce in size over time, but it 
is suggested that the lump(s) may take a number years to disappear completely, in the 
case where HIFU treatment is not followed by conventional surgery. Although 
cosmetic this may cause some patients to reconsider whether HIFU treatment is the 
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most suitable treatment methodology for their own particular case. This decision 
would most probably vary from patient to patient. 
In 2004 The Haifu group of Chongqing treated a further 24 patients with breast cancer 
[17]. These patients underwent HIFU treatment 1-2 weeks before receiving modified 
radical mastectomy, with no patients undergoing any discomfort throughout the 
procedure. Following treatment patients experienced slight oedema around the area 
of treatment but this rapidly faded. Pathological examination showed a very clear 
boundary between ablated and healthy tissue and also the complete necrosis of the 
target volume, including the predefined boundary of healthy tissue. 
Also in 2004, the HAIFU group produced an overview of the work carried out to date 
[18]. This report described many treatments for different types of cancer and will now 
be briefly summarized. A total of 474 patients with liver cancer and tumour size from 4 
to 14 cm received HIFU treatment. The survival rates after 6 months and one year 
were 82.6 % and 53.4 % respectively. 106 patients with biopsy proven breast cancer 
underwent HIFU treatment along with adjuvant therapy. After a mean follow-up time 
of 22 months all the patients were alive, with one patient experiencing local 
recurrence that was subsequently treated by modified radical mastectomy. Some 153 
patients diagnosed with osteosarcoma were treated using HIFU. These patients had 
tumours ranging from 5 to 46 cm in size. After a mean follow-up time of 23 months 
survival rate was reported as 85 %. Additionally 77 patients with soft tissue sarcoma 
were treated, and after a mean follow-up time of 21 months, survival rate was 90 %. In 
addition to the cases mentioned above patients with renal cancer were treated 
successfully. Interestingly 10 patients with pancreatic cancer were also successfully 
treated, with an unexpected effect that HIFU treatment alleviated pain immediately 
following treatment. 
In 2005 and 2007, 22 and 23 patients with breast cancer were treated respectively. In 
both cases treatment was successful with no severe complications. Both papers 
conclude that HIFU is a safe, effective and feasible treatment for patients with breast 
cancer, although large scale clinical trials are suggested to confirm the future role of 
HIFU treatment [19], [20]. 
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In 2008 work was carried out to determine the feasibility of using a split beam 
transducer, modified from a Sonablate 500 machine [12] to create multiple focal 
points simultaneously [21] thus reducing treatment time. This transducer was 
compared to another, single focus transducer, operating at an identical frequency. The 
transducers were concave and spherical in shape with a diameter of 5 cm, utilizing 1 
MHz frequency ultrasound for therapeutic purposes and a 10 MHz diagnostic 
transducer for imaging. To split the focus adjacent sections were driven 180 degrees 
out of phase, creating four focal points simultaneously without significant changes in 
intensity in front and behind the focal area. Although the application of these 
transducers was limited to that of hyperthermia, involving heating tissue to only a few 
degrees above body temperature for an extended period of time, the results did show 
that a split focus transducer has the benefit of reducing treatment time and producing 
similar effects, given a suitable (power) correction factor. Scanning of this split focus, in 
terms of HIFU transducers may be more complex depending on the target volume and 
shape, but nevertheless a reduction in treatment time benefits both patients and 
those administering the treatment. For this reason a split focus transducer seems 
beneficial, although more development work may be needed before clinical trials are 
undertaken using such a device. 
In 2009 a study was performed to determine the effective use of HIFU for the ablation 
of deep tumours (10 to 20 cm from the skin surface) [22]. This group, working from 
Shanghai Jiao Tong University in China developed a large scale spherical array, using 90 
circular elements with unequal spacing. The array had an effective diameter of 21 cm 
and a radius of curvature of 18 cm. This allowed the array to focus within a volume of 2 
cm x 2 cm x 3 cm at a distance of 15 to 18 cm from the back of the transducer without 
grating lobe intensity reaching the predefined unacceptable level of 15 % of the main 
lobe intensity. Outside of this volume grating lobe levels were unacceptable. Porcine 
muscle tissue was used to demonstrate the capability of the transducer successfully. 
The group also showed that two focal points could be generated simultaneously. In 
conclusion, the thermal ablation of deep tumours is theoretically possible using the 
transducer designed in this study, although it would seem more experimental work 
would be beneficial before clinical trials commence. 
18 
 
2.3: In-depth Literature Review 
As the technology for accurate and efficient use of HIFU has only become readily 
available within the last decade or so the majority of papers reviewed here were 
published in the period from 2000 to 2010. Nevertheless, there still remain papers 
published prior to 2000 that contain much relevant information and indeed some that 
date back to the early 1940s when the potential applications of HIFU were first 
considered. To give an overall view of the works reviewed to date an attempt will be 
made to order these publications chronologically, although in some cases work carried 
out by certain groups may span a number of years, such as in the case of on-going 
medical trials. In these cases relevant publications will be presented together to 
preserve the continuity of the review. Additionally the literature reviewed will be 
divided between papers relating to transducer design and acoustic field simulation and 
those relating to medical (and animal) trials. In total thirty-three separately published 
papers will be reviewed. 
2.3.1: Transducer Design & Acoustic Field Simulation 
In 1989 the Institute of Cancer Research UK, led by Gail ter Haar, published a paper 
focusing on the use of HIFU for the treatment of liver tumours [23]. In this study in 
vitro tests using excised porcine liver were carried out. The equipment used was of 
particular interest as an acoustic (Perspex) lens system was utilised, alongside a 10 cm 
diameter piezoelectric (PZT4) disc transducer, to create lesions at a focal distance of 14 
cm with all equipment (and experimental material) being mounted within a degassed 
water bath. The focal region was ellipsoid in shape and measured approximately 1.5 
cm (length) and 1.5 mm (centre diameter) and could be said to be similar in size to a 
grain of rice. Focal region shape and placement were the objects of this study, and it 
was found that more energy is required to create a lesion of comparable size at deeper 
target depths. This energy can be obtained by either increasing exposure time or by 
increasing the intensity of the incident ultrasound. When exposure time is increased 
with intensity held constant the resulting lesion becomes larger. This continues until 
the lesion increases to a size at which additional exposure time does not create a 
larger legion, seen as a plateau in the graph of exposure time against lesion volume. 
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Increasing the ultrasonic intensity (by altering the applied voltage to the transducer) 
also increases the lesion size observed and additionally causes the lesion to be formed 
nearer to the surface of the tissue, closer to the transducer. This is thought to be 
caused by non-linear distortion of the ultrasound, causing part of the high frequency 
components to be absorbed prior to the focal plane being reached. Also worth noting 
here is the use of ultrasonic imaging to follow the lesion formation in real-time, as 
lesion tissue shows up as a highly echogenic area on ultrasound images although it is 
acknowledged that more detailed studies are required to correlate these areas with 
realized tissue damage, which would hence allow for more accurate treatment and 
treatment planning. 
In 1993 a paper produced by INSERM, France and authored by J.Y. Chapelon was 
published in the IEEE Ultrasonics Symposium [24]. This publication describes the 
demonstration of an annular array type transducer using electronic focusing, a 
significant improvement over using fixed focus transducers. The spherically curved 
annular array was truncated by two parallel planes to facilitate use via the rectal 
cavity, for the treatment of prostate cancer. Simulations were performed and acoustic 
pressure fields were calculated to allow relevant design criteria to be determined. An 
ultrasound guided prototype was constructed, and the piezoelectric surface was 
divided into 7 rings operating at a frequency of 2 MHz. This was chosen to minimize 
the total number of elements and hence reduce the complexity of the driving 
electronics. Simulation was performed using the impulse response method [25], using 
a modified impulse response evaluated for a curved strip transducer in a separate 
paper [26]. Following simulation the array design parameters were decided. The 
frequency was chosen by considering desired focal area, target depth and optimal heat 
deposition. In this case frequency was maximised to allow increased heat deposition 
and better control over ablation (as attenuation increases with frequency [27]) and to 
avoid the effects of cavitation which occurs above a threshold acoustic pressure [4]. 
The aperture size was selected according to the power density tolerated by the system 
(approximately 25 W/cm2) and as this device was designed for transrectal application, 
the annular transducer was truncated by two parallel planes to reduce size in one 
dimension thus decreasing patient discomfort. The geometric focal length is 
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determined by the radius of curvature of the shell and is defined somewhere in the 
mid-range between the minimum and maximum focal lengths of the array when using 
electronic focusing. The number of elements and the element arrangement were 
chosen to maximise element area, thus reducing element crosstalk, minimising the 
number of elements and hence reducing the number of inter-element gaps, which in 
turn allows for an increased sensitivity of the array while keeping grating lobes at an 
acceptable level. Also noted is that, in line with basic ultrasound theory, grating lobes 
can be avoided (for any focal range) if individual elements are less than a wavelength 
wide. Consequently, two probes were fabricated (Imasonic, France), both air-backed 
with a quarter wave matching plate. The final dimensions were a diameter of 50 mm, 
truncated at 31 mm (outer four elements) with inter-element gaps of 0.3 mm. The 
power was provided by an eight channel amplifier with variable power from 5 to 50 W, 
used in conjunction with a 6-bit delay line module with a resolution of 50 ns. The 
driving electronics were controlled using a 486 personal computer (PC). Once 
manufactured, the transducer was tested using a hydrophone. These tests showed a 
very close correlation between simulated and practically obtained results, with small 
discrepancies thought to be caused by non-linear effects, which were not accounted 
for in the simulation. Additionally the transducer was shown to produce lesions in 
bovine liver after 25 exposures of four seconds each, at an intensity of 1000 W/cm². 
Also published in the 1993 IEEE Ultrasonics Symposium was a paper from the Intec 
Research Company/Focus Surgery based in California (USA). In this paper quantitative 
Schlieren imaging [28] was used to non-destructively test the acoustic field produced 
in a water bath by a transducer [29]. The resulting image was combined with an 
attenuation function to give an approximation of the beam profile in 3D. The dose rate 
of therapy is defined (power deposited per unit mass) by assuming linear behaviour 
and a non-temperature dependent dose rate. Several factors, useful when comparing 
therapeutic transducers are also given. These include the peak-to-skin dose ratio (ratio 
of dose at focus to elsewhere in tissue, especially important at the skin interface) the 
total acoustic power (TAP) at focus (fraction of power at focus compared to that 
delivered by the transducer, at the transducer surface) and various axial profiles 
(acoustic intensity along the beam path). Although numerous assumptions and 
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emissions have been made in order to simulate the acoustic fields, the work presented 
in 1993 is still largely relevant and accurate. In addition a number of equations are 
derived concerning the expected focal spot size (related to the transducer size and 
frequency used) and the optimum frequency to give a maximum net acoustic gain. In 
summary, although dated, this paper contains valuable information on basic 
transducer characterisation, useful when approximations are necessary. 
One year later, the Intec Research Company/Focus Surgery (CA, US) published another 
paper in the 1994 IEEEE Ultrasonics Symposium. In this publication the design of an 
annular phased array for therapeutic treatment of deep tissue targets, in the range 6 
to 10 cm, is described [27]. The annular array was designed with a natural focus (radius 
of curvature of the array) of 10 cm, operating at 1.25 MHz. This frequency was chosen 
using the method presented in a separate publication [29]. The ‘f-number’ or ratio of 
aperture to focal length [31] of the array was set to unity to allow a large focus to skin 
dose ratio. Instead of using the ‘equal area element’ approach, commonly used in the 
design of annular arrays, here the smallest number of elements (advantageous due to 
reducing the complexity of driving electronics) required for the defined focal range is 
given when their ‘weighted mean radii correspond to equal phase shifts’. It so happens 
that in this case the resulting elements are very close to being equal in area, although 
this is only true due to the specific dimensions of transducer, and this may not hold for 
non-identical arrays. This design resulted in ten elements that differ from their 
neighbours at most by 90⁰ (a quarter wavelength). To simulate the designed array a 
Rayleigh-Sommerfeld integration was performed. The results of this simulation were 
eventually compared to Schlieren images of the manufactured transducer, which 
showed actual focal distances to be within 2 mm of those simulated, although cross-
talk between elements remained - indicating an area that could be improved on. 
Moving forward a few years to 1999 INSERM (France) published a paper on the use of 
1.5D phased arrays for HIFU applications in the 1999 IEEE Ultrasonics Symposium. The 
array was designed with the treatment of prostate cancer in mind and as such has the 
ability to electronically focus the produced ultrasound beam in a 2 by 2 cm area 
centred at the natural focus of the spherically curved transducer [32]. The feature that 
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sets this transducer apart from similar arrays is that annular elements were not used. 
Instead use was made of lateral (parallel) strips each containing a number of elements. 
From simulation the number of strips (‘n’) and the number of elements on each strip 
(‘m’) were decided. This lead to n=5 and m=42 being used with the central strip having 
width 11 mm and lateral strips 5.5 mm, the latter being connected in pairs about the 
central strip to simplify driving electronics. This resulted in a total of 126 separately 
driven elements, designed such that all have a common, equal area. The array was 
built to be compatible with existing apparatus (Ablatherm - EDAP Technomed, France) 
for transrectal use and as such had a 54 mm diameter shell, truncated at 36 mm with a 
focal length of 40 mm. The material used was 1-3 piezocomposite (Imasonic, France 
[33]) driven at 2.5 MHz, with a quarter-wavelength matching layer and air backing. The 
efficiency of the produced array was found to be approximately 40 % when using a 
bandwidth of 1 MHz (2 – 3 MHz), a reduction from the 75 % obtained using the same 
material in a single element transducer. By comparing simulated to realized results, it 
was shown that a phase resolution inferior to one tenth of the signal period causes the 
beam focusing to deteriorate significantly. Phase resolutions more accurate than one 
tenth signal period were found to give no improvement and so a phase resolution of 
one tenth was chosen as the most practical. One final point worth noting here is that, 
as the developed transducer had a large bandwidth, it is possible that it could be used 
in a dual-mode application, providing imaging and treatment modalities using the 
same device. This is an interesting characteristic that has the potential benefit of a 
single device capable of performing the function of two separate machines: diagnostic 
and therapeutic. 
Finite Element Analysis (FEA) is a commonly used tool to simulate acoustic fields 
caused by piezoelectric sources. One such study, published in the 2000 IEEE 
Ultrasonics, Ferroelectrics and Frequency control conference proceedings, used FEA 
(Boundary Element Method, BEM) on a 1D linear phased (diagnostic) transducer to 
investigate (numerically) inter-element crosstalk, effects of sub-dicing elements and 
directivity patterns [34]. The latter it was found heavily depends on transducer size 
and interestingly on the materials used to ‘fill’ the kerf (spaces between elements) 
while sub-dicing can reduce lateral modes which are detrimental to the transducer’s 
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operation. Using a ‘lossy’ (soft material with high mechanical damping) kerf filler can 
also reduce lateral modes and sub-dicing can be used to ‘artificially’ alter the ratio of 
element height to width (aspect ratio) to a value of two or more, causing unwanted 
(lateral) modes to be pushed to higher frequencies. Reducing element crosstalk is 
especially important for phased arrays as it will adversely affect the directivity pattern 
and the sensitivity of the array. The software package ANSYS [35] was used, and care 
was taken to ensure at least 8 (finite) elements per wavelength were present in the 
mesh used (reduced error to less than 1 %). A linear phased array was simulated with a 
steering angle of 54⁰, operating at 2.5 MHz. The kerf between elements was 0.1 mm, 
with element width of 0.3 mm (approximately equal to half a wavelength in water, 
hence no grating lobes [36]). The results were checked using an analytical solution of 
the Helmholtz integral for two simple cases, which showed a good correlation to the 
FEA simulations. It was shown that to reduce crosstalk and lateral modes of vibration 
all matching layers (and to some extent the backing layers) should be sub-diced. Sub-
dicing of the elements alone is not sufficient to achieve acoustic isolation and as a rule, 
crosstalk between neighbouring elements should be less than -30 dB to avoid artefacts 
in acquired images. Also shown in this paper is the effect of element diameter on the 
directivity pattern. It is shown graphically that the directivity of a 0.5 mm diameter 
(less than one wavelength) element is much broader than that from a 5 mm diameter 
element (more than one wavelength) when both are operating at 1.25 MHz 
(wavelength 1.2 mm) although the latter case shows small side lobes around the main 
lobe (the 0.5 mm directivity pattern is almost semi-circular, comprising only a single 
lobe). 
Focus Surgery (Indianapolis, US) in conjunction with Kitasato University (Japan) and the 
Hitachi Ltd. Central Research Laboratory (Japan) produced a publication in 2001 
regarding the use of split-beam transducers for the transrectal treatment of prostate 
cancer. Six transducers were compared using simulation with the goal of increasing the 
volume of tissue treated at one time. The objective was to reduce the overall 
treatment time and hence reduce costs and decrease patient discomfort [37]. Final 
lesion volume, focal and rectal wall temperatures, sonication time and TAP were used 
as the criteria for comparison. The Sonablate 500 (Focus Surgery) transrectal probe 
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was used to mount and control the different transducer configurations, which were 
subsequently tested on turkey breast tissue held within a degassed water bath. The 
majority of the configurations involved dividing the transducer surface into four 
quadrants, with controllable phase (90⁰ resolution) for each. Results showed that 
overall treatment times could be reduced by a factor of 1.85, compared to the control, 
a single element transducer with similar dimensions. Although encouraging results 
were achieved in this study, in the case of breast cancer treatment only a relatively 
small volume of tissue is sought to be ablated, whereas the entire prostate gland is 
commonly ablated in prostate cancer treatments. In the case of breast cancer a larger 
focal volume, as produced by the split-beam transducers, is not necessarily 
advantageous, as a smaller focal volume would allow more accurate ablation control. 
For this reason it may be assumed that split-beam transducers, although very useful in 
other applications, are not particularly suitable for the treatment of breast cancer, at 
least in early diagnosed cases (involving smaller tumour volumes). 
Also in 2001 a series of papers and articles were published by the Department of 
Physics (Royal Marsden Hospital/Institute of Cancer Research, UK) authored by Gail ter 
Haar. One such article presents a history of HIFU and an in depth description of the 
effect on tissue and relevant parameters to consider when designing and using a HIFU 
system [4]. Of particular interest here were two equations; one to estimate tissue 
heating due to attenuation and the other to quantify the ‘thermal dose’ so as to 
compare different treatment regimes. The latter outputs a time (in seconds) 
equivalent to the case that the tissue was held at 43 ⁰C (for example 56 ⁰C for 1 to 2 s 
is equivalent to 43 ⁰C for 240 mins). The trials described show the ability of HIFU to 
seal blood or occlude blood vessels, which could potentially lead to tumour shrinkage 
without ablating the entire volume. This could be used as a standalone procedure or 
indeed as a pre-treatment to tumour ablation, thus reducing treatment times and 
therefore increasing the viability of HIFU as a cancer therapy. Also of interest is the 
suggestion that Reflex Transmission Imaging (RTI) or Elastography could be used to 
locate ablated volumes, thus improving treatment accuracy over (USgFUS) which 
encounters problems when visualising ablated tissue. Although this technology 
(Elastography) would be greatly beneficial when producing a lower cost FUS system (as 
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compared to an MRgFUS system) its widespread use has not yet been accepted, and it 
remains an interesting developing technology. In another publication it is stated that 
lesion size is dependent on frequency used, with smaller lesions being created using 
higher frequencies [38]. For example a 10 cm transducer with a focal length of 14 cm 
driven at 1.7 MHz will produce a lesion approximately 1.5 mm in diameter and 15 mm 
in length (ellipsoid). Also suggested is that the effect of heat removal by blood 
perfusion during FUS can be largely ignored if exposures with durations of less than 
three seconds are used [39]. Another interesting point made was that (assuming a 
tissue attenuation of 0.7 dB/cm/MHz) the optimum frequency for HIFU treatments is 
one that gives a total attenuation through the tissue (skin surface to focal point) of 10 
dB [40]. In a further publication by members of the same group, an in-depth look into 
the histological appearance of tissue damage caused by HIFU treatment is presented 
[41]. Also included is a description of the applications of HIFU in terms of which tissues 
can be treated, along with a brief history of HIFU clinical trials up to the point of 
publication and a comparison with other thermal ablation techniques. Although 
relevant and useful, this information will not be presented here and readers are 
advised to refer to the relevant publication [41] if further details are sought. 
Although not directly related to HIFU a paper on the design of a novel ‘2D’ phased 
array for hyperthermia cancer therapy was published (2001). In contrast to HIFU 
applications, hyperthermia involves prolonged, moderate heating typically for 
durations of an hour or more, and transducers for hyperthermia generally utilise lower 
frequencies and are not necessarily focused. This study involves the computer 
simulation of three transducer configurations, one utilising square elements and the 
other two circular elements of differing geometries. The resulting pressure fields from 
the arrays were simulated using the pseudo-inverse method [42] with the equations 
used and a simplified process of derivation being presented. The results of these 
simulation studies showed arrays with circular elements to be superior to those with 
square elements. Indeed if an equal intensity distribution pattern is input, the 
simulation shows that the necessary number of circular elements is smaller and the 
intensity gain greater (by 1 dB) than that obtained using square elements, in addition 
to much smaller grating lobes being generated (30 dB reduction). Although the 
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information presented in this publication pertains to hyperthermia cancer treatment, 
much of the transducer array design work is relevant to HIFU transducer design, 
especially when attempting to reduce grating lobes which can cause undesirable 
heating effects if present in FUS applications. 
Imasonic (France) published a paper on piezocomposite materials developed for high 
performance transducers in 2002 [33]. These materials offer several advantages over 
standard piezoelectric materials. The generation of high power densities and high 
efficiencies of the composites allow transducer size to be minimized. The composites 
consist of rod shaped piezoceramics embedded in a matrix of polymer material, 
commonly epoxy. This allows the effect of lateral modes, and indeed of element cross 
talk to be greatly reduced, the former allowing an increased flexibility of the aspect 
ratio (element thickness to width) which has typically to be kept above two. In addition 
reducing element crosstalk allows more accurate beam control and hence a higher 
quality transducer. The use of a piezocomposite material also allows for a more 
mechanically robust transducer, less affected by small shocks than purely piezoceramic 
transducers. Two piezocomposites are described, named ‘HI-1’ and ‘HI-2’. The former 
has efficiency between 60 % and 70 %, can operate at frequencies up to 10 MHz, is air 
backed and can produce a maximum acoustic power output of 10 W/cm2. ‘HI-2’ has a 
slightly lower efficiency (40 % to 60 %), can operate up to 5 MHz, has solid backing 
and, most importantly, has a maximum acoustic power output of 30 W/cm2. This latter 
material has a very high acoustic power output compared to that of piezoceramic 
transducers, thus can allow smaller sized arrays equally capable of therapy as their 
larger, non-composite counterparts. The wide bandwidth, especially of ‘HI-1’ opens 
the path to the fabrication of dual-mode transducers and has been previously 
investigated [43] allowing images to be obtained from an array primarily designed for 
therapy. In conclusion the piezocomposites described here provide a much more 
attractive option than generic piezoceramics. Modern transducers utilise these 
advantages and use piezocomposites in their construction. It is recommended that 
Imasonic ‘HI-2’ be used where space is a concern, such as in the case of the HIFU/EIM 
project for the present research. This will be covered in more detail in the relevant 
following chapters. 
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An interesting paper was published in 2003, at the Third International Symposium on 
Therapeutic Ultrasound. This paper documents the design and characterization of four 
transrectal phased array transducers for HIFU treatment of the prostate [44]. Three of 
the transducers were spherically sectioned annular arrays, truncated by two parallel 
planes as is commonly used for transrectal devices. All were based on the Sonablate 
500 (Focus Surgery, US). These three arrays vary in size, operating frequency and 
piezoelectric materials used and were designed to ablate at a focal depth range of 25 
mm to 45 mm. The arrays were fabricated and tested, all giving satisfactory results. A 
fourth array is also described in this paper. This array, although not fabricated, 
suggests an advantage over the other three due to the proposed ability to focus not 
only in the depth direction, but also in the longitudinal direction. Use of an array such 
as this would eliminate the need for the linear displacement of a transrectal 
transducer, replacing physical displacement with an electronic focal range of -20 to 
+20 mm (longitude) and 25 mm to 45 mm (depth). This ‘concept’ array measures 80 
mm by 22 mm, operates at 4 MHz and has a cylindrical section (curvilinear) type shape. 
Six element rows are present, each with a large number of small elements, allowing 
electronic focusing in the depth direction. Use of sub-apertures allows steering in the 
longitudinal direction. A further feature of interest concerning this transducer is that it 
is capable of performing imaging as well as therapy, thus is another example of a ‘dual-
mode’ transducer. This is achieved by using the centre two rows of the array to acquire 
1D radio frequency (RF)-lines, via electronically scanning a small sub-aperture. These 
1D lines are then combined to give a 2D image. In conclusion this type of array offers a 
large advantage over other transrectal transducers, and the ability to use imaging in 
addition to therapy makes the design an attractive option for limited space 
applications. It is yet to be seen however if the images obtained from the transducer 
are of sufficient quality to be feasibly used to guide surgery, as the work was limited to 
simulation. Regardless, it is this author’s opinion that the described array represents a 
vast improvement over similar transducers, with the ability to act in both imaging and 
therapeutic modalities, likely representing the ‘next generation’ of HIFU arrays for 
focused ultrasound surgery. 
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In 2004 a paper was published by the Pennsylvania State University in the International 
Journal of Hyperthermia. This paper describes the design, simulation and ex vivo 
testing of a two-dimensional MRI compatible phased array for the ablation of benign 
prostatic hyperplasia [45]. The array was fabricated using 1.79 mm thick piezo-material 
PZT-8 (high power) with a 14⁰ steering angle (transverse and longitudinal) and natural 
focus at 40 mm from the transducer when operating at 1.2 MHz. To simulate, the array 
was modelled as a 64 element (8 by 8) rectangle measuring 20 mm by 20 mm. Initially 
the elements measured 2.5 mm by 2.5 mm (diced 70 % through material, with kerf 96 
µm) but this design was found to produce -3.47 dB grating lobes. This was reduced to -
8.24 dB by using tapered elements to remove periodicity [46] the central elements 
being largest and tapering towards all edges (2 mm, 2.33 mm, 2.66 mm, 3 mm, 3 mm, 
2.66 mm, 2.33 mm, 2 mm). A conductive matching layer was used to allow maximum 
power transfer and had acoustic impedance equal to the geometric mean of that of 
PZT-8 and tissue. For simulation purposes the phase of each element was determined 
by measuring the path between each element and the focus, and comparing this 
distance against the path between the centre of the array and the focus. The 
calculated phase of each element was then used to calculate the pressure at each 
point (x,y,z) in the field using Huygen’s principle (see [45] for equation(s) used). Using 
the pressure field the acoustic intensity at all points was calculated. The intensity was 
then used to calculate the power deposited at each point, and this power was used as 
the heat input term in the BHTE to approximate the expected temperature rise in 
tissue caused by the incident ultrasound. For comparison the resultant pressure field 
from the constructed transducer was measured using a hydrophone. To test the 
ablation ability of the transducer ex vivo tests were performed on porcine liver held in 
a water bath. For these tests each element was driven at an average electrical power 
of 8 W, for sonications lasting 10 s, 12 s, and 20 s, at distances between 30 mm and 40 
mm from the transducer. These sonications resulted in lesions 2 mm, 2.9 mm and 4 
mm (diameter) respectively. Interestingly the array was able to produce a single large 
lesion by phasing elements to create four individual foci that are close enough to each 
other such that a single, larger lesion is formed. Sonication was set to 25 s to allow for 
the additional power required, and the focal depth was set to 30 mm. The resultant 
lesion was approximately 4 mm in diameter. Additionally the phasing of elements 
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could generate a heating regime that could reduce inter-sonication cooling time by 
sonicating non-neighbouring elements in a predetermined pattern. One final point 
worth noting here is that the use of piezocomposites could address the low width to 
thickness ratio used in this study. This would improve results as the effect of lateral 
modes on the ultrasound propagation would be reduced, hence the overall efficiency 
of the array would be improved. 
In 2006 a novel HIFU transducer was modelled and fabricated, allowing ‘rib-sparing’ by 
switching off certain elements of the transducer. The design of this device was 
described in a paper published in the 5th International Symposium on Therapeutic 
Ultrasound (2006). The transducer itself was built in collaboration with Imasonic 
(France) and consisted of a spherical (11 cm diameter, 15 cm radius of curvature) shell 
transducer with 10 lateral strip elements operating at 1.7 MHz [47]. This is unusual as 
spherical section arrays commonly have ring-shaped electrodes as opposed to the strip 
shapes used here. It was shown that by phasing the excitation of these elements the 
focus could be displaced +/- 4 mm from the beam axis. Larger displacements however 
caused secondary peaks to become too large, thus causing an undesirable heating 
pattern. The focus could also be shifted by up to 10 mm axially, but both this, and the 
radial focusing caused the focal area to widen. Above 5 mm and 10 mm (radial and 
axial steering) respectively caused the focal peak intensity to be reduced by 50 % or 
more. Beam broadening was achieved by focusing each side (5 elements) to the 
opposing side, thus allowing a larger focal spot to be created. This would therefore 
allow treatments to be completed more rapidly while covering the same target 
volume, but does however increase the power required by at least 50 %, which may 
not be possible with smaller transducers where overall size limits the maximum 
producible acoustic power. 
Also in 2006 a paper was published describing the development of an annular phased 
array for the ablation of uterine fibroids with a focal range from 30 to 60 mm [48]. 
Sonications at depths of 30 mm (acoustic intensity 4100 W/cm2) and 60 mm (acoustic 
intensity 6100 W/cm2) lasted 15 s, the latter (deeper) focus producing lesions at least 
63 % larger than the former (more shallow) focus. Also sonications with focal spots 
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that began further from the transducer produce longer lesions than those that were 
targeted nearer to the transducer. The transducer array operated at 3 MHz and 
comprised 11 elements all made from 1-3 piezocomposite (Imasonic, France [33]) with 
a natural focus at 50 mm. The element areas were all equal to 105 mm2 with a gap of 
0.3 mm between neighbouring elements. The overall transducer shape was that of a 
typical transrectal device (spherical section truncated by two parallel planes) and 
measured approximately 75 mm by 35 mm. A clamp held an imaging probe to the 
therapeutic probe and a polyurethane ‘pillow’ was used, with a pump, to circulate 
water around the HIFU transducer to ensure the temperature remained below 40 ⁰C. 
Using a computer controlled driving system the phase of signals applied to all elements 
were calculated, with the total electrical power delivered to the device being varied 
between 0 and 165 W. Using this system the sonication time could be controlled by 
entering values on the computer screen user interface. Interestingly a novel imaging 
algorithm was used to allow improved visualisation during the HIFU process. This 
involved sampling the ultrasound images and interleaving this sampling with the 
sonication periods. The resultant ultrasound images (during HIFU treatment) were 
interference free. To test the effectiveness of the device lesions were created in 
excised porcine liver, following characterisation using a hydrophone. The results of 
these experiments showed that larger lesions form when higher electrical power was 
applied to the transducer, and this effect increased with increasing focal depth. Also 
the lesion position shifted slightly from the expected location when target depth was 
greater than 35 mm, with these shifts increasing in magnitude when higher powers 
were used. This summarises the main findings of the paper. As this paper includes a 
novel idea and also much in depth results data it is recommended that the interested 
reader refer to the original publication [48] for more details. 
Presented in another paper published in 2006 was a modified method for simulating 
the pressure field produced by a 2D square phased array. The aim of this study was to 
analyse the feasibility of using a square (NxN) phased HIFU array for neurosurgery 
applications. Although different methods exist, Huygen’s principle is used here taking 
into account ultrasonic propagation through two homogenous media (water and brain 
tissue). This method is presented for a 2D and 3D geometry and an expression 
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including the transmission coefficient is derived, thus allowing the effect of 
attenuation to be included in the model. The final simulation used the following 
parameters. There were 25 (5 by 5) square elements, each having area 4 mm x 4 mm 
with a 0.5 mm gap between neighbouring elements. The transducer was driven at 1.6 
MHz at a total acoustic power of 120 W. The density and sound velocity of water and 
brain were taken to be 1000 kg/m3, 1480 m/s and 1030 kg/m3, 1541 m/s respectively. 
The corresponding attenuation coefficients were (water) 0.023 Np/m MHz and (brain) 
5 Np/m MHz. Using these parameters the operation of the transducer was simulated. 
The result was a maximum intensity of 1.5 MW/m2, and the resulting plots, focused at 
(0, 0, 50 mm) showed large grating lobes. The model was then modified to include 
more elements (10 by 10) of a smaller size (approximately 1 - 1.5 mm2). When focusing 
at exactly the same point there were almost no grating lobes present, although the 
maximum intensity was reduced by a factor of approximately three, which is to be 
expected as the overall dimensions, and therefore surface area (and maximum applied 
electrical power) were less than in the previous model. In conclusion it was shown that 
it is possible to obtain focused beams by utilising phasing of elements in an N by N 
square array. 
One year later, in 2007, a paper describing a novel transducer for the ablation of larger 
volumes was published. The transducer was designed to reduce treatment times by 
increasing the focal zone size [49]. This is achieved using a toric transducer shape 
comprising eight (segmented) elements. In operation, each sector performs a 5 s 
sonication, followed by the next sector. This resulted in a conic focal zone, 
approximately 9 cm3 (average diameter 2 cm) in volume after a total of 40 s treatment 
time (8 sectors activated for 5 s each). The transducer operated at 3 MHz with a focus 
at 70 mm and a 7.5 MHz imaging probe was located in the central aperture of the 
array, coaxial to the HIFU beam path. When used during surgery, a polyurethane 
envelope surrounds the transducer, through which 0.3 L/min of degassed water at 15 
⁰C is passed for cooling purposes. To assess the transducer operation in vivo 
experiments were performed on healthy porcine liver following a laparotomy 
(abdominal incision). The subjects were anesthetised and exposures were performed 
using an acoustic power of 60 W with the HIFU transducer being held by hand. Four 
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days post treatment the subjects were euthanized, and the liver was sliced to allow 
inspection of lesions and a histological analysis to be performed. In conclusion, 
different to other transducers the transducer described in this paper allows the typical 
waiting times between sonications (to allow cooling) to be removed completely. 
Instead once one sector has completed sonication (5 s) the next sector is activated 
immediately. It has therefore been shown that a large reduction in treatment time 
(one of the potential drawbacks of widespread use of FUS) has been achieved, 
although this will be mostly beneficial to applications in which large volumes are to 
ablated, such as the prostate, and less so to those requiring very precise control of the 
focal spot size and position. 
In the same year another paper containing much useful information on transducer 
design, was published in the 6th International Symposium on Therapeutic Ultrasound 
[50]. The transducer was designed to be capable of ‘rib-sparing’ by switching off 
certain elements when sonicating close to or around the ribs. Called the ‘Teleson II’ the 
transducer design was based on the ‘Teleson I’ produced by the same group, except in 
the earlier model the user had to switch between imaging and therapeutic arrays 
during treatment. In the Teleson II the power amplifier has the ability to perform rapid 
switching and can successfully interleave the HIFU and the imaging wave propagation. 
Also included in the Teleson II are some new features, including controlled cavitation 
and radiation force elastography. The latter utilises a pulse of HIFU to displace the 
tissue a very small amount such that a ‘tissue stiffness’ image can be produced 
allowing accurate visualisation of the lesion location which, using typical ultrasound 
imaging, is rather difficult. Control software was developed to allow control via a 
graphical user interface (GUI). This software was capable of automated beam plotting, 
automated temperature mapping and HIFU delivery control, which all control a 
motorised gantry allowing movement in three dimensions. The HIFU delivery control 
can be adjusted to create single lesions, arrays of lesions, straight line tracks, arrays of 
tracks and even non-linear tracks such as circles and 3D spirals. It was shown that using 
a 2D spiral pattern the same amount of lesion volume could be created in under three 
minutes compared to the 30 minutes or more it would take if using single lesions. 
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Cavitation, due to the propagation of ultrasound through tissue, is a phenomenon that 
has the potential to greatly increase the efficiency of HIFU treatments, and indeed 
cavitation typically precedes thermal effects (with results appearing within one 
acoustic cycle [51]) although its effects can be largely unpredictable. In a paper 
published in 2008, experiments were performed to evaluate the use of cavitation for 
predictable thermal ablation [52]. This had been achieved in the past by using pulsed 
HIFU (PHIFU), high focal intensities and short duty cycles (one cycle being a short 
sonication followed by a long pause) [53], [54]. Using these previous studies as 
guidelines, a successful preliminary study showed non-thermal ablation using PHIFU 
exposures of frequency 0.87 MHz, a pulse repetition frequency (PRF) of 100 Hz, a duty 
cycle of 15 % and a peak (spatial) intensity of 5900 W/cm2 [55]. Previous studies also 
found that ultrasound contrast agent (UCA) can enhance the effects of cavitation and 
so for the main experiments the same parameters were used (at a focal length of 150 
mm) with the addition of UCA. The test subjects were 20 rabbits, divided into a control 
(10) and a PHIFU group (10) who had been inoculated with VX2 tumour cells 2-3 weeks 
prior to PHIFU treatment. Twenty-four hours following surgery the subjects were 
sacrificed and an immunohistochemical examination was performed showing that 
PHIFU with UCA can inhibit tumour cell proliferation and cause cell apoptosis. 
Interestingly it is stated that “non-thermal effects (mechanical and cavitational) will 
occur” if focal intensity is greater than 1500 W/cm2. Although the exact boundary is 
dependent on other factors as well, this is an interesting guideline figure to consider 
when designing a transducer for thermal ablation however should not be considered 
an absolute value. 
One type of transducer that does not appear in many papers is the cylindrical array 
type transducer. In a paper published, again, in 2008 a 1.5D cylindrical phased array 
was developed and tested. Following a study concerning dimension optimisation, the 
aperture of the array was chosen and measured 150 mm (azimuth) by 120 mm 
(elevation) with a radius of curvature (and natural focus) of 150 mm. The transducer 
was fabricated from PZT-4 1-3 composites comprising 512 (64 in azimuth direction by 8 
in elevation direction) elements operating at 0.9 MHz [56]. The design was then 
simulated using the Field II software [57] and demonstrated the ability to focus from 
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145 mm to 175 mm and -15 mm to +15 mm in the depth and azimuth directions 
respectively. As a precaution a surface acoustic intensity of 12.6 W/cm2 was applied to 
a sample piece of PZT-4 (22 elements) which showed no appreciable temperature rise 
within a period of 50 minutes, indicating the feasibility of using such an intensity for 
long treatments. Interestingly it was found that using a water bag could extend the 
dynamic focusing range by 2 cm, in the depth direction. 
Constant wave (CW) HIFU procedures, given suitable parameters, essentially ‘fix’ tissue 
in situ. PHIFU exposures however, as has previously been stated, are more likely to 
give rise to cavitation when propagated through tissue. This can be utilised for more 
efficient tissue destruction and is also thought to be useful in the enhancement of drug 
delivery via altering tissue permeability, although accurate control is required for both 
these applications. One concern of using PHIFU is the possibility that it may 
inadvertently increase the metastatic burden by facilitating dissemination of tumour 
cells. This was investigated in a 2008 paper in which lung cancer in a murine model was 
used to evaluate the extent, if any, of the exacerbation of metastases cause by PHIFU 
exposures [58]. The exposures were performed using a modified Sonablate 500 (Focus 
Surgery, US) with a 5 cm diameter, 4cm focal length concave spherical transducer 
operating at 1 MHz. The parameter used for exposures were a TAP of 40 W, an 
intensity (spatial average) of 2685 W/cm2, a PRF of 1 Hz and duty cycle of 5 % with 100 
pulses at each point. The average treatment time was 15 minutes. Mice were split into 
a control and a PHIFU group, the control group given ‘sham’ exposures of 0 W, but 
otherwise treated identically to the PHIFU group. Twenty four hours following 
treatment subjects were sacrificed and a histological examination was performed. 
Samples were analysed using a custom built MATLAB image processing code to 
quantify the extent of metastases in each case by calculating the metastatic area 
fraction of the lung in question. In conclusion the results showed that although PHIFU 
can increase metastases, the results between the control and PHIFU group were ‘not 
statistically different’ using a paired student t-test. It is for this reason, along with the 
unpredictable nature of its action that until further evidence is presented cavitation 
should be avoided, at least in this author’s opinion. 
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One particular area of interest in the development of HIFU for surgical use is the case 
of the ‘dual-mode’ transducer. As previously mentioned this type of transducer uses 
the same array for therapy and imaging, the imaging elements generally being located 
centrally and coaxially to the therapeutic elements, thus allowing the same acoustic 
path to be followed. A paper published in 2009 describes an investigation into using 
such an array for the simultaneous diagnosis and therapy of prostate cancer, in real 
time [59]. Typically dual mode transducers operate in pulsed wave (PW) operation, 
thus allowing signal timing to be utilised to interleave imaging with HIFU exposures, 
hence avoiding unwanted interference. In contrast the transducer described has been 
designed to additionally allow real-time imaging during CW operation. This was 
achieved using a Barker code implementation with various cycles-per-bit settings for 
the coded excitation of the imaging elements, thus when the returning signal (coded 
excitation plus interference from HIFU) was received the coded signal could be 
extracted (for more details please see [59]). The integrated multi-functional confocal 
phased array (IMCPA) had a cylindrical section shape and comprised three rows of 
phased elements, the centre (6 MHz, with a -6 dB fractional bandwidth of 50 %) for 
imaging and the outer two (4 MHz, with a -6 dB fractional bandwidth of 30 %) for 
therapy. The imaging array had 128 elements with a 0.73 wavelength (188 µm) pitch, 
25 µm inter-element spacing (kerf), 8 mm height and was fabricated from PZT-5H 
piezocomposite. The therapeutic arrays had 0.5 wavelength pitch (also 188 µm), 25 µm 
kerf and 15 mm height, were fabricated from PZT-4/PZT-8 piezocomposite, had a 
natural focus at 40 mm and were capable of generating a focal intensity of 2000 
W/cm2. In addition the overall size of the transducer was 24mm by 28 mm, thus 
facilitating use via the rectal canal. The transducer was simulated using the Field II 
program [57]. In conclusion imaging was made possible due to the use of coded 
excitation, although the images received were not completely interference free. It is 
suggested that the additional use of a notch filter could improve this, but until there is 
a broader understanding on how to implement these filters, this type of transducer 
may overcomplicate applications for which a simpler, single-mode transducer is more 
suitable. 
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The surgical resection of tumours deep within a tissue is only feasible in a low 
percentage of cases, as access to the tumour maybe restricted due to overlying tissues 
and in some cases organs. FUS offers a practical alternative to open surgery for the 
treatment of these types of tumours, and one such transducer was designed and 
described in a paper published in 2009. In this study the designed transducer was of 
spherical section (bowl shape) with diameter 21 cm and radius of curvature of 18 cm. 
The transducer comprised 90 circular PZT-8 elements, each with diameter 1.4 cm and 
thickness 0.2 cm, arranged into six rings, with all elements being driven at a frequency 
of 1 MHz. All elements were mounted onto the shell at tangents to the element 
centres. The transducer was designed to be able to electronically focus with a 3D 
volume (2 cm by 2 cm by 3 cm), thus is termed a 2.5D transducer. Previous arrays 
similar to that described were designed with large numbers of elements, typically over 
200 [60]. As element size is inversely proportional to frequency, small elements used in 
conjunction with high frequencies would make the required target depth very difficult 
to achieve. Therefore, provided that the target depth can be achieved, the element 
number should be minimized, and the elements themselves must not be excessively 
small. With this in mind the element number was kept below 100. The f-number (ratio 
of focal length to aperture) was set to unity to minimize unwanted heating in the near 
field (pre-focal volume). As has been previously stated, the ratio of inter-element 
spacing to the wavelength should be kept as low as possible to avoid the presence of 
grating lobes. In contrast however the aperture of the array should be maximised to 
increase the focal steering range. Eventually it was decided to use a large array with 
unequal element spacing to reduce grating lobes [61] and as such the elements were 
arranged in rings, with the first elements in each ring at a different angle (to the x-axis) 
meaning varying distances between elements in every two neighbouring rings. The 
vertical distance between elements in neighbouring rings was also varied. The electric 
power provided to the transducer (for simulation) was approximately 840 W, with a 
(TAP) output of 540 W, or 6 W per element. The operation of the transducer was 
simulated using the inverse method [61] to calculate element phase and amplitude of 
signals, and the point source method [62] was used to simulate the resultant pressure 
field. To verify the simulated results ex vivo experiments were performed on porcine 
muscle, cut into cubes. Using a TAP of 300 W, these experiments showed the ability to 
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focus within the defined volume and also that the array could produce two separate 
lesions by generating multiple foci simultaneously, with lesions created being between 
5 and 6 mm in diameter after a 50 s heating period. Other lesions generated were 
between 2 and 6 mm in diameter (17 s heating period) depending on how far away 
from the natural focus they were targeted (further away gave larger lesions). The array 
described in this paper is of particular interest due to the ability to steer in a (pre-
defined) 3D volume. Although this transducer was large and intended for deep tissue 
ablation, a similar approach could be taken with smaller transducers designed for 
reduced focal depths. This will be investigated in further works, as it offers a major 
advantage in situations where motorised gantries are not suitable. 
A final paper that will be reviewed in this section describes a novel method of creating 
focused sound waves, without the use of a traditional transducer. Instead a tuneable 
non-linear acoustic lens, in the form of ordered arrays of granular chains is used [63]. 
The amplitude, size and location of the resulting focal ‘sound bullet’ (a single wave 
front, as opposed to comparable, linear lenses that produce oscillations) can be 
controlled by varying the pre-compression of the chains, a method that has not been 
reported previously. A ‘conformal striker’ is used to create an impact on the acoustic 
lens, which is coupled to an (elastic) interface at which spherical wavelets are emitted 
into the medium, following the pattern of the displaced ‘power law’ spheres which is 
in turn controlled by the pre-compression of the chains of spheres (pre-compressed 
using bottles containing varying volumes of water). If a striker of mass equal to 21 
spheres (in the lens) has a velocity of 1 m/s it was shown that a 38 dB pressure gain (or 
79 Pa relative to a reference pressure of 1 Pa) can be achieved. Due to the non-
linearity of the lens the pressure gain can be increased arbitrarily by increasing the 
speed of the strikers’ impact, and indeed at a velocity of 4 m/s a pressure gain of 57 dB 
(674 Pa) can be obtained. In addition to small ‘bullets’ the acoustic lens apparatus was 
capable of producing planar wavelengths, by approximating a focal point at infinity. 
Although not designed particularly for FUS procedures, the system could potentially be 
used for HIFU treatments as the focal points (‘bullets’) are very well defined and come 
into focus in a similar manner to a typical curved HIFU transducer, although the 
pressures involved would have to be increased by more than one order of magnitude. 
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Interestingly this method of producing focused sound waves can be performed using 
air as the propagation medium. The system was simulated using the assumption of 
many radiating circular wave fronts, the actual modelling being performed using a 
finite elements (FE) model coupled to a discrete-particle (DP) model. 
2.3.2: Medical Trials: A Brief Review of Literature 
In the 1999 IEEE Ultrasonics Symposium a paper concerning the feasibility of MRI 
monitored HIFU therapy was published by the University of Heidelberg Medical School, 
Department of Radiotherapy (Germany). In the study 15 target volumes of sheep 
breast were treated by applying 30 to 128 pulses of ultrasound at a frequency of 1.7 
MHz (25-75 W per pulse giving acoustic powers of 16-47W) using a specially designed 
MRI-compatible transducer system [64]. The transducer was mounted on a positioning 
system that allowed linear translation in addition to tilt angles up to 20⁰ and was 
covered with a Mylar film window. The transducer was capable of producing a focal 
ellipsoid of 8.7 mm length and 1.1 mm diameter (-3dB zone). Using this setup eight 
female sheep were treated, each receiving two treatments with a four week interval. 
Treatment was performed using 9 s sonications followed by a 20-50 s pause to prevent 
accumulation of energy (heat) in the tissue. Following treatment the test subjects were 
sacrificed and a histological examination was performed, revealing a very good 
correlation between MRI monitored results and actual, realized results. This showed 
MRI was capable of measuring temperature rise in the treated tissue (thermometry). 
In conclusion, following successful treatment of sheep breast tissue it is suggested that 
human trials are feasible and would be possible using a slightly modified setup. 
Following on from the above study a further paper was published by the same group in 
2001, again on the use of MRIgFUS. In this study a clinical trial was carried out on a 
human patient for the treatment of breast cancer, the first such report of MRIgFUS 
used to treat a malignant tumour in humans [65]. HIFU treatment was given as an 
adjuvant therapy so as not to compromise other treatment modalities, and the 
treatment was followed by surgical removal of the tumour 5 days post HIFU surgery, in 
turn followed by other (commonly used) adjuvant therapies. The patient was a 56-
year-old menopausal female deemed a typical candidate for breast conserving surgery, 
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with a well circumscribed tumour mass of 2.2 x 2 x 1.4 cm3. The treatment plan utilised 
80 ultrasound pulses of 9 seconds each at an acoustic power of 30 – 50 W. A 13 s 
cooling period between sonications was also implemented to prevent unwanted 
temperature rise in the surrounding, healthy tissues. During the treatment the patient 
experienced no pain despite being given no anaesthesia, with only a mild sensation of 
pressure being experienced during the sonications. Histological examination of the 
resected tumour showed a very good correlation between the location and boundaries 
of the ablated volume and that observed during treatment using MRI, showing 
MRIgFUS to be a useful and effective procedure for the treatment of breast cancer. In 
addition it is suggested that FUS could be used to facilitate gene transfer and targeted 
drug deployment, although this topic is beyond the scope of the described work. 
In the period 2003 to 2007 the Chongqing University of Medical Sciences published a 
series of papers detailing the outcome of HIFU treated clinical trial patients. The 
Chongqing group have, to this authors knowledge, treated the highest number of 
human patients using HIFU, with 1038 patients with solid tumours treated in the 
period from December 1997 to October 2001 alone [18]. In a report published in 2003 
an account is given of the treatment of 48 women with biopsy proven breast cancer 
(clinical trial phase II) [16]. All patients had a single palpable tumour no more than 6 
cm in diameter and located 0.5 cm and 2 cm (minimum) from the ribcage and nipple 
respectively. The women were randomised into a control group (25) and a HIFU 
treated group (23) with all patients undergoing breast conserving surgery and adjuvant 
treatment (radiation/chemo/hormone therapy) with the HIFU group receiving a FUS 
procedure 1-2 weeks prior to open surgery. During the surgery the entire tumour 
volume was ablated, including a 1.5 to 2 cm margin of healthy tissue as is regularly 
performed during traditional breast conserving surgery. In total the HIFU treatment 
lasted from 45 mins to 2.5 hrs, with median treatment time of 1.3 hrs. Following 
exposure to HIFU some of the treated patients experienced oedema in the tissue 
surrounding the treated area, although this disappeared in all patients after 7-10 days 
post treatment. Fourteen patients in the HIFU group experienced mild skin burns, but 
in all cases this had recovered fully 10 days post HIFU. Immediately prior to HIFU 
treatment all patients were given intravenous sedation (4) or general anaesthesia (18). 
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Following open surgery the ablated specimens were examined histologically and 
lesions created by HIFU were measured. No bleeding was observed in any of the 
patients, indicating the safety of the procedure. There was however a palpable lump 
and an observable ‘rim’ of cells surrounding the ablated zone representing an 
inflammatory response to the treatment. The device used for treatment was a 12 cm 
PZT-4 transducer with a focal length of 90 mm operating at 1.6 MHz. The transducer 
had a fixed focus, which was displaced using six-direction movement controlled via PC. 
The peak focal intensities ranged from 5 to 15 kW/cm2 and produced focal zone 
ellipsoids approximately 3.3 mm in length and 1.1 mm in diameter. The procedure was 
guided using a 3.5 – 5 MHz imaging transducer situated at the centre of the HIFU 
transducer, coaxial to the therapeutic beam. In a similar study published the following 
year 24 patients with pathologically confirmed breast cancer were treated, aged 23-65 
years. Here the HIFU apparatus remained unchanged as that described previously, 
except the transducer (Haifu Model-JC) was driven at 0.8 MHz, with an average 
exposure time of 3500 s [19]. The patients selected had tumour masses ranging from 2 
to 4.7 cm in diameter (mean 3.2 cm) and the majority of patients (19) were at clinical 
stage IIb. Following HIFU treatment patients underwent modified radical mastectomy 
and ablated tumour masses were removed and subsequently examined. Three of the 
patients underwent MRI and Single Photon Emission Computed Tomography (SPECT) 
examination before and after treatment, and the changes in tumour properties were 
observed. 
A further paper was published by the above group (Chongqing, China) in 2004, 
providing an account of the 1038 patients with solid carcinomas treated in China from 
1997 to 2001, 313 of whom were treated at the Chongqing University of Medical 
Sciences [19]. All patients were treated with the same device (described previously) 
operating at 0.8 MHz or 1.6 MHz depending on the application, and the procedure was 
similar for all those treated. A total of 106 patients with biopsy-proven breast cancer 
were successfully treated, with at least half of patients exhibiting total reabsorption of 
ablated tissue within 1 to 2 years. After a mean of 22 months a 100 % survival rate was 
observed, with all but one patient disease-free. Some 153 patients with primary and 
metastatic malignant neoplasms (osteosarcoma) in various locations (including bone 
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and lungs) were treated, with tumours of up to 46 cm in some cases. In a follow-up to 
the treatment (mean time 23 months) 85 % of patients were still alive, with five 
undergoing limb amputation due to local recurrence. Of the 77 patients treated for 
soft tissue sarcoma 18 were treated at the Chongqing Centre. Of these 18, 90 % (16) 
survived, after a mean follow-up time of 21 months 10 % (2) died of metastasis post 
HIFU treatment, and three of the survivors had to undergo a second HIFU treatment. 
Of the nine patients treated at the Chongqing Centre seven were alive at the follow-up 
time (mean 9 months) and showed stable lung metastases. Two patients died, one and 
three months postoperatively, due to cachexia and dyspnoea caused by severe lung 
infection. For the ten patients with unresectable pancreatic cancer, treatment with 
HIFU was a success. An interesting phenomenon was observed in these and other 
advanced stage cancer patients. In these patients, that suffered from severe cancer 
related pain HIFU was observed to effectively reduce this pain, thus improving patients 
quality of life both physically and psychologically. Overall complications with HIFU 
treatment were very low. Between 5 and 10 % patients suffered from mild fevers up to 
38.5 ⁰C for up to seven days following treatment, and it was observed that fever 
severity was proportional to the volume of the ablated tissue with several patients 
treated for very large tumours exhibiting fevers of up to 39.5⁰C for two to three weeks. 
In total 10-20 % of patients experienced mild skin burns, however this was reduced to 
just 5 % through experience in evaluating skin damage as seen in real-time diagnostic 
images (during treatment). A sizable portion of treated patients (20-30 %) experienced 
mild local pain within the week following HIFU treatment, although only 5-10 % were 
given analgesics (oral) to combat this effect.  
In a further study twenty two patients were selected (non-randomized) with disease 
stages I to IV. These patients’ results were followed up at intervals, with the mean 
total follow-up time being 54.8 months [19]. The trial used the same equipment as 
previously described and the cosmetic result was judged to be ‘excellent’ in 94 % of 
treated patients. Disease free survival (and recurrence free survival) rates were 100 % 
(100 %), 100 % (89 %), 100 % (89 %), 95 % (89 %) and 95 % (89 %) at one, two, three, 
four and five years respectively. An interesting point made in this paper is the fact that 
compared to the West, in China women tend to be examined less regularly, hence 
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once discovered tumours are commonly above 2 cm, a size for which breast conserving 
surgery is not recommended in the West. Instead a radical mastectomy is commonly 
performed, and this becomes a more attractive option with increasing tumour size as 
treatment with HIFU will result in a palpable lump remaining, which although benign, 
will adversely affect some patients psychologically. Providing more information to 
patients may reduce this somewhat but as FUS is a non-invasive procedure there is no 
easy method of removing ablated tissue, apart from leaving the body to remove the 
cell debris by natural phagocytosis. 
In a subsequent paper the histological and microscopic cellular changes of the patients 
treated in a previous study were quantified and analysed. As this does not relate 
directly to the project at hand a summary of these results will not be presented here. 
For more information please see [20]. One interesting equation given in this paper is 
that for calculating the volume of a (focal) ellipsoid, expressed as: 
 
-./	 × 23 456789	 × 23:,;89	 × 23 89,<=65>>   {2.1} 
In 2006 a report in the European Oncological Disease Briefing (Issue 1) detailed the 
HIFU treatment of 118 patients who experienced local recurrence following 
radiotherapy for prostate cancer treatment from 1995 to 2002 [66]. All patients 
showed an absence of metastases on bone scan, computed tomography (CT) and MRI. 
In all cases patients were treated using the ABLATHERM transducer device 
manufactured by EDAP-TMS (France). Of the 118, 56 patients required hormonal 
treatment due to positive follow-up biopsies. Overall the survival rate was 71 % at 60 
months post-operatively, with negative biopsies in 84 % of patients. Progression free 
survival rates were dependent on patients’ initial risk and were 78 %, 49.5 % and 14 % 
for low, medium and high risk patients respectively. A number of patients experienced 
side effects due to the necrosed tissue ‘migrating’ into the urethra. These included 
some cases of urethrorectal fistula, but this was prevented by modifying the treatment 
parameters for later patients (post 2002). Using these modified parameters also 
reduced the more common narrowing (stenosis) of the urethra and bladder neck from 
35 % to 6 %.
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2.4: Chapter Conclusion 
In this second chapter a literature review of a number of relevant publications has 
been given, describing the work of various groups focusing on HIFU techniques and 
devices, along with a number of accounts and results from relevant medical trials and 
other topics relevant to the narrative of the work described in this research. Revolving 
around the development of HIFU as a surgical technique, much of the information 
presented will be referenced in the following chapters and as such serve as both 
background and introduction to the main body of work presented henceforth. 
In addition to general information and inspiration gathered from these reviewed 
publications, particular note should be given to the paper published in 2001 and 
authored by Gail ter Haar. In this article [4] a ‘thermal dose’ model was introduced, 
describing a method of quantitatively comparing the effect different heating regimes 
has on the necrosis of tissue. Using this model allows different temperature and 
exposure times to be compared. To such an end this technique will be utilised in a later 
section of this thesis when the results of simulations are being analysed. 
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Chapter 3:        
           
                 
Acoustics Theory & HIFU 
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3.1: Chapter Introduction 
In this third chapter theory relevant to the interaction of acoustics and matter will be 
presented, with a focus on interaction with biological tissue. Background information 
involving HIFU and HIFU devices briefly described in the preceding chapter will be 
expanded on with examples of currently available HIFU devices being given. 
Ultrasound transducers will be described and characterised beginning with simple 
single-element transducers. Transducer arrays and methods of beam focusing will be 
also be explained. Finally a comparison of various transducer geometries will be 
presented and considered, with an emphasis on the ability to focus and steer the 
propagated ultrasound within a three dimensional space, or volume. 
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3.2: Physics of Sound Waves & Interaction with Matter 
Sound is by definition a mechanical energy that propagates through a medium via 
compression and rarefaction of the particles present in the medium [27]. This motion 
can be described as a longitudinal wave and is analogous to the motion of an elastic 
spring attached to a piston. The pressure variations, due to the compression and 
rarefaction caused by the sound wave, vary sinusoidally with time, with the compression 
corresponding to the peaks and the rarefactions to the troughs of the sine wave.  
Ultrasound is defined as sound at a frequency of above 20 kHz (the human hearing 
threshold) with diagnostic ultrasound using frequencies of up to 30 MHz [31]. As 
ultrasound passes through a medium it transports energy. The rate of this energy 
transport is termed 'power', but as in most cases the ultrasound beam is focused into a 
small area (on a defined two dimensional plane) it is more prudent to refer to ultrasound 
in terms of 'intensity', or power per unit area. The intensity (I) of an ultrasound wave is 
related to the maximum pressure in the medium and is given by the following equation 
[31] 
   ? = 	AB² 3D<⁄       {3.1} 
Where 'Pm' is the maximum pressure, 'ρ' is the density of the medium and ‘c’ is the local 
speed of sound [31]. 
The velocity of ultrasound propagation is dependent on the medium it is propagating 
through. For example the speed of sound in air is approximately 330 m/s whereas 
through soft tissue and lead zirconate titanate (PZT, a common material used for 
transducer elements) sound velocities are approximately 1540 m/s and 4000 m/s 
respectively [27]. 
As ultrasound propagates through a medium energy is lost. This is due to scattering, 
absorption and reflection. The cumulative effect of these mechanisms is generally 
referred to as 'attenuation' and is important as the majority of energy lost (due to 
absorption) is irreversibly converted to heat (in soft tissue absorption accounts for 60 – 
90 % of the attenuation, and scatter accounts for the remainder [31]). 
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The resulting behaviour when a sound wave encounters an object depends greatly upon 
the size of the object in comparison to the wavelength of the sound wave. As the 
frequency (f) of the wave is in general controllably fixed, the wavelength (λ) then 
depends on the local speed of sound in the medium. 
   F	 = 	 < G⁄        {3.2} 
Thus the wavelength of sound in air and soft tissue are approximately 0.33 mm and 1.54 
mm respectively, at a frequency of 1 MHz. If an encountered object is much larger than 
the wavelength and is relatively smooth [31] then part of the beam will be reflected and 
part will be transmitted, with an expected loss of intensity. This is termed 'specular 
reflection'. If the obstacle is small in comparison to the wavelength (surfaces become 
more 'rough' as wavelength decreases) then the wave energy will 'scatter' in numerous 
directions and little, if any, energy is transmitted in the original direction of the beam. 
This effect can be referred to as 'non-specular' reflection and is analogous to a mirror 
surface that has been 'steamed up' with the water droplets acting as non-specular 
reflectors, scattering the incident light thus reducing visibility [31]. Scattering can also 
occur due to small particles reflecting the beam within a medium. It is this mechanism 
that gives rise to characterized organ images that can be identified when using 
diagnostic ultrasound. Areas with high scatter amplitude are termed 'hyperechoic' and 
those with a lower scatter amplitude 'hypoechoic' [27]. Generally acoustic scatter from 
non-specular reflectors (scatterers) increases with increasing frequency, while non-
specular scatter is generally frequency independent. 
Following the encounter of a boundary or interface between two mediums, the 
remaining energy in the ultrasonic beam will drop exponentially. It is therefore 
beneficial to describe this loss in decibels (dB) using the following established formula 
   ;H	 = 	2I4J7	 ? ?I⁄      {3.3} 
Where 'I0' is the reference intensity, which is in this case the intensity of the beam 
immediately prior to encountering the boundary. 
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[NB: When dealing with pressure changes the above formula is altered to dB = 
20log(p/p0), where ‘p’ is pressure and ‘p0‘ is the reference pressure] 
This can be calculated if the attenuation coefficient 'α' is known. For soft tissues 'α' can 
be approximated as 0.5 dB per cm per MHz [27]. Some attenuation coefficients are given 
below (see Table 1, [27]) for reference. 
Table 1 - Examples of attenuation coefficients in human tissues 
Substance Attenuation coefficient for 1 MHz beam 
(dB/cm/MHz) 
Water 0 
Blood 0.18 
Soft tissues 0.3 - 0.8 
Fat 0.5 - 1.8 
Muscle 0.2 - 0.6 
Bone 13 - 26 
For example if a 1 MHz ultrasound beam propagates through 2 cm of fat, then 3 cm 
muscle the total energy loss would be as follows. 
   (0.6 dB/cm)*(2 cm) + (1,2 dB/cm)*(3 cm) 
   = 4.8 dB 
This 4.8 dB loss equates to an approximate loss of 66 % of the original beam energy. 
The ultrasound 'half-value thickness' (HVT) corresponds to the thickness of tissue that 
causes a 50 % (-3dB) decrease in intensity and is a useful measure when dealing with 
diagnostic ultrasound problems. 
Reflection of ultrasound at an interface is dependent on the 'acoustic impedance' (Z) of 
the medium involved. This value is equal to the product of the density in the medium 
and the local speed of sound. 
   K	 = 	D<       {3.4} 
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The magnitude of energy reflected at a boundary can be calculated using the acoustic 
impedance values of both media, giving a 'reflection coefficient' (αR) as follows [31]. 
   LM 	= 	 [K3	– 	K2 K3 	+ 	K2⁄ ]3    {3.5} 
The amount of energy reflected varies greatly when dealing with different pairs of 
media. For example 99.95 % of energy is reflected at an air-liver interface, whilst only 
1.5 % is reflected from the interface between muscle and liver, due to the differences in 
acoustic impedance. The differences of acoustic impedance in tissues allows diagnostic 
ultrasound scanning to visualize internal bodily structures, although if the angle of 
incidence is more than three degrees it is unlikely that the reflected portion of the beam 
will return to the transducer, as the angle of incidence and of reflection are equal. This 
obviously depends on the transducer’s size and of the depth of the reflector. 
 Another important interaction of ultrasound at a boundary is that of refraction. In this 
case the angle of the transmitted beam is altered due to the difference in local speed of 
sound on either side of the boundary as follows [31] 
   >,6R, >,6RS⁄ 	= 	 <, <S⁄      {3.6} 
Here θ denotes the angle and 'i' and 'r' refer to the incident and refractive regions 
respectively. Also if cr > ci then the angle will become steeper as it passes over the 
boundary. If the magnitude of the incident angle is great enough no ultrasound is 
transmitted. The angle at which this occurs is termed the 'critical' angle and is obtained 
by setting the refractive angle to 90 °, therefore θi becomes θc, the critical angle. 
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3.3: HIFU Background Theory 
3.3.1: Summary 
HIFU makes use of a focused ultrasound device to precisely and effectively destroy 
target tissues by thermal ablation (see Figure 2, [15]). 
This process can be guided by computerized MRI or by ultrasound, which is more 
commonly referred to as ultrasonography when used in this type of application. These 
two systems are generally referred in their abbreviated forms, MRgFUS (or MRIgFUS) 
and USgFUS respectively. Currently only MRgFUS is able to accurately measure the 
heating effect produced by HIFU in real-time. Additionally MRI can operate from any 
angle and also has an increased tissue contrast than that of ultrasound. The drawback 
when using MRgFUS is that it cannot provide a continual feed of data due to the 
nature of its operation, instead images have to be captured at discrete intervals using 
computer equipment. Regardless of this MRgFUS is generally accepted to be the 
superior of the two processes, although future developments in both procedures may 
alter this balance. 
As previously mentioned, the HIFU procedure operates on the principle that when an 
acoustic wave travels through tissue some of the energy of the wave is absorbed and 
converted to heat. Using focused beams this effect can be exploited deep within 
tissues, using a very small focus point to localize heating such that surrounding tissues 
are unaffected [11]. This occurs due to the energy in the individual waves being of 
small enough magnitude to not adversely affect the overlying or surrounding tissues. 
When focused correctly the areas of high pressure are superimposed (at the focal 
point) meaning energy deposition is much higher in the focal region than in the 
surrounding tissue. The focus is very well defined such that a target tissue (such as a 
cancerous tumour) can be rapidly heated and subsequently necrosed (given 1-2 s at a 
temperature of 56 °C or an equivalent dose[4]) without any permanent damage to the 
surrounding cells. By focusing consecutively at more than one location, or indeed 
scanning the beam a larger portion of tissue can be ablated. 
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Focusing and scanning of the beam can be achieved in a number of different ways. The 
beam can be focused geometrically using a curved transducer, or with an adjustable 
(acoustic) lens system. If the focal length is fixed, then an external positioning system 
with sufficient degrees of freedom can be used to adjust the position and depth of the 
focus by physically displacing the transducer and therefore the fixed focal point. 
Alternatively a phased array of transducer elements can be used to electronically focus 
and direct the ultrasound beams [27]. This is accomplished by dynamically adjusting 
the phase of the signals applied to the array elements, effectively steering the beam to 
the desired location(s). These differing transducer types will be discussed in detail in a 
subsequent section of this thesis (see Section 3.4). 
Once the ultrasound beams are focused for a sufficient period, the target tissue 
undergoes coagulative necrosis and the oxygen supply to the cell is halted due to the 
destruction of the surrounding blood vessels [68]. The architecture of the tissue 
remains intact with the affected cells appearing grey and faded under microscopic 
analysis, which at least one author has described as having an ‘island and moat’ 
structure [27]. As this procedure involves precise ablation of the target tissue without 
the need to physically reach the tissue it is referred to as a non-invasive surgical 
process and can also be combined with more conventional methods of treatment such 
as radiotherapy and chemotherapy to achieve a desirable systematic effect. 
A further point worth noting is the effect of 'cavitation' in the propagation of 
ultrasound. If gas bubbles are present in a medium then the compressions and 
rarefactions of the sound wave will cause the bubbles to shrink and expand, which can 
give rise to increased scatter. This is referred to as 'stable cavitation' [68]. If the 
ultrasound beam is intense enough the disturbance caused can be of such magnitude 
that extremely small bubbles are produced in the medium, generally in zones of 
rarefaction. These bubbles grow in size until the next compression, in which they will 
shrink and will eventually collapse creating shock waves and extremely high 
temperatures at the cellular level. This effect is generally termed as ‘unstable’ or 
'dynamic cavitation' and is currently being researched as an additional method to 
destroy pathogenic tissue in HIFU treatments [69]. 
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3.3.2: Uses of HIFU 
As already stated guided HIFU procedures have been successfully used to destroy 
cancerous tumours in various bodily organs. However, the widespread use of this 
technique has not yet been approved by most major health organizations, and more 
research work is called for before HIFU treatments become common practice. 
Nonetheless there are other interesting areas in which HIFU has been used to 
successfully treat patients. 
One of these areas is the combined use of HIFU to directly treat cancer at the same 
time of facilitating a localized release of anti-cancer drugs. This can be achieved by 
encasing the drugs in temperature sensitive bubbles (often referred to as vesicles) 
artificially created from a similar material to that found in cell membranes [21]. The 
structure of these 'liposomes' is such that one ‘end’, the 'head' of the vesicle is 
hydrophilic while the 'tail' is hydrophobic, which causes the liposomes to orientate 
themselves such that they are similarly lined when up in the presence of water. The 
‘bilayer’ formed prevents the encapsulated drugs from escaping the liposome until 
some trigger causes the drug to be released. This can be achieved when the bilayer 
interacts with a particular cell membrane, or in the case of their use with HIFU, when a 
temperature above that which is found in the body is used to breakdown the bilayer, 
thus releasing the 'packet' of drugs to the area within which this high temperature 
occurs. The high temperature region may be created by using HIFU technology, or 
more commonly using a hyperthermia device, that heats a larger portion of tissue 
(than HIFU generally does) to a lower temperature, of around 45 °C. Using liposomes 
for targeted drug release allows concentrations of drugs 10 times higher than those 
used in traditional methods to be released, hence allowing for more effective drug use 
with greatly reduced side effects as the drugs are not released system wide. There are 
presently three main types or categories of these liposomes: multilamellar vesicles 
(MLV) small unilamellar vesicles (SUV) and large unilamellar vesicle (LUV) all of which 
are generally used to deliver different types of drug [21]. 
Uterine fibroids can also be treated using HIFU. This procedure was approved by the 
FDA in 2004 and is widely accepted as a plausible method of treatment. The treatment 
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of atrial fibrillation, a common form of heart arrhythmia can also be achieved using 
HIFU. In this procedure defective heart tissue is ablated, allowing treatment without 
the need for largely invasive conventional surgery. The use of HIFU in this application 
has been approved throughout Europe and is undergoing approval by the FDA for use 
in America. 
3.3.3: Advantages of HIFU 
By far the largest advantage of HIFU procedures is the non-invasive nature of 
treatment. The capacity to precisely target areas deep within tissue using external 
equipment while simultaneously avoiding damage to the surround tissues is largely 
unique within the medical procedures of today. In effect HIFU can be used as a surgical 
tool, performing operations inside the body without the need for open surgery. While 
radiation and chemotherapy are accepted methods of treatment in the area of cancer, 
HIFU can be used to non-systematically target the affected zone. This is possible due to 
the nature of the passage of ultrasound through biological tissue, which only has a 
destructive effect when precisely focused, in this case on the tumour or other diseased 
tissue. It is this characteristic that makes the use of HIFU such an attractive, non-
invasive option. Additionally blood vessels surrounding the ablated volume are 
effectively cauterized, preventing repair of the ablated tissue and also bleeding into 
the surrounding tissues(s). 
3.3.4: Other Groups’ Work & Example Devices 
Fully guided HIFU systems are already available commercially. One company that 
offers these systems is Chongqing Haifu Technology of China which was briefly 
mentioned earlier in this thesis. Chongqing offer Magnetic Resonance guided systems, 
and an example of the kind of specification that they offer is given for reference below 
(see Table 2 [70]). 
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Table 2 - Example specification of typical Chongqing surgical HIFU device 
Focal region for treatment:  1.1mm × 3.3mm—1.4mm × 5.6 mm 
Range of acoustic intensity within focal field: 5000 W/cm2—25000 W/cm2 
Therapeutic frequency: 0.8 MHz—2.4 MHz 
Accumulative error of the linear movement: ± 1 mm 
System noise: ≤65 dB(A) 
 
Blatek Ultrasound Transducers is a company that offers MRI compatible HIFU 
transducers to a worldwide market. They will design and fabricate transducers to meet 
customer specific requirements or applications. An example of a typical set of 
parameters that can be specified by the customer is given below (see Table 3 [71]). 
Table 3 - Example specification of typical Blatek Ultrasound Transducers surgical HIFU device 
Material availability 1-3 piezocomposites, PZTs 
Power handling  Up to 30 W/cm2  
Efficiency 50 % to 75 % 
Frequency range  0.2 MHz to 6.0 MHz  
Shaping capability Spherical and Cylindrical (F Number 1)  
Size range / spherical Up to 6 ” Diameter  
Size range / cylindrical  Unlimited 
Bandwidth 30 % to 70 % 
Impedance 50Ω ± 5Ω 
Phase angle 0º ± 5º 
Array capability Yes 
MRI compatibility Yes  
Piezo Technologies is another company that specialises in HIFU products, in particular 
custom, semi-custom and modular transducer products. Also Precision Acoustics is a 
company that design and fabricates HIFU transducers, as is Sonic Concepts, which 
offers a wide range of HIFU transducers for different applications and also provide data 
sheets for all their products on their website. 
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3.4: Characterisation of Different Transducer Types 
Ultrasound transducers convert electrical energy into mechanical energy and, in the 
case of imaging (diagnostic) transducers, mechanical to electrical energy. This is made 
possible by the use of piezoelectric materials that deform when a voltage is applied to 
either side. Similarly a mechanical deformation causes a voltage to be developed 
across the material [31] (see Figure 3, [27]). 
 
 
Figure 3 - Piezoelectric principle 
Many natural crystal structures exhibit piezoelectric characteristics (such as quartz) but 
this is generally at low temperatures. Synthetic piezoelectric crystals are most often 
used in ultrasound transducers. One such material is PZT (a piezoelectric ceramic) 
which has no piezoelectric properties at room temperature. To prepare PZT for use the 
material is heated to above its 'Curie' temperature (approximately 340 °C for PZT) and 
a voltage is applied to align the dipoles in the crystal structure [27]. The material is 
then cooled whilst the voltage remains applied. The resulting material shows 
piezoelectric properties at room temperature. 
The deformation of the piezoelectric material due to a voltage being applied causes a 
pressure wave to be emitted from the surface of the transducer. If an alternating 
current (AC) source is used a series of sinusoidal pressure waves will be produced. In 
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focused ultrasonic transducers this effect is exploited, and many pressure waves can 
become superimposed at the focal point, thus resulting in an elevated acoustic 
intensity. This is the principle on which FUS operates. 
3.4.1: Ultrasound Transducers  
3.4.1.1: Single Element Transducers 
In resonance transducers a voltage 'spike' is applied, causing the material to resonate 
at its natural frequency, which is determined by the material thickness. When the 
material undergoes contraction-expansion-contraction (one cycle) compression waves 
move toward the centre of the crystal, from the front and back faces. If the crystal 
element thickness is equal to one wavelength (in the crystal) then the compression 
waves would arrive at the edges just as the next contraction begins, thus the second 
signal would be dampened, meaning a large reduction in efficiency. If the element 
thickness is equal to half of the local wavelength then the compression wave reaches 
the transducer edge just as expansion begins, meaning they constructively combine. 
This case is true for all transducer element thicknesses with an odd multiple of half 
wavelengths [31] although increased thickness adds to attenuation and therefore 
decreases efficiency. In general the element thickness should be equal to half the 
wavelength of ultrasound in the material such that each compression wave adds 
constructively to the subsequent expansion (see Figure 4, created using [3]) and that 
extra attenuation is not added by excessive thickness of the material (for example 
three or even five half wavelength thicknesses). Resonant transducers generally 
transmit (and receive) at a 'centre frequency' [27]. 
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Figure 4 - Pressure field showing effect of piezoelectric material thickness on preferential wave 
emission: Red (compression), Blue (rarefaction) 
 
In general transducer assemblies have certain common features, including an 
insulating case, a shield, an acoustic absorber, a backing block, the piezoelectric 
element and a matching layer as shown in the diagram below (see Figure 5, [27]). 
 
Figure 5 - Single element transducer 
The backing (or damping) block, if present, is located behind the piezoelectric element. 
This block absorbs the backwards propagated ultrasonic waves caused by the vibration 
of the element. It also absorbs stray signals from the housing, but its main function is 
to dampen the forwards propagated ultrasound to create a pulse, rather than a 
continuous wave. In diagnostic applications short pulses allow detail along the main 
beam axis to be enhanced, although it also introduces a broader band of frequencies 
around the resonant frequency. This effect is generally termed 'ring-down' and is 
quantified using a measure named the 'Q-factor' (Q) [27]. 
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  T	 = 	<5685S	S5>J6U68	GS5VW56<X/HU6;:,;89  {3.7} 
A high Q-factor value indicates a narrow bandwidth and long (spatial) pulse length 
given rise to by a small amount of damping, while a low Q means shorter pulses and a 
wider bandwidth, the effect of heavier damping (see Figure 6, [27]). When designing a 
HIFU transducer it is preferable to have a high Q-factor. One exception to this is in the 
case of a dual mode transducer where the same array is used for both imaging and 
therapy, such as that suggested in a previous study [72]. Here there will be a 
compromise between wide bandwidth (for more comprehensive imaging) and narrow 
bandwidth (for efficient therapy). 
Figure 6 - Relationship between damping, pulse length and Q-factor 
The matching layer (see Figure 5) exists to minimize the loss caused by the difference in 
acoustic impedance between the transducer and the propagation medium and as 
stated is designed to have a thickness equal to one-quarter of the ultrasound 
wavelength in the piezoelectric material used. This layer should have acoustic 
impedance equal to the geometric mean of the piezoelectric material and the tissue, in 
line with the formula below [31]. 
   KBU8<9,67	4UX5S 	= 		ZK8SU6>;W<5S		[		KB5;,WB  {3.8} 
Where, as previously stated 
   K	 = 		D<       {3.4} 
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There can in fact be more than one matching layer, and in this case the layers are 
chosen such that they have acoustic impedance that are intermediate to those of the 
transducer and the tissue being diagnosed or treated, although as already noted if 
more than one layer is present, the total layers must be an odd multiple of the one-
quarter wavelength measure, for example three layers each with a one-quarter 
wavelength thickness. From the above, an increased number of matching layers may 
appear to improve efficiency, but the increase in material thickness leads to increased 
attenuation. For this reason only one matching layer, of one-quarter wavelength 
thickness is typically used. 
Non-resonant transducers can be adjusted to alter their centre frequency, and for this 
reason they are sometimes referred to as 'multi-frequency' transducers, with 
bandwidths exceeding 80 % of the centre frequency [31]. These transducers are 
commonly fabricated using rod like elements mounted to a plate, with epoxy used to 
create a smooth face and are generally referred to as piezocomposites. An advantage 
of this type of transducer is that acoustic properties are closer to that of tissue, 
therefore matching layers are not as important and the efficiency of transmission is 
increased [27]. These transducers are excited using a square wave 'burst' allowing the 
centre frequency to be chosen within the limits of the transducers bandwidth. 
3.4.1.2: Transducer Arrays 
Up to this point only single element transducers have been discussed. It is much more 
common for transducers to employ multiple piezoelectric elements arranged into 
arrays, typically containing 128 to 512 individual elements of rectangular shape [27] 
although circular and other shaped elements can be used. These arrays can be 
activated in a linear, or in a phased sequence. 
Linear arrays typically have more elements and as such are generally larger assemblies. 
Each operation involves the activation of a number of adjacent elements, which in 
effect produces a 'synthetic aperture', the width of which is determined by the number 
of elements activated and the element spacing. Linear arrays can also utilise phasing of 
elements to direct and control the ultrasound propagation (linear phased array). 
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Phased arrays generally comprise less than 128 elements and are physically smaller 
than their (non-phased) linear counterparts [27]. In this kind of array all elements are 
used, with small time delays between element excitation signals that allow the beam 
to be steered and focused without physically moving the transducer (see Figure 7, [73]). 
This presents a major benefit over linear arrays, which generally require a very precise 
mechanical positioning system for accurate steering and focusing. 
 
Figure 7 - Steering and focusing using a phased array 
 
3.4.1.3: Beam Properties 
As previously stated an ultrasound beam propagates as a longitudinal wave from the 
transducer into the medium. The beam pattern created consists of two sections. In the 
'near field' the beam converges progressively towards the focal point. After reaching 
this point the beam diverges (the 'far field'). 
In a simple, single-element transducer the near field length is proportional to the 
transducer diamete. In multiple element transducers the 'transducer diameter' is taken 
as the diameter of the group elements that are excited at one time (synthetic 
aperture). 
The near field or Fresnel zone [27] convergence occurs due to the constructive and 
destructive interaction of waves emitted from the transducers surface. This can be 
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modelled as a large, or infinite, number of small (point) sources, each of which 
emitting ultrasound radially (see Figure 8 [27]). 
Figure 8 - Huygen's principle – showing radial propagation from point sources 
The length of the near field is dependent on transducer diameter (or radius (r) as 
below) and frequency, and it can be calculated, for flat faced transducers, as follows 
[31]. 
   \5US	G,54;	456789	 = 	S²/F    {3.9}  
This shows how a transducer with a higher frequency and a larger diameter leads to a 
longer near field length and therefore will have a greater range before intensity begins 
to decrease. 
It is worth noting here that pressure distributions in the near field are complicated due 
to the interactions of the wavelets created. Only once the far region is reached do the 
pressure variations decrease in a continuous fashion [27]. 
The far field or Fraunhofer zone is defined as the point at which beam divergence 
begins. The divergence angle can be given by [31] 
   >,6R	 = 	I. ^F/S                              {3.10} 
These estimations of Fresnel zone length and beam divergence apply mainly to linear 
diagnostic transducers, although they can be used to provide indications in HIFU 
transducer design. In medical imaging applications transducers with long near field 
lengths are preferred. This leads to higher frequencies being used and employing 
larger diameters when designing transducers for this type of use. 
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3.4.1.4: Focusing 
Single element transducers can be focused by using a curved element, or by using a 
focusing lens. In both cases the focal point is generally fixed, and movement is 
achieved through mechanical devices. In a phased array transducer the constructive 
and destructive interferences between waves are used to steer and focus the beam. 
For example a shallow focus is achieved by activating the outer elements first and the 
centre elements last (see Figure 7). In both cases a focal point is produced. The 
intensity at the focal point can be 100 or more times the intensity produced at the 
surface of the transducer [31]. 
For example, in the case of ‘cupped’ transducers the focal length is approximately 
equal to the radius of curvature of the transducer. Furthermore the focal zone length 
can be approximated using the formula below [31]. 
   _J<U4	`J65	456789	 = 	2IF aG;b3   {3.11} 
Where (
G;) is referred to as the ‘f-number’ of the transducer. This then shows the focal 
zone length, for a transducer with f-number equal to one (common for HIFU 
transducers) will be approximately 10 times the local wavelength of the propagated 
ultrasound (approximately 15 mm at a frequency of 1 MHz in soft tissue, similar to that 
observed in a previous study [4]). 
The degree of focusing of a transducer can be quantified by the ratio of near field 
length to focal length. If this value is lower than six, the focusing is considered weak, if 
it is equal to 20 or more then the transducer can be said to have a strong degree of 
focus [31]. 
Note: As previously stated, the term ‘aG;b’ or the ratio of focal length to diameter of the transducer, is 
generally referred to as the 'f-number', and it is widely used to concisely describe transducer geometry. 
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3.4.2: Transducer Geometries 
As the geometry of a particular transducer depends heavily on the application it is 
designed for there exists a multitude of differing geometries to choose from. In the 
following section transducer geometries that can be effectively utilised for HIFU use 
will be described here. 
3.4.2.1: Planar + Lens 
This type of transducer setup generally involves a planar, single element transducer 
used in conjunction with a suitable acoustic lens, commonly fabricated from acrylic 
resin (see Figure 9, created using [74]). One example of this apparatus is used in a 
previous study [23] where a 10 cm diameter PZT-4 disc transducer (single element) is 
focused using a Perspex lens with radius of curvature 6.3 cm, resulting in a total focal 
length of 14 cm. A similar transducer arrangement is used in the Haifu model JC [70]. 
Here a 12 cm diameter PZT-4 disc transducer again constructed as a single element, is 
used in conjunction with an acoustic lens resulting in a total focal length of 90 mm, 
although in this case the transducer/lens assembly can be displaced using a highly 
accurate mechanical positioning system, allowing adaptable treatment planning. This 
type of arrangement can be said to be analogous to the focusing of the incident 
sunlight using a magnifying glass, which given the right conditions, can cause the 
temperature at the focus to become elevated to the point that combustion occurs. 
The drawback of using this kind of transducer arrangement is that energy is lost as the 
ultrasound propagates through the lens. This results in a lower overall efficiency. In 
addition the focal spot can only be shifted by physically moving the apparatus, or 
changing the lens used. 
 
Figure 9 - Diagram showing planar transducer (A) focused to a point (C) using an acoustic lens (B) 
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3.4.2.2: Linear & Linear Phased Arrays 
Linear arrays comprise a number of elements, generally in just one direction (one row) 
although this is not always the case. The elements in liner phased arrays can be used 
to alter the position of the focus by altering the phase (or timing) of the input signal to 
each element. This allows not only transverse steering but also dynamic depth 
focusing, as can be seen in the diagram below (see Figure 10, [75]). This type of 
transducer is commonly used in diagnostic ultrasound devices, where the focusing is 
weak and is utilised to obtain a higher quality image, rather than focusing to create 
high peak intensity at the focus, as is performed when using HIFU in surgical 
applications. In HIFU applications there is a need to focus in the elevation direction, as 
well as in the transverse. This generally requires a different type of transducer 
geometry. 
 
Figure 10 - Using phased excitation signals to steer and focus a linear array 
3.4.2.3: Linear Phased Array with Lens 
Similarly to phased cylindrical-section arrays this kind of transducer assembly allows 
pre-focusing in the elevation direction while utilising phased signals to focus in the 
azimuth direction (see Figure 11, [75]). Using this type of arrangement does not seem 
to carry any major advantage over using a cylindrical-section phased array, which 
utilises curved elements in place of a curved acoustic lens, to allow pre-focusing in the 
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elevation direction. One advantage that this type of transducer arrangement may 
provide is a lower initial cost, as the manufacturing process to create a cylindrical-
section linear array is more complicated and therefore generally more expensive. 
Although this is true, the higher running caused by using a lens due to decreased 
efficiency will eventually overshadow the lower initial cost of fabrication. It is for these 
reasons that the arrangement described cannot be recommended. If this general type 
of assembly is sought it is this author’s opinion that a curved linear phased array, with 
radius of curvature equal to the equivalent lens radius of curvature should be used 
thus allowing focusing in two planes with no ‘extra’ losses in the lens apparatus. It 
should be noted here that using this type of arrangement, controlling focal depth is 
made difficult by the fixed curvature of the lens, while focal position in the azimuth 
direction can be controlled using phased excitation signals to the individual elements 
in the array. 
 
Figure 11 - Diagram of a phased linear array, pre-focused in the short axis dimension using an 
acoustic lens 
3.4.2.4: Spherical-section / Annular Phased 
Spherical-section transducers generally resemble the shape of a bowl and have a 
natural focus equal in length to the radius of the transducer (see Figure 2 for an 
example). It is common when using annular transducers to also use a motorised gantry 
to allow the transducer to be accurately positioned for use. 
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Spherical section phased transducers generally make use of annular or ‘ring’ 
electrodes, which can be used to control the focal depth by manipulating the phase 
difference of the excitation signals provided to each element. An important design 
note for this type of ring arrangement is that grating lobes (for example side lobes 
around the main, focal lobe) can be avoided if the pitch of the ring elements 
(measured between element centres) is less than a wavelength wide in the transducer 
material used [24]. 
3.4.2.5: Annular Truncated (Transrectal/Transvaginal) 
This type of transducer is a modified version of the above. Here two parallel planes are 
used to truncate the originally bowl shaped transducer. This results in a ‘spoon’ or 
‘scoop’ shape, the primary advantage of which is the facilitated entry of the transducer 
into the rectal or vaginal cavities.  
As with their non-truncated counterparts, these transducers can also make use of ring 
elements and phasing of excitation signals, the difference here is that only the 
centremost elements are full rings, while the outer elements form partial rings due to 
the truncation of the two parallel sides (see Figure 12, [76]). 
 
Figure 12 - Diagrammatic representation of a truncated annular phased array – coloured bands 
represent neighbouring ring elements 
 
3.4.2.6: Cylindrical-section / Linear-concave 
As previously mentioned this type of transducer array utilises geometry to pre-focus in 
the elevation direction. Just as the spherical-section type transducers have a natural 
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focus at a distance equal to the radius of the ‘bowl’, annular arrays are pre-focused at 
a distance equal to the radius of curvature of the cylindrical section used in 
construction. Compared to their annular counterparts the cylindrical focusing will be 
weaker because they are naturally focused in only one direction (the elevation 
direction) not two (azimuth and elevation) as in annular transducers. In effect these 
transducers focus ‘along a line’ rather than to a predetermined central point. 
3.4.2.6.1: Cylindrical-section / Linear-concave - Phasing Techniques 
Using differently phased signals applied to the elements of an array in this type of 
transducer allows more than one method of dynamic focusing. As the ‘beam’ produced 
is already focused in the elevation direction (as described above) using multiple 
elements in the azimuth direction therefore allows the beam to be steered along the 
‘line’ of focus (in the ‘x-direction’ shown in Figure 13, left [77]). This is an effective 
method of use in terms of FUS provided there is sufficient intensity at the desired focal 
point. It is worth noting here that the resultant focal zone (when focusing off-centre 
using phasing) and hence the lesion produced would be at an angle to the cylindrical z-
axis, therefore a more complex treatment plan would be required to compensate for 
this effect to allow optimal coverage of the target volume. 
Another option is to use synthetic apertures. This involves exciting only some of the 
elements in the (hypothetical) cylindrical array. If for example the array had sufficient 
power output using only half the available elements then a focus could be achieved 
anywhere within the centre two-quarters (of the array (see Figure 13, right). The focus 
formed in this case would not be at angle as the beam has not been steered. 
 
Figure 13 - (Left) Diagram of a cylindrical phased array transducer - (Right) Half of transducer 
elements activated, giving a focus at one quarter along transducers length 
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3.5: Chapter Conclusion 
In conclusion this chapter has introduced theory relevant to acoustics and sound wave 
propagation and its interaction with matter. The concept of acoustic intensity has been 
introduced, as well as an expanded description of attenuation coefficients with 
examples of typical values for the attenuation of acoustic waves within some common 
tissues being given. Acoustic impedance has also been introduced which will be an 
important physical property to consider during HIFU transducer design. 
A further explanation of HIFU has been given, with information on ultrasound and 
magnetic resonance imaging as methods of guiding surgical HIFU treatments. 
Furthermore an explanation of the basic construction of devices capable of producing 
ultrasound has been presented along with factors that affect the properties of the 
acoustic fields, produced by these transducers. The concept of a focal ‘f-number’ has 
been briefly introduced. Information on various methods of beam focusing and 
steering has also been presented, which is an important factor when considering the 
design of a surgical device capable of tissue ablation within a volume, as is the main 
focus of this research. A number of ultrasound transducer geometries have been 
described and characterised, forming a basis for the suitability study presented in the 
following chapter (see Section 4.3). 
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Chapter 4:        
           
                 
Integration of HIFU & EIM 
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4.1: Chapter Introduction 
In this chapter the problem at hand, to integrate a HIFU device into an existing 
Electrical Impedance Mammography (EIM) imaging system, will be fully defined. From 
this definition a suitability study of the transducer geometries described in the 
previous chapter will be given, with a focus on integration with the EIM system. A 
suitable transducer geometry will then be selected and following this a design 
specification will be created. Various properties of the proposed transducer will be 
decided in this section, specifically those that will affect the resultant acoustic field of 
the resultant HIFU device and thus the effectiveness of the device as a surgical tool. 
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4.2: Problem Definition 
As stated in the introduction to this thesis, the main objective of this study is to 
integrate a HIFU transducer into the existing EIM scanning apparatus. In addition the 
field of view of the HIFU transducer, and therefore the treatable zone, should be as 
close as possible to the entire volume scanned by the EIM system. This must be 
considered when defining suitable transducer designs. It is therefore now pertinent to 
define the restrictions imposed by this existing imaging device. 
The existing device is designed to diagnose and locate cancerous tissue within the 
human breast and to this effect has been designed to have a patient interface in the 
form of a cylindrical tank, with a diameter of approximately 18 cm. Within this 
cylinder, or ‘scanner head’ (see Figure 14, created using [74]) an ‘electrode plate’ (see 
Figure 15, created using [74]) is installed, fixed within which are a number of equally 
spaced electrodes covering the plate, that form the active part of the apparatus when 
performing an EIM scan (note in Figure 14 all but the central electrode hole have been 
removed due to intellectual property issues). The electrode plate can be translated 
vertically using a stepper motor (located below the scanner head) via a leadscrew 
arrangement. The plate can also be rotated using a second steeper motor. 
The electrodes are a vital part of the EIM system, to which modifications should be 
minimised. Having said that, in previous projects involving modifications and additions 
to this plate removal of a small number of these electrodes has been permitted. 
Without going into great detail this removal leaves an available space of approximately 
7 cm by 2.5 cm, therefore this is the maximum available space for addition of a HIFU 
transducer, assuming it were to be installed into the plate. This space would therefore 
allow a physical footprint of 17.5 cm2, a figure that must be considered when 
determining the acoustic power produced, and therefore the maximum focal intensity 
possible, as the power produced is directly proportional to the active surface area of 
the transducer. It should be noted here that different piezoelectric materials will have 
differing maximum acoustical powers, therefore with a limited available space a 
material with a high acoustic power output should be selected. Appropriate material 
selection will be covered later in this thesis. 
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Figure 14 - EIM system ‘scanner head’; (A) ‘Electrode plate’, (B) ‘Top surface of scanner head’ 
(flush with system bed cushioning prior to patient being positioned) 
 
Figure 15 - Plan view (left) and 3D view (right) showing simplified ‘electrode plate’ showing centre 
EIM electrode hole and rectangular section removed for hypothetical installation of HIFU transducer 
One of the challenges that must be overcome if the HIFU transducer is to be installed 
into the electrode plate is the centre electrode (see Figure 15). This electrode is vital in 
the operation of the EIM system, thus cannot be removed. This means that the centre 
‘column’ above this electrode would not easily be covered by the field of view of the 
HIFU transducer, if the transducer was to be placed in the gap shown. Although this is 
a potential drawback to the operation and effectuality of the FUS treatment it has 
been decided that at this prototyping stage it is more important to achieve a working 
‘proof of concept’ design that confirms the feasibility of HIFU transducer incorporation 
and that the problem of this centre electrode will be addressed at a later date once the 
prototype has been proven successful. One possible solution to this problem is to focus 
outside the length of the array by using phased excitation signals. The feasibility of this 
‘extreme’ focus will be explored using simulations, the results of which will be 
presented later in this thesis (see Chapters 5 & 6). 
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At present the patient is required to lie face down on the system ‘bed’ and insert one 
breast into the scanner head (located in a cut-out in the bed cushioning) after which 
the electrode plate is lifted using a motor to a distance of less than 1 cm away from the 
skin of the prone breast. The breast itself may be compressed using a second plate 
giving a maximum tissue ‘height’ of 4 cm. During an EIM scan the scanner head is filled 
with a weak saline solution at temperature of approximately 37 °C. Therefore the total 
distance from the plate to the chest wall of the patient is 5 cm, 1 cm saline solution 
(maximum) and 4 cm breast tissue. A further challenge to HIFU transducer 
incorporation is that there must be no interval between the EIM scanning of the 
patient and the HIFU treatment, as movement of the patient, be it purposeful or not, 
would adversely affect the treatment plan and could result in ablation of healthy tissue 
or failure to ablate the target tumourous tissue. The compression of the breast itself 
will assist in preventing movement but the main consideration here is that the HIFU 
transducer must be in place before the EIM scan commences to ensure minimum 
movement between scanning (EIM) and treatment (HIFU). Therefore it is not possible 
to ‘swap’ the electrode plate for a ‘HIFU’ plate and as such, the HIFU transducer must 
be incorporated into the existing plate, or must be situated outside of the scanner 
head itself. Situating the HIFU transducer outside the scanner head has some 
drawbacks. Firstly, the scanner head is housed in a bed or ‘trolley’ that contains the 
various subsystems allowing EIM scans to take place. At present the space within the 
trolley and around the scanner is limited by design. This allows the physical footprint 
of the complete system to be minimised (to be of similar size as that of a standard 
hospital bed) but also means that the available space is limited. Secondly the scanner 
head cylinder itself is constructed from thick Perspex, so the ultrasound waves would 
be attenuated somewhat. This means the transducer would have to be able to provide 
enough ‘extra’ acoustical power output to compensate for this. Given the limited 
space around the scanner head this may become a problem, as the acoustical power 
output is dependent on the active surface area of the transducer. Furthermore, to 
avoid this problem an acoustic ‘window’ would have to incorporated into the scanner 
head design, and as the scanner head must be watertight, this would mean a 
significant if not total redesign of the apparatus would be needed. In this author’s 
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opinion this should be avoided unless absolutely necessary, at least at this ‘proof of 
concept’ design stage. 
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4.3: Suitability Study 
Now the problem at hand as been defined and a brief description of relevant 
transducer types has been given (see Section 3.4) it is relevant to shortlist the 
transducer types that are most compatible with the existing apparatus. The possible 
configurations therefore will be briefly described and following this the most 
appropriate design will be selected. 
One possible configuration is to use a spherical-section array from underneath the 
cylinder. Using annular elements would allow ‘depth’ of the focus to be controlled, 
such that a focal point could be created anywhere along the ‘central axis’ of the 
transducer. Although this would allow a focus along the central axis of the cylinder 
from where the transducer is mounted, steering side-to-side would be difficult to 
accomplish. Tilting the transducer to achieve this would mean the coupling to the 
cylinder would be made difficult. Also to allow this tilting there would have to be an 
auxiliary movement system in addition to those already present in the existing 
apparatus. Alternatively this movement system would have to be capable of 
translating the transducer around the base of the cylinder such that the whole volume, 
and therefore the whole of the breast, could be treated. All these methods would 
involve not only an additional motorised movement system, but also a suitable 
coupling or acoustic window. As described previously this would be difficult to achieve 
due to the cylinder having to remain watertight at all times. For this and all the 
previous reasons mentioned it is suggested that this design not be used, unless a 
complete redesign of the existing scanner head is to be carried out. 
A cylindrical-section transducer mounted to the side wall of the scanner head cylinder 
is another option. In this case, with a transducer of sufficient length, a focus could be 
generated anywhere along the length of the transducers focal plane within the 
cylinder volume. The problem here then would be achieving a variable focal depth 
(‘into’ the cylinder) which is difficult even when using a phased cylindrical-section array 
due to pre-focusing in the perpendicular direction. Also coupling to the cylinder would 
remain a problem, as with the case of a spherical-section array, which is a major 
concern if the present design is to main unchanged. 
76 
 
A further possibility would be to use a number of cylindrical-section or spherical-
section arrays with differing radii of curvature. This would allow focusing at a number 
of depths. The drawback here is that to cover the entire range of possible focal regions 
many transducers would have to be incorporated. This means higher costs, additional 
space requirements and very precise placement would be necessary. Also the issue of 
coupling and an acoustic window would remain. Therefore this may not be the most 
efficient or effective solution, given the existing setup and geometryof the system. 
Given the above arguments it seems logical not to mount the HIFU transducer(s) to the 
side of the cylinder (although it should be noted this does not mean this will 
necessarily be the case in future designs). Another option, discussed in passing earlier 
in this thesis is to position a transducer underneath the target volume. The easiest way 
to implement this would be to integrate a transducer into the existing electrode plate, 
such that the active surface is in direct contact with the liquid in the scanner head 
(which is in turn in direct contact with the patient). This would minimise losses due to 
attenuation that would be present if the ultrasound had to propagate though the thick 
Perspex scanner head cylinder, as in the previous suggested designs. In addition the 
existing electrode plate has not one but two motors, one controlling the height of the 
plate, and the second the rotation, both present already for EIM scanning. Given that 
in the existing design the plate can both rotate and move vertically it seems that the 
optimum solution, at least with the present EIM system, would be to mount a 
transducer into the plate, thus removing the need for an additional movement system 
and keeping the costs of implementation to a minimum. Given the volume of the 
prone breast, a HIFU transducer situated in the gap in the plate (see Figure 16) could, 
when combined with the existing movement system, potentially cover the entire 
volume of the scanner head cylinder, minus the central ‘column’ above the centre 
electrode as previously explained. At present this seems to be a most effective and 
efficient solution for the integration of a HIFU device into the existing EIM apparatus. 
As described earlier two transducer types seem suitable for use if placement is to be 
below the target volume. The first would be to use spherical truncated type transducer 
(see Figure 12) typically used in transrectal treatment, such as that of the prostate. The 
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parallel truncated planes would allow the transducer to fit into the gap in the 
electrode plate, and using annular elements, would allow control of focal depth. A 
disadvantage however would be that a motor system would still be needed to 
translate the device from one end of the gap to the other, thus allowing the full 
volume to be targeted. This could be achieved also by tilting the transducer, but would 
also require an additional motor to be added to the system. Furthermore the 
advantage of controlling focal depth is somewhat negated by the fact the plate already 
has a motorised mechanism allowing vertical movement, therefore it is suggested that 
this arrangement is not the optimum solution. 
Finally the configuration that seems most effective is that of using a linear concave 
(cylindrical-section) transducer mounted in the gap in the electrode plate (see Figure 
16, created using [74]). 
 
Figure 16 - Linear concave HIFU transducer array situated within gap in electrode plate. 
As described earlier in this thesis this type of transducer naturally focuses ‘along a line’ 
at a distance from the transducer equal to the radius of curvature of the section. This 
line can be ‘concentrated’ into a single focal point by making use of phase differences 
between the excitation signals sent to each element. Furthermore this point can be 
steered anywhere along the line by altering the phase difference between elements, 
thus allowing a focal point to be generated anywhere along the line of natural focus 
(the transducer lateral axis). Adding to the usability of this type of transducer is that 
use can be made of ‘synthetic apertures’ in that not all elements have to be excited at 
once. This provides a double advantage as it would allow perpendicular focal points 
and therefore lesions (when focused within tissue) to be created rather than those at 
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an angle which would be produced when steering the beam using phasing of elements, 
so allowing for a less complex treatment plan to cover the area to be ablated. In 
addition unwanted grating lobes could be avoided by selecting only certain elements 
and avoiding those which destructively interfere with the treatment plan. This second 
advantage would require a fair amount of planning and simulation to perfect, but 
would be a great help when targeting unhealthy tissue close to bone, such as the 
ribcage [50] and thus would facilitate treatment of patients with smaller breast sizes. 
An example model of a transducer of this type is shown below (see Figure 17, created 
using [78]). 
 
Figure 17 - Example geometry of an extracorporeal linear curved phased array transducer 
Finally the issue of targeting above the centre of the centre electrode of the electrode 
plate may be circumvented by using phased signals to focus outside the length of the 
HIFU array. This will be verified by simulation to check the feasibility of such a focus. 
Thus targets within the centre two-quarters of the length of the array could be treated 
using half the total number of elements, centred on the target volume, while focal 
targets outside the centre two quarters of the array could be treated by using all 
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elements, with phase difference being employed to focus, even at points outside of the 
transducer’s length (an ‘extreme’ focus).  
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4.4: Design Specification 
Now that the geometry of the transducer has been described it is relevant to begin to 
detail the exact parameters that would be best suited to the application at hand. All 
transducers have particular common features, most of which interrelate to each other 
in some way or another. These features will now be listed and then detailed according 
to the geometry selected in the previous section of this thesis. It should be noted 
however that certain parameters will only be known once manufacturers have been 
consulted, as not all information, for example concerning the piezoelectric material 
used, is freely available and manufacturers often have their own proprietary materials 
of which details are not released to the public. 
The features common to all transducers are: 
• Piezoelectric material 
• Operating frequency 
• Array dimensions 
• Element dimensions (thickness, width and length) 
• Inter-element spacing (kerf) 
• Matching layer 
• Backing/damping materials 
• Housing and Insulation  
• F-number 
• Driving electronics and circuitry (see Section 7.3.2) 
• Control system  
In addition to being inter-related to one another, the above factors will affect the 
resulting: 
o Q-factor 
o Electrical efficiency 
o Total acoustical power (TAP) output 
o Intensity at focus 
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And therefore the: 
• Resulting heat deposition or ‘thermal dose’ in the tissue being treated 
4.4.1: Piezoelectric Material 
As space is strictly limited by the dimensions of the available gap in the electrode plate 
the piezoelectric material must be selected carefully. To successfully ablate tissue it is 
advantageous to have as high a focal intensity as possible (within reason) and 
therefore the material used in this case must be capable of producing a high peak focal 
intensity. Due to space restrictions this means a high TAP which will vary depending on 
the material used. Below (see Table 4) is a comparison of a number of materials 
commonly used in transducer construction [33], [79], [80]. 
Table 4 - Comparison of common piezoelectric materials used in transducer manufacture 
Material name Comparative description Commonly used in 
PZT-4 Low dielectric losses, commonly used in 
electrical power generating systems 
Medium to high 
power applications 
PZT-5H Very high sensitivity and permittivity, best 
suited to receiving/measuring applications 
Diagnosis/Imaging 
(eg. Hydrophones) 
PZT-8 Similar to PZT-4 with even lower 
mechanical losses, used in application 
requiring high power output 
High power 
applications 
IMASONIC HI-1 
 
Proprietary piezocomposite offering high 
efficiency (60-70 %), mechanically robust 
and flexible in shape and size (when used 
in construction of arrays) up to 10 W/cm2 
acoustical output 
Medium power 
applications 
IMASONIC HI-2 Proprietary piezocomposite  with lower 
efficiency than HI-1, but offering a high 
acoustical output of up to 30 W/cm2 
High power 
applications (eg. 
Therapy) 
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As the limited space available is a major concern, both PZT-8 and Imasonic HI-2 seem 
to offer potential benefits. Imasonic have been pre-selected as the manufacturers for 
the designed transducer and so it seems that their proprietary material HI-2 would be 
the most logical choice. Given that the properties of HI-2 are not publically available 
PZT-8 properties will be used for any estimations in later sections of this thesis. It 
should be noted that this will lead to an underestimation of produced powers which 
could later be improved once more information on HI-2 is obtained. 
4.4.2: Operating Frequency 
When using a HIFU transducer for tissue ablation certain parameters have to be 
decided upon. These parameters include dimensions, geometry, materials used in 
construction, required output power and also the frequency at which the transducer 
will be driven. This last parameter, the frequency, should be chosen to match the 
required depth of focus, with lower frequencies being used to ablate deeper targets 
and vice-versa. As this parameter effects other design decisions it is pertinent to define 
it before continuing on. 
 It has been shown that a suitable frequency is such that the transmitted signal 
undergoes 10 dB attenuation when propagating through the tissue overlying the target 
zone [38], [56], [26]. At present, the maximum volume of breast tissue that can be 
scanned in the existing EIM device gives a maximum breast ‘height’ of 4 cm, so if we 
assume a tissue attenuation coefficient (α) of 0.7 dB/cm/MHz [38], [56] we can then 
approximate the optimum frequency to be used, given the transducer being mounted 
below the target volume (for example incorporated into the electrode plate, see Figure 
16 & Figure 19, created using [74], also see Figure 18). 
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Figure 18 - Diagram showing possible arrangement of HIFU transducer in existing EIM system 
(vertical) 
 
Figure 19 - Diagram showing possible arrangement of HIFU transducer in existing EIM system);    
(A) ‘Scanner head cylinder’, (B) ‘Electrode plate’, (C) ‘Central EIM electrode’, (D) ‘Transducer 
element array’, (E) ‘Edge of transducer’, (F) ‘’Possible focus points (anywhere along length of line)’ 
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-Given 4 cm tissue depth, attenuation will be:  2.8 dB/MHz 
It is worth noting here that a 1 cm water ‘stand-off’ will also be used, giving an actual 
focal distance of 5 cm, but as the attenuation coefficient of water is approximately 
0.0022 dB/cm/MHz [81] compared to 0.7 dB/cm/MHz of breast tissue the 1 cm of 
water will attenuate the sound waves far less and therefore can be fairly omitted from 
estimations made at this stage. 
Given optimum frequency is when total attenuation in tissue is equal to 10 dB 
-Optimum frequency will be:  3.57 MHz 
It can also be shown that optimum frequency can be estimated using the following 
formula [41] 
   _ = a 3I462Ib ∗  2[d      {4.1} 
Using this formula, with focal height ([) equal to 4 cm and d equal to 0.7 dB/cm/MHz, 
gives an optimum frequency of 3.1 MHz. 
Another point here worthy of note is that the attenuation coefficient for breast tissue 
(α) is very difficult to calculate or quantify as each individual will have a different 
composition of tissues making up the breast. For general ‘soft tissue’ however, an 
attenuation coefficient in the range 0.3 to 0.8 is widely accepted [27] with 0.5 to 0.7 
being values that have been used in previous, similar estimations, 0.7 being used most 
commonly. 
Cavitation can be caused by low frequencies of ultrasound [22] and therefore it is 
recommended that the higher of the above two frequencies should be used to avoid 
the unnecessary effects and unpredictability that cavitation may cause. To simplify 
further calculations 3.57 MHz will be rounded down to 3.5 MHz. 
This frequency is similar to those used in transrectal type devices (35 mm focal 
length/5 MHz [82], 50 mm focal length/3 MHz [48]). Although these devices are 
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relatively small they can still produce focal intensities (spatial average) of above 6000 
W/cm2 [48] well within the range needed for HIFU ablation (100 – 10 000 W/cm2 [83] 
and typically around 1500 W/cm2). 
In the case that the transducer is mounted to the side of the EIM system cylinder, a 
similar estimation to that just performed can be carried out. In this case the maximum 
focal depth will be greater, so the optimum frequency will be lower. Here the 
maximum focal depth into the tissue is approximately 8 cm. 
 
Figure 20 - Diagram showing possible arrangement of HIFU transducer in EIM system (horizontal) 
Using 8 cm focal depth and assuming an attenuation coefficient (α) of 0.7 MHz/dB/ cm 
[38], [56] as previously, we can see that 
 -Given 8 cm tissue depth, attenuation will be:  5.6 dB/MHz 
Given optimum frequency is when total attenuation in tissue is equal to 10 dB 
-Optimum frequency will be:  1.79 MHz 
As previously stated it can also be shown that optimum frequency can be calculated 
using the following formula [41] 
   _ = a 3I462Ib ∗  2[d      {4.1} 
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With ‘[’ set equal to 8 cm and ‘d’ equal to 0.7 MHz/dB/cm, this formula yields an 
optimum frequency of 1.55 MHz. Again, for the reasons described previously, the 
higher of these two frequencies should be chosen, and to simplify further calculations 
this will be taken to be 1.8 MHz. 
This frequency is similar to those used in larger, extracorporeal devices such as the 
1.25 MHz annular array with a focal length of 10cm, as described in [30]. 
4.4.3: Intensity at Focus:  Transducer Power Requirements 
As stated in the preceding section the minimum focal intensity produced by the 
designed transducer must be greater than 1000 W/cm2 and preferably more than 1500 
W/cm2. Using this as a benchmark figure the required acoustic power output from the 
transducer can be estimated. This is an important step as it will determine the 
necessary transducer surface area, for a given transducer material with a set maximum 
(material) power density.  
As the cross section of the focal region (ellipsoid) can only be determined by 
simulation or indeed physical measurement there will be a certain amount of error 
involved in this estimation, as such the power estimation here should not be taken as 
exact. Nevertheless, using an estimation of this kind allows an idea of the order of 
magnitude of power necessary to ablate tissue to be obtained and therefore the 
minimum required transducer surface area which will determine the feasibility of use 
in space-restricted applications. Using the formula below [41] and assuming an annular 
transducer with focal length 4 cm and aperture of 3 cm, operating at 3.5 MHz in water 
(sound velocity 1526 m/s at 40 °C [84]) the focal ellipsoid cross sectional area is 
approximately 
   U	 = 		 F3G3e         {4.2} 
Here ‘’ is the cross sectional area of the focal ellipsoid, ‘f is the wavelength of 
ultrasound (0.43 mm at 3.5 MHz) in water, ‘f	 is the focal length (50 mm) and ‘A’ is 
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the area of the transducer (1750 mm2). This approximation yields a focal area of 0.27 
mm2. 
This is obviously only an estimation as the actual, realized focal ellipsoid cross-section 
can only be calculated by precise simulation or physical measurement given the 
material properties of soft tissue (breast tissue) are not exactly the same as that of 
water, although they are similar. However this value is comparable to those obtained 
experimentally, with one such paper reporting cross sections of 0.4 to 1.5 mm2 for 
focal depths of 30 to 60 mm, with a transducer operating at 3 MHz [48]. Also smaller 
focal zones are generally associated with higher frequencies, so it can be assumed that 
this value is within the order of the expected focal cross-section, once it is (physically) 
measured. 
Using this focal area the required power output of the transducer can be approximated 
by working backwards, starting with a set required intensity at the focus. If we assume 
that the required focal intensity is set at 2000 W/cm2 (overestimated) we can then 
calculate the corresponding focal power by multiplying by the area of the focal 
ellipsoid. This calculation yields a focal power of 5.4W. In calculating the optimum 
frequency earlier we defined the attenuation in tissue to be 10 dB. This then allows the 
power, incident at the tissue boundary, to be calculated as 54 W. Between the 
transducer and the tissue boundary there is a small gap that, when in operation, would 
be weak saline solution (effectively water). If this standoff is taken to be 1 cm, then the 
attenuation in this area can be calculated using the attenuation coefficient of water 
(0.0022 dB/MHz/cm [31]). Working through similar steps as for the attenuation in 
tissue it can be shown that the attenuation in 1 cm of water (at 3.5 MHz) will be 0.0077 
dB, which equates to an approximate power loss of 0.1 W. This means the total 
acoustic power output from the transducer must be at least 54.1 W to achieve a 
reasonable intensity at the focus, given a transducer with dimensions as described 
above. Assuming a transducer efficiency of 50 % (material IMASONIC ‘HI-2’ [33]) this 
means an approximate electrical power of 108.2 W should be applied to the 
transducer. 
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Given the available space in the EIM system electrode plate (as previously described) 
this power will be applied to a transducer with a maximum surface area of 17.5 cm2 (7 
cm x 2.5 cm). As the maximum acoustical output from HI-2 is 30 W/cm2 [33] the 
required power should be relatively easy to achieve, although the maximum output 
may be dependent on other factors that will not become apparent until discussions 
with Imasonic themselves commence. Ignoring this for the time being, and assuming a 
maximum achievable output power of 25 W/cm2 coupled with the available space, it 
can be shown that an acoustical power output of 437.5 W is theoretically achievable. 
For the transducer shown previously (see Figure 20, 1.8 MHz, focal length 8 cm, 
aperture 6 cm) working through the same steps, yields an approximate focal area of 
1.66 mm2 and an acoustic power output of 333 W with a corresponding electrical 
power input of 666 W. 
4.4.4: Array Dimensions, Element Dimensions & f-number 
The maximum physical ‘footprint’ of the completed array has already been defined as 
the size of the space in the EIM electrode plate (7 cm x 2.5 cm). The dimensions of the 
piezoelectric material used in the construction of an ultrasound transducer are of vital 
importance. This must be taken into account when designing the array and, more 
importantly, when deciding the dimensions of each element in the array. The 
dimensions used will be dependent on the operating frequency. The thickness of the 
material for example, as mentioned previously, must be equal to half the wavelength 
of sound (in the piezoelectric material) for preferential emission [31], [27]. 
Given a frequency of 3.5MHz and the sound velocity in the piezoelectric material used, 
the wavelength is known and therefore the optimum element thickness can be chosen. 
PZT-8 (as example, although Imasonic HI-2 will eventually be used) has a sound 
velocity of 4600 m/s [84] therefore the wavelength of sound (in PZT-8) equals 1.314 
mm, while the wavelength in water (at 40 °C [84]) equals 0.43 mm and the wavelength 
in tissue equals 0.44 mm. Therefore the optimum thickness of PZT-8 used in 
transducer construction would be (1.314/2 mm) or 0.657 mm. 
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Although the thickness of the piezo material used is quite easily defined, determining 
suitable width and length of each element in the array is more difficult. If we assume a 
cylindrical-section array is to be used we can, at least for the time being, estimate the 
dimensions from those used in a previous study [56]. Here element width was varied 
between one and three wavelengths (in water) with one wavelength being the most 
effective in terms of preventing the creation of unwanted, non-focal lobes. If we take 
the element width to be one wavelength in water, this gives a width of 0.43 mm, which 
doesn’t agree with the ‘rule’ that the aspect ratio (thickness to width) of each element 
must be equal or greater than two to avoid unwanted lateral modes of vibration [34]. 
It should be noted however that simulations, of which results will be presented later, 
will be used to determine if these dimensions are valid, and these values will not be 
finalised until confirmation is obtained from the results of these simulations. 
The ‘length’ of each element is dependent on the radius of curvature of the cylindrical-
section, which will be equal to 5 cm. As the available space in the EIM electrode plate 
is 2.5 cm this is the maximum aperture in the ‘height’ direction, although the measure 
itself will be equal to the cord length of the arc section (see Figure 21). 
 
Figure 21 - Diagram showing cross-section of cylindrical transducer with radius of curvature and 
aperture length 
Finally the inter-element spacing or ‘kerf’ needs to be defined. This parameter will also 
be varied in simulations to find the optimum value or range but as space is limited it 
follows the kerf should be minimised to allow the active transducer surface to have 
maximum surface area, hence maximum power output given the space and power 
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restrictions described previously. As a guide, at least one group have reported good 
results using a kerf with a size of half a wavelength (in water) [56]. It should also be 
noted that the minimum sized kerf will depend in part on the limits of the 
manufacturing techniques involved in the manufacture of the transducer, a limit that 
will only become known once discussions with the manufacturers commence. 
As the transducer will have a 2.5 cm aperture and a focal length of 5 cm, the 
transducer can be said to have an ‘f-number’ of 0.5. This measure may not be as useful 
for characterising cylindrical transducers as compared to their annular counterparts, 
but it has been included to facilitate comparison between this and other transducers. 
4.4.5: Transducer Construction 
4.4.5.1: Matching Layer 
As mentioned in a previous section of this thesis a matching layer is generally present 
between the piezoelectric material and the propagation medium. This allows losses 
caused by differences in acoustic impedance (at the boundaries) to be minimised, thus 
increasing the overall efficiency of the transducer. The matching layer is designed to 
have thickness equal to one-quarter of the wavelength in the piezoelectric material 
used and, again as previously mentioned, should have an acoustic impedance  given by 
the formula below [31]. 
  KBU8<9,67	4UX5S 	= 		ZK8SU6>;W<5S		[		KB5;,WB   {3.8} 
Where, as before 
 K	 = 		D<        {3.4} 
More than one matching layer can be used, but as this would increase the attenuation 
of the ultrasound it is generally recommended to use just one matching layer. As the 
density and sound velocity of the material most likely to be used (Imasonic HI-2) is 
presently unknown, values for PZT-8 will be used instead. Assuming a density and 
sound velocity of 992.2 kg/m3, 1526 m/s and 7600 kg/m3 , 4600 m/s for water (at 40 °C 
[84]) and PZT-8 [85] respectively, we can calculate the corresponding acoustic 
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impedances as 1.514 MRayl and 34.96 MRayl. This gives an optimum matching layer 
acoustic impedance of 7.275 MRayl, if PZT-8 wereto be used in the transducer 
construction. 
Although the density and sound velocity of Imasonic HI-1 and HI-2 technologies are 
unknown, the range of acoustic impedance has been presented [33] and is in the range 
8 to 12 MRayl. This gives an optimum matching layer impedance in the range 3.48 to 
4.26 MRayl 
4.4.5.1: Backing & Damping, Q Factor 
As described previously the backing (or damping) block is located behind the 
piezoelectric element (see Figure 5) and absorbs backwards propagated and stray 
ultrasonic waves produced by the piezoelectric elements. The main function of the 
damping block is to dampen the forward propagated ultrasound to create a pulse, 
rather than a continuous wave. Increased damping introduces a broader band of 
frequencies around the resonant frequency. The extent to which the damping causes 
this effect is quantified using a measure named the 'Q-factor'. 
  T	 = 	<5685S	S5>J6U68	GS5VW56<X/HU6;:,;89  {3.7} 
Here, as previously mentioned, a high Q-factor value indicates a narrow bandwidth 
around the resonant frequency (long pulses) caused by a small amount of damping, 
while a low Q-factor indicates a wider bandwidth (short pulses) given rise to by heavier 
damping. 
Generally, excluding certain special cases, it is preferable to have a high Q-factor for 
HIFU applications, such that a narrow bandwidth is achieved. This allows the effects of 
attenuation to be more easily predicted as attenuation is directly proportional to the 
frequency of the ultrasound propagating through the medium of interest, thus the 
energy deposited, or thermal dose can be more accurately planned for. This is an 
important feature of HIFU transducers designed for precise thermal ablation of target 
tissues. 
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The backing material that will be used for the transducer design outlined in this thesis 
will not be known until the manufacturers are consulted. Having said this there will be 
some solid backing present going on the available description of the HI-2 material 
technology manufactured by Imasonic. This backing is present to allow more efficient 
cooling and to provide increased resilience to mechanical and thermal shocks [33]. 
4.4.5.1: Housing & Insulation 
The housing and insulation of a typical, single element transducer has been presented 
diagrammatically earlier in this thesis (see Figure 5 - ‘plastic casing’). The shape, 
dimensions and material used will be defined with the aid of the manufacturers and 
will be influenced by the available space in the EIM electrode plate, described earlier. 
It is important that both the housing and the transducer’s active surface are all 
watertight and submersible as the transducer will be sealed into the plate to prevent 
liquid reaching the sensitive electronics mounted below. Again, the details of this will 
become more apparent once discussions with the manufacturers begin. 
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4.5: Chapter Conclusion 
To conclude, in this chapter a full problem definition has been given, describing various 
factors that must be taken into consideration for the successful design of a HIFU 
transducer capable of integration with the existing EIM system. A suitability study has 
shown that for this integration a cylindrical-section / linear concave geometry will be 
effective, using a phasing technique to steer the focused beam along one axis while 
using the stepper motor controlled movement of the EIM electrode plate to control 
movement in the remaining two axes. This will theoretically allow targeting of a focal 
point within the majority of the cylindrical 3D volume within the scanner head of the 
EIM system. 
Numerous properties of the proposed transducer have also been defined. The 
piezoelectric material selected was a proprietary material manufactured by transducer 
specialists Imasonic (France) allowing a high output from a small active surface area. 
An optimum frequency of 3.5 MHz was chosen and array dimensions were decided 
based on the available space between electrodes mounted in the EIM electrode plate. 
It has also been shown that a suitable focal intensity is theoretically achievable using 
the approximate design parameters selected. Finally a matching layer, backing, 
damping and housing were also discussed, although final decisions will be effected by 
the manufacturer’s preferred fabrication techniques.  
The properties selected in this section will be used, where appropriate, in the 
simulations presented in the following chapter. It should be noted here that these 
properties may be subject to change as simulation results illuminate factors that were 
not yet considered at this point in the research. 
  
94 
 
 
Chapter 5:        
           
                
Pressure Field Simulations 
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5.1: Chapter Introduction 
In this chapter the theory and model used in the simulations will be described and 
referenced. The results of these simulations will then be presented. These results will 
be divided between those used to calculate the acoustic field intensity created by the 
selected transducer geometry (performed in MATLAB) and those used to calculate the 
resulting temperature distribution in the simulated target tissue volume (performed in 
COMSOL Multiphysics). The results of the latter simulations will be presented in the 
following chapter (see Chapter 6). 
A brief account of why certain parameters had to be modified prior to manufacture 
will also be given, including the reasoning behind the optimisation of relevant 
parameters. 
Care has been taken to omit research and information not directly related to the 
numerical analysis involved. For more information on why this type of transducer has 
been chosen, and for a comprehensive background of HIFU applications, transducer 
design and theory please refer to the previous chapters of this thesis. 
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5.2: Simulation Theory 
The simulations presented here were performed primarily using a custom-written 
MATLAB code (see Appendix A) to solve the Rayleigh integral based on Huygen’s 
principle (see formula below) [86] [45], thus allowing the resultant pressure field 
produced by the transducer in question to be calculated. 
, ,  = 	gh2

j
kl
m# n exp rs m	 − 2u n − v		
           {5.1} 
Where ‘, , ’ is the pressure at field point , , , ‘P’ is the total acoustic power, 
‘S’ is the element area, ′′ represents the distance from the centre of each element to 
the field point , , , ‘	 ’ is the phase of each element and all other symbols are as 
previously stated.  
The phase of each element ‘	 ’ can be calculated using an inverse method, outlined 
in the formula below. 
    	 = xyz 	 −      {5.2} 
Where ‘dif’ is the distance from the centre of element ‘i’ to the focal point and ‘dcf’ is 
the distance from the centre of the array to the focal point (see Figure 22, created using 
[78]). 
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Figure 22 – Diagram showing the inverse method used for calculating ‘+, ’ 
Using this method simulations involved choosing an arbitrary focal point and using the 
inverse principle to calculate the necessary phase difference for each element in the 
array. Thus the desired focal point is produced by the superposition of waves 
(produced from all the excited elements) at the pre-determined focus. 
Once pressure fields had been obtained, the corresponding acoustic intensity field 
could be calculated using the formula presented below. 
, ,  = 	 |, , |x2  
       {5.3} 
The acoustic intensity field is a useful indicator of how the transducer will perform, 
with almost every HIFU transducer on the market being able to produce an acoustic 
intensity in excess of 1 kW/cm2 (at the focus) and commonly in excess of 1.5 kW/cm2.  
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5.3: Simulation Details 
The parameters and variables used in all simulations are tabulated here, for reference 
(see Table 5). 
Table 5 - List of parameters used in simulations 
Parameter Description Value Unit Used in 
P Total 
acoustical 
power (TAP) 
20 W cm-2 Rayleigh integral 
ρ Density 1000 Kg m-3 Rayleigh integral & BHTE 
c Acoustic 
velocity 
1500 m s-1 Rayleigh integral & BHTE 
A Total active 
transducer 
area 
(Dependent 
on element 
dimensions) 
m2 Rayleigh integral 
f Frequency 3.5 MHz Rayleigh integral 
S Element area (Dependent 
on element 
dimensions) 
m2 Rayleigh integral 
λ Wavelength 4.29 x 10-4 m Rayleigh integral 
α(*) Attenuation Various: 
(5 / 7.5 / 10) 
Np cm-1 
MHz-1 
Rayleigh integral 
di Distance from 
element ‘i’ to 
field point 
Variable m Rayleigh integral 
ϕi Phase 
difference of 
element ‘i’ to 
centre 
element  
Variable m Rayleigh integral 
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Ct Specific heat 
(Tissue) 
3550 J kg-1 
°C-1 
BHTE 
K Thermal 
conductivity 
0.5 W m-1 
°C-1 
BHTE 
w Blood 
perfusion rate 
0.5 Kg m-3 
s-1 
BHTE 
Cb Specific heat 
(Blood) 
3550 J kg-1 
°C-1 
BHTE 
Ta Arterial 
temperature 
37 °C BHTE 
T Field 
temperature 
Variable °C BHTE 
 
(*) Note that the attenuation can only be estimated, with different authors generally using different 
attenuation coefficients. The range of values quoted as used by other researchers was 5 to 10 Np m-1 
MHz-1, thus it was decided to use 7.5 Np m-1 MHz-1 for most simulations. Additionally, 5 and 10 Np m-1 
MHz-1 were also used as in a number of simulations to investigate the effect this had on the resultant 
pressure, intensity and heating patterns. 
In a previous section of this thesis the decision process for the choice of transducer 
geometry and positioning in the existing apparatus is described in detail. To briefly 
summarise the transducer geometry is of the linear concave or curvilinear type, 
allowing pre-focusing in the short axis dimension. The transducer will be of such a size 
to fit into an electrode plate similar to those used in the current EIM system. This 
allows rotation and vertical translation of the transducer using the existing movement 
mechanisms and control system. Using a design such as this will allow focal points 
virtually anywhere within the scanner head main cylinder, for ablation at tissue depths 
up to 5 cm (see Figure 16 & Figure 19, created using [74]). 
As the design specification of the transducer requires the ability to focus a small 
distance outside the length of the array (as can be seen in Figure 19) in the space above 
the central electrode and between the outer end of the array and the scanner head 
wall) simulations were designed to observe the level of unwanted grating lobes given 
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this condition. This was investigated for the case of half elements and for the case of 
all elements being excited in the simulations performed. As the total possible length of 
the array was fixed at 70 mm, this meant that only 35 mm of array was simulated at 
any one time for the case of half elements being activated. Therefore the experimental 
distance outside the arrays length related to a field co-ordinate of 0, 25 mm, assuming 
that the centre of the half array elements was positioned at 0, 0 mm. This 
experimental focus at 0, 25 mm equated to a focus at a distance of 7.5 mm outside the 
length of the array for the case of half elements. Similarly for the case of all elements 
being activated, the centre of the array is again positioned at 0, 0 mm, with an 
experimental focus at 0, 45 mm, or 10 mm outside the array length. Both of these 
targeting regimes, if successful, would allow the total volume of the scanner head 
cylinder to potentially be ablated. 
To avoid confusion, the results presented focus on the plane shown below (see Figure 
23, created using [78]). 
 
Figure 23 - Model showing simulation plane (XZ) & axes 
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5.3.1: MATLAB Simulation Results 
Initially tests were carried out to determine the parameters that would give a suitably 
accurate answer in a reasonable time frame. A summary of these results is presented 
herein. 
5.3.1.1: Sub-element Spacing Test Results 
From these results (see Table 6) it can be seen that the ‘most efficient’ sub-element 
spacing was λ/6, which was within approximately 0.2 % of λ/10, showing an 
acceptable degree of accuracy whilst allowing simulations to be performed more 
rapidly and not using up all the PCs resources such that supporting research work 
could continue in parallel. The tests were performed using an operating frequency of 1 
MHz, with a grid (or mesh) size of λ/5, a high enough value to be sure that a ‘fair’ 
result could be observed, without taking more than 24 hours to run. 
Table 6 - Results of initial sub-element spacing suitability tests 
Sub-
element 
spacing ('λ') 
No. sub-
elements 
Max 
pressure 
(Pa) 
Change 
from 
previous 
(%) 
‘Efficiency rating' 
(% change X no. 
sub-elements) 
1 17 5026.32 - - 
1/2 34 4789.15 4.7186 160.4319 
1/3 51 4756.41 0.6837 34.8702 
1/4 68 4743.83 0.2644 17.9784 
1/5 85 4736.31 0.1586 13.4830 
1/6 102 4731.41 0.1034 10.5420 
1/8 135 4725.40 0.1270 17.1427 
1/10 169 4721.65 0.0793 13.4126 
1/15 253 4716.84 0.1020 25.8023 
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5.3.1.2: Mesh/Grid Size Test Results 
The following table shows the results of the grid/mesh size tests (see Table 7). These 
tests had to be cut short due to the PC on which simulations were performed 
encountering problems due to lack of available memory (RAM). For this reason the 
mesh size of λ/5 was chosen, which coincides with the generally accepted minimum 
value for the measuring of a periodic (for example sine) wave.  
Table 7 - Results of initial mesh/grid size suitability tests 
Mesh/grid size 
('λ') 
Max pressure 
(Pa) 
Change from 
previous (%) 
PC RAM 
used (%) 
1 3786.21 - 20 
1/2 3787.40 0.0313 25 
1/3 3787.44 0.0012 25 to 30 
1/4 3787.40 0.0011 70 
1/5 3787.48 0.0020 85 
1/6 - - (PC Crash) 
5.3.1.3: Pressure Field Simulation Characterisation 
The following were performed using the parameters listed at the beginning of this 
section. Any other relevant parameters will be listed, along with the results as they are 
presented. As there are many different test results, presenting all the associated plots 
would be wasteful. Instead only those directly relevant to that which is being described 
will be included, although references to plots not presented may be made at times. 
All simulations here were performed by simulating only half the total number of 
elements in the array, thus allowing steering and focal strength to be more rapidly 
evaluated. Therefore the total length of the simulated array comprising half the 
elements was 35 mm. This ‘half’ array is centred around x=0 mm, therefore a focus at 
x=25 mm represents focusing beyond the end of the array by 7.5 mm ((25 - (35/2)) 
mm). The table below (see Table 8) shows the attenuation coefficients and focal point 
distances used in simulations performed at this early stage in the design process. 
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Table 8 - List of attenuation coefficients & focal points used in simulations 1 to 16 
Simulation 
no. 
Attenuation 
coefficient used 
 (Np m-1 MHz-1) 
Distance from 
centre of array to 
focus (mm) 
1 5 0 
2 5 10 
3 5 20 
4 5 25 
5 5 40 
6 5 0 
7 5 10 
8 7.5 0 
9 7.5 10 
10 7.5 20 
11 7.5 25 
12 7.5 0 
13 10 0 
14 10 10 
15 10 20 
16 10 25 
[NB. The simulations underlined in Table 8 are those that are presented graphically below (see Figure 25 
to Figure 30)] 
The results of the above simulations will now be presented, graphically. Please note all 
plots in this chapter use the axes format shown below (see Figure 24) with the co-
ordinate system as shown previously (see Figure 13 (left)). 
104 
 
 
Figure 24 - Representative Intensity plot showing axis labels 
 
Figure 25 - Acoustic Intensity (W m-2), Focus at x=0, α = 7.5 Np m-1 MHz-1 (Sim No.8) 
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Figure 26 - Acoustic Intensity (W m-2), Focus at x=-10, α = 7.5 Np m-1 MHz-1(Sim No.9) 
 
Figure 27 - Acoustic Intensity (W m-2), Focus at x=20, α = 7.5 Np m-1 MHz-1(Sim No.10) 
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Figure 28 - Acoustic Intensity (W m-2), Focus at x=25, α = 7.5 Np m-1 MHz-1(Sim No.11) 
From the above four intensity plots it can be seen that zero grating lobes are present. 
All four plots were obtained using an attenuation coefficient of 7.5 Np m-1 MHz-1. For 
reference the following two plots (see Figure 29 & Figure 30) show the results of two 
further simulations, showing the effect of modifying the attenuation coefficient to 5 
Np m-1 MHz-1 and 10 Np m-1 MHz-1. Both of these simulations were performed 
assuming an extreme focus which in this case is x=25 mm (as in Figure 28). 
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Figure 29 - Acoustic Intensity (W m-2), Focus at x=25, α = 5 Np m-1 MHz-1(Sim No.4) 
 
Figure 30 - Acoustic Intensity (W m-2), Focus at x=25, α = 10 Np m-1 MHz-1(Sim No.16) 
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5.3.1.4: Initial Optimisation Tests - Pre-manufacturing Discussions: 
As talks with the manufacturers had not begun before the first simulations began the 
manufacturing limitations were unknown. After some testing and troubleshooting of 
the simulation code the first set of simulations were performed. In these tests an 
element width of 0.22 mm and an inter-element spacing (or ‘kerf’) of 0.05 mm were 
used. These equated to approximately half a wavelength and an eighth of a 
wavelength (in water) respectively, thus adhering to the rule of thumb that grating 
lobes can be avoided for extended focal ranges if the element width is kept to half a 
wavelength in the propagation medium, or less. Given that the maximum allowable 
physical footprint of the array is 70 mm (by 25 mm) this meant that using the element 
dimensions stated, the total array would comprise 259 elements. In these simulations 
half the array elements were used, rounding down to 129 elements so as to keep an 
odd number (as the centre element is located at the origin) and therefore an evenly 
balanced contribution from elements both ‘sides’ of the centre element. 
From the previous two plots (see Figure 29 & Figure 30) we can see observe the 
expected change in intensity due to a different attenuation coefficient being used. At 
an extreme focus of x=25 mm using 7.5 Np m-1 MHz-1 gave an approximate focal 
intensity of 1000 W cm-2. In contrast reducing the attenuation coefficient to 5 Np m-1 
MHz-1 gave rise to a focal intensity of close to 3000 W cm-2, triple that obtained at 7.5 
Np m-1 MHz-1. At 10 Np m-1 MHz-1, a focal intensity of approximately 400 W cm2 was 
observed, equal to approximately half the value obtained at 7.5 Np m-1 MHz-1. 
For all the following simulations an attenuation coefficient value of 7.5 Np m-1 MHz-1 
will be used. Generally values of 5 to 7 Np m-1 MHz-1 are used for simulations of this 
type, however using 7.5 Np m-1 MHz-1 allows us to therefore underestimate slightly the 
focal intensity achieved and so will ensure that the designed transducer will be able to 
ablate tissue in a reasonable timeframe even if the active surface area of the 
transducer is further reduced, to fit in and be compatible with the existing system. 
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5.3.1.5: Initial Optimisation Tests - Post-manufacturing Discussions: 
Prior to beginning discussions with the chosen manufacturers of the transducer all 
simulations were performed to find the optimum design parameters that would allow 
firstly a satisfactory acoustic intensity at the focus (given the dimensional restrictions) 
and secondly would not produce any grating lobes that would cause undesirable 
heating in non-targeted tissue areas. From the simulation results presented previously 
this was achieved for a range of focuses as shown in the intensity plots (see Figure 25 to 
Figure 30). 
Unfortunately, following initial discussions with manufacturers the element 
dimensions were found to be unrealistic due to manufacturing limitations and the 
predicted difficulty of designing electronics for the driving of the array. To overcome 
this problem it was obvious the element dimensions and spacing would have to be 
modified such that manufacture and driving of the array would be feasible. Therefore 
another set of simulations were performed, using a range of element sizes, from 0.32 
mm to 1.0 mm, with inter-element spacing of 0.05 mm (as in previous simulations), 0.1 
mm and in some cases 0.2 mm. The following table (see Table 9) shows a summary of 
the variables used in the simulations carried out. 
Note: As in the previous section only the results directly related to the narrative of the thesis will be 
presented so as to avoid including meaningless results and to facilitate focus on those that have more of 
a bearing on the design of the transducer to be manufactured. In this case a range of element widths will 
be simulated each with inter-element spacing of 0.05 mm and 0.1 mm, all focused at the ‘extreme’ focal 
point of x=25 mm. 
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Table 9 - List of variables used in simulations 17 to 41 
Simulation 
no. 
Element 
width 
(mm) 
Inter-
element 
spacing / 
kerf (mm) 
Distance 
from centre 
of array to 
focus (mm) 
No. of 
elements 
simulated 
17 0.32 0.05 15 95 
18 0.32 0.05 25 95 
19 0.32 0.1 25 83 
20 0.35 0.05 15 87 
21 0.35 0.05 25 87 
22 0.35 0.1 15 77 
23 0.35 0.1 25 77 
24 0.35 0.2 25 63 
25 0.4 0.05 0 77 
26 0.4 0.05 15 77 
27 0.4 0.05 25 77 
28 0.4 0.1 25 71 
29 0.4 0.2 25 59 
30 0.43 0.05 15 73 
31 0.43 0.05 25 73 
32 0.43 0.1 25 68 
33 0.5 0.05 15 63 
34 0.5 0.05 25 63 
35 0.5 0.1 25 59 
36 0.6 0.05 25 53 
37 0.6 0.1 25 51 
38 0.64 0.05 15 51 
39 1 0.05 15 33 
40 1 0.05 25 33 
41 1 0.1 25 31 
[NB. The simulations underlined in Table 9 are those that are presented graphically in Figure 31 to Figure 
44] 
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Figure 31 - Acoustic Intensity (W m-2), element width 0.32 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.18) 
 
Figure 32 - Acoustic Intensity (W m-2), element width 0.32 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.19) 
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Figure 33 - Acoustic Intensity (W m-2), element width 0.35 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.21) 
 
Figure 34 - Acoustic Intensity (W m-2), element width 0.35 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.23) 
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Figure 35 - Acoustic Intensity (W m-2), element width 0.40 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.27) 
 
Figure 36 - Acoustic Intensity (W m-2), element width 0.40 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.28) 
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Figure 37 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.31) 
 
Figure 38 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.32) 
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Figure 39 - Acoustic Intensity (W m-2), element width 0.50 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.34) 
 
Figure 40 - Acoustic Intensity (W m-2), element width 0.50 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.35) 
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Figure 41 - Acoustic Intensity (W m-2), element width 0.60 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.36) 
 
Figure 42 - Acoustic Intensity (W m-2), element width 0.60 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.37) 
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Figure 43 - Acoustic Intensity (W m-2), element width 1.0 mm, Focus at x=25, kerf = 0.05 mm (Sim 
No.40) 
 
Figure 44 - Acoustic Intensity (W m-2), element width 1.0 mm, Focus at x=25, kerf = 0.1 mm (Sim 
No.41) 
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In summary, the optimum element width and spacing values from this set of 
simulations were found to be 0.35 mm and 0.05 mm respectively. This can be seen 
from the plots (see Figure 31 to Figure 44) and from the collated results data, presented 
in the table below (see Table 10). 
Table 10 - Results of initial optimisation tests post-manufacturer discussions (Figure 31 to Figure 44) 
Sim. 
No. 
Elem 
width 
(mm) 
Kerf 
(mm) 
No. of 
elements 
simulated 
Max. 
Focal 
Int.        
(W m-2) 
Max. Front 
lobe Int        
(W m-2) 
Max. 
Side lobe 
Int.      
(W m-2) 
Max. lobe 
/ Max. 
Focal Int. 
(%)) 
18 0.32 0.05 95 1300 400 200 30.8 
19 0.32 0.1 83 1040 190 350 33.7 
21 0.35 0.05 87 1350 300 380 28.2 
23 0.35 0.1 77 1050 180 350 33.3 
27 0.4 0.05 77 1390 180 450 32.3 
28 0.4 0.1 71 1180 150 380 32.2 
31 0.43 0.05 73 1400 125 490 35.0 
32 0.43 0.1 65 1100 100 400 36.3 
34 0.5 0.05 63 1400 120 550 39.3 
35 0.5 0.1 59 1250 300 500 40.0 
36 0.6 0.05 53 1480 700 600 47.3 
37 0.6 0.1 51 1350 550 500 40.7 
40 1 0.05 33 1580 750 600 47.5 
41 1 0.1 31 270 100 280 103.7 
Although the above plots show the existence of grating lobes, the previous set of plots 
(see Figure 25 to Figure 30) were produced using parameters that cannot be used for 
manufacture, performed prior to discussions with manufacturers. Selecting suitable 
element dimensions now comes down to a compromise between manufacturing and 
electronic driving difficulties, and the reduction of unwanted lobes. From the above 
plots it appears that using an element width of up to 0.43 mm seems to give 
acceptable levels of grating lobes, compared to larger element widths, even at the 
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extreme focus (x=25 mm). Also reducing the element width to 0.32 mm (approximately 
¾ of a wavelength, in water) does not seem to be of great benefit compared to an 
element width of 0.35 mm, which still remains under one wavelength in magnitude 
(approximately 0.43 mm) and so should give satisfactory results according to other 
studies [56]. 
Considering all the above tabulated results it seems as though using an element width 
of 0.35 mm and spacing of 0.05 mm gives the optimum results, in terms of both 
maximum focal intensity and ratio of grating lobes to main lobes (28.15 %, see Table 
10). Hence, if the manufacture and driving of an array with these dimensions is 
feasible, then these are the values that will be used. If these values are still too small 
for manufacture then it is possible that the element width could be increased to 0.43 
mm and the spacing to 0.1 mm (as necessary). Although this would not be desirable as 
such, if it would allow for manufacture to proceed where other, smaller dimensions do 
not, then it would be the next most suitable choice. 
It should be noted at this point that the simulations presented in this section were 
performed using a ‘one-media code’, assuming the entire field comprises of 
homogenous breast tissue, with an attenuation coefficient of 7.5 Np m-1 MHz-1. Work 
to expand the code to include the case of two-media, namely breast tissue and water, 
as would be the case when the array is in normal operation would be necessary for 
accurate treatment planning. Using the one-media code will therefore underestimate 
the focal intensity (as the attenuation coefficient of breast tissue (approximately 5 to 
7.5 Np m-1 MHz-1) is much larger than that of water (approximately 0.025 Np m-1 MHz-
1) the attenuation would be lessened using the two-media code and the focal intensity 
would be increased) and so the intensities at focus obtained from the previous set of 
simulations can be said to be the minimum possible values that may be obtained when 
targeting at the maximum possible tissue depth. Furthermore the attenuation 
coefficient value used was larger than that generally used by other researchers, so as 
the focal intensity would be further underestimated, thus ensuring a desirably high 
value of intensity at the focus when the transducer itself is manufactured and tested.  
120 
 
5.3.1.6: IMASONIC Design Suggestions & Modifications  
At this point in the design process transducer manufacturer Imasonic specified a 
minimum element width and inter-element spacing of 0.43 mm and 0.1 mm. This is 
not ideal but is close to that suggested previously, and so these values will be used, at 
least for the initial ‘proof of concept’ transducer. 
The use of IMASONIC HI-1 piezocomposite was also suggested for this particular 
application as the dimensions and geometry involved makes using HI-2 piezocomposite 
much more difficult. A solid backing is generally not used with HI-1. Instead an air 
backing is used. Reported transducer efficiency will be in the region of 40 %, according 
to manufacturer Imasonic. 
Additionally Imasonic have suggested an acoustical power output of 1 to 10 W cm-2. 
This is very low compared to the 20 W cm-2 used in the above simulations. To check 
the feasibility of such a low power a new set of simulations was performed (see Figure 
45 to Figure 50). In these simulations acoustical powers of 1 W, 5 W and 10 W were 
used, with each being simulated using attenuation coefficients of 5 Np m-1 MHz-1 and 
7.5 Np m-1 MHz-1 (six simulations in total). Additionally, to compensate for the reduced 
acoustical power all elements are active in creating a single focus, and the ‘extreme 
focus’ will therefore be at x=45 mm (half the total array length + 10 mm to allow the 
focus to reach the central column of the scanner head) with the transducer centre 
being located at x=0. 
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Figure 45 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 5 
Np m-1 MHz-1 TAP = 1 W cm-2 (Sim No.42) 
 
Figure 46 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP = 1 W cm-2 (Sim No.43) 
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Figure 47 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 5 
Np m-1 MHz-1 TAP = 5 W cm-2 (Sim No.44) 
 
Figure 48 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP = 5 W cm-2 (Sim No.45) 
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Figure 49 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 5 
Np m-1 MHz-1 TAP =10 W cm-2 (Sim No.46) 
 
Figure 50 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =10 W cm-2 (Sim No.47) 
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As can be seen in the above intensity mesh plots the use of the lower attenuation 
coefficient (5 Np m-1 MHz-1) has the effect of reducing unwanted areas of higher 
intensity near to the face of the transducer. Additionally using a lower attenuation 
coefficient gives a much higher focal intensity, as presented in the table below (see 
Table 11). 
Table 11 - Results of the effects of TAP on focal & lobe intensities (see Figure 45 to Figure 50) 
Sim. 
no. 
TAP        
(W cm-2) 
Attenuation 
coefficient     
(Np m-1 MHz-1) 
Max. 
focal Int. 
(W cm-2) 
Max. 
front 
lobe Int.  
(W m-2) 
Max. 
side 
lobe 
Int.     
(W m-2) 
Max. 
lobe / 
Max 
Focal Int.   
(%) 
42 1 5 375 50 75 20.00 
43 1 7.5 125 40 25 32.00 
44 5 5 1450 200 270 18.62 
45 5 7.5 485 150 110 30.93 
46 10 5 3750 400 700 18.67 
47 10 7.5 1240 400 280 32.25 
To ablate tissue a higher focal intensity is advantageous. From the above results (see 
Table 11) it seems that using a TAP of 1 W cm-1 may not achieve a desirable level of 
intensity at the focus, thus may not be able to rapidly heat the target volume to a 
temperature at which thermal ablation would occur. Furthermore using an attenuation 
coefficient of 7.5 Np m-1 MHz-1 in combination with a TAP of 5 W cm-2 yields a focal 
intensity of less than 500 W cm-2, which is significantly less than the recommended 
focal intensity of 1000 W cm-2 recommended for tissue ablation earlier in this thesis. 
This is however not to say that this particular combination cannot be used, but 
ablating using such a low intensity may result in unwanted tissue heating and will also 
increase the necessary exposure (and therefore treatment) times involved. This will 
become more apparent in a subsequent section of this chapter in which the COMSOL 
simulations are presented, showing the actual heating effect caused by the intensity 
fields similar to those presented above. The reader is advised to refer the section 
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entitled ‘COMSOL Simulations’ (see Section 6.3) to observe these effects on tissue 
heating. 
As the attenuation of each individual breast will vary it seems relevant to take the 
higher of the two values used in the previous six simulations. For this reason an 
attenuation coefficient of 7.5 Np m-1 MHz-1 will be used in all subsequent simulations. 
Again, this will allow powers and heating regimes to be underestimated and therefore 
ensures that the power produced by the transducer is not below the simulated values, 
but above or equal to them, in reality. 
5.3.1.7: Phase Range & Resolution Simulations 
To facilitate the design of the driving electronics circuitry it is pertinent to define the 
range and the resolution of the time delay (ns) necessary to achieve adequate focal 
intensities while minimising unwanted grating lobes. Higher resolution will lead to 
more of a defined focus, as waves will superimpose more accurately, while low 
resolution could lead to unplanned superimposing, leading to unexpected areas of high 
acoustic intensity, which could adversely affect the treatment planned. On the other 
hand, as the complexity of the time delay circuitry will increase with increasing (more 
defined) resolution, the resolution should be minimised, while retaining as high a 
degree of accuracy as possible. 
To allow the effect of time delay resolution to be investigated a number of simulations 
were carried out. These were performed for two cases, all elements being activated 
and half elements being activated. The tables below (see Table 12 & Table 13) show the 
results of these simulations and compares results, in terms of grating lobe level, max 
pressure and max intensity levels against those obtained with no rounding. 
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Table 12 - Phase resolution test results, all elements focused at the extreme focus of x=45 mm 
Phase 
Res. 
(rads) 
Time 
delay 
res. 
(ns) 
Grating 
lobe 
value        
(W m-2) 
Change 
in lobe 
value 
(%) 
Max 
Pressure 
‘P’    
(kPa) 
Change 
in ‘P’      
(%) 
Max Int.     
(W cm-2) 
Change 
in Int.       
(%) 
no 
rounding 
(n/a) 440220 - 3358.5 - 484.24 - 
0.01 0.455 440202 0.0041 3358.4 0.0030 484.22 0.0041 
0.05 2.276 440287 0.0152 3358.8 0.0089 484.32 0.0165 
0.1 4.552 439806 0.0939 3356.9 0.0476 483.79 0.0929 
0.2 9.104 438973 0.2833 3353.7 0.1429 482.87 0.2829 
0.5 22.760 432437 1.7678 3328.7 0.8873 475.68 1.7677 
1 45.520 407449 7.4442 3231.1 3.7934 448.19 7.4447 
Table 13 - Phase resolution test results, half elements focused at the extreme focus of x=25 mm 
Phase 
Res. 
(rads) 
Time 
delay 
res. 
(ns) 
Grating 
lobe 
value        
(W m-2) 
Change 
in lobe 
value 
(%) 
Max 
Pressure 
‘P’    
(kPa) 
Change 
in ‘P’      
(%) 
Max Int.     
(W cm-2) 
Change 
in Int.       
(%) 
no 
roundin
g 
(n/a) 506631 - 2547.7 - 278.65 - 
0.01 0.455 506660 0.0056 2547.7 0 278.66 0.0036 
0.05 2.276 506646 0.0029 2547.7 0 278.66 0.0036 
0.1 4.552 505404 0.2422 2544.6 0.1217 277.97 0.2440 
0.2 9.104 504042 0.5110 2541.2 0.2551 277.22 0.5132 
0.5 22.760 499585 1.3910 2529.9 0.6987 274.77 1.3924 
1 45.520 460646 9.0766 2429.3 4.6470 253.36 9.0759 
Furthermore, in previous studies a digital time delay circuit has been used to produce a 
time delay of 2 ns [44]. With an operating frequency equal to 3.5 MHz this 
approximately equates to a phase resolution of 0.044 rads. To confirm the feasibility of 
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using a 2 ns resolution two more simulations were performed, one for the case of all 
elements and one for half the elements being excited (see Table 14). As before, the 
extreme foci of x=45 (all elements) and x=25 (half elements) were used. 
Table 14 - Effect of time delay resolution on simulation results 
No. 
Elem’s  
Phase 
Res. 
(rads) 
Equiv. 
Time 
delay 
res. (ns) 
Grating 
lobe 
value    
(kW m-3) 
Change 
in lobe 
value 
(%) 
Max 
P 
(kPa) 
Change 
in P 
(%) 
Max Int.  
(W cm-2) 
Change 
in Int.       
(%) 
All 
(128)] 
None (n/a) 440.2 - 3359 - 484.24 - 
All 
(128) 
0.044 2 440.2 0.0038 3359 0.0030 484.26 0.0041 
Half 
(64) 
None (n/a) 506.6 - 2548 - 278.65 - 
Half 
(64) 
0.044 2 506.5 0.0172 2547 0.0118 278.6 0.0179 
Looking at the above tabulated simulation results (see Table 12 to Table 14) it can be 
seen that for the case in which only half the elements are excited that there is no 
change when increasing the resolution to 0.01 rads from 0.05 rads, both of which are 
less than 0.006 % different to the reference in terms of grating lobe level, maximum 
pressure and maximum acoustic intensity levels. Using 2 ns resolution (approximately 
0.044 rads) still allows error, in terms of intensity and grating lobe level, to be kept 
below 0.02 %. To facilitate the design of the driving electronics 2 ns appears as an 
acceptable delay resolution, with increasing resolution having little effect. Also as 2 ns 
has been used previously [44] this seems to offer the best compromise between 
electronic circuit complexity and realistic accuracy approximations. 
For the case in which all elements are excited using a phase resolution of 0.05 rads 
gives a deviation of less than 0.02 % from the reference simulation. Using 0.044 rads 
(approximately 2 ns) gives an error of less than 0.005 %, which is deemed to be 
acceptable. 
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In fact there seems to be little change between resolution values up to the point that 
resolution exceeds 0.2 rads. Between 0.2 rads and 0.5 rads the difference to the 
reference simulation becomes greater than 1 %. At this point however it will be 
assumed that a resolution of 2 ns will be used as this will ensure accuracy while 
avoiding overly complex driving electronic circuitry. 
5.3.1.8: Expected Focal Intensities of Suggested Design 
This set of simulations was designed to allow the effect of TAP on focal intensity to be 
observed. As stated in a previous section the attenuation coefficient will be taken to be 
7.5 Np m-1 MHz-1. The element width and spacing (kerf) will be equal to 0.43 mm and 
0.1 mm respectively for the reasons described previously (Imasonic manufacture 
limitations) and TAP at the transducer will be taken to be 3 W cm-2 (representing a 
comparatively low TAP which would allow the transducer to produce longer exposures 
with less probability of damage, a concern when using higher TAP values) with 
simulations to be repeated if this TAP appears to give too high or too low a focal 
intensity. The focal spot will be steered from x=0, to x=20, x=35, x=37.5 and x=45 mm 
(all elements being activated, x=37.5 mm being vertically above the far end of the 
transducer array length) to additionally allow the effect of steering (on focal intensity) 
to be observed. Furthermore, as discussed in the previous section, a phase resolution 
of 2 ns (or 0.044 rads) will be used in this next set of simulations, which will allow more 
realistic results to be obtained. Following these simulations involving all the elements 
of the array (see Figure 51 to Figure 55 & Table 15) another set will be performed in 
which only half the elements will be activated, with adjusted focal points at x=0, x=15, 
x=17.5, x=20 and x=25 mm (see Figure 56 to Figure 60 & Table 16). 
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5.3.1.8.1: All Elements 
 
Figure 51 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=0, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, ALL elements activated (Sim No.48) 
 
Figure 52 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=20, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, ALL elements activated (Sim No.49) 
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Figure 53 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=35, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, ALL elements activated (Sim No.50) 
 
Figure 54 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=37.5, kerf = 0.1 mm, α = 
7.5 Np m1 MHz-1 TAP =3 W cm-2, ALL elements activated (Sim No.51) 
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Figure 55 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=45, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, ALL elements activated (Sim No.52) 
The numerical results from the plots presented above are tabulated below (see Table 
15). It can be observed that grating lobes are generally acceptable up to the point at 
which the focus is steered out of the transducer array length. This will be discussed 
further following the next set of simulations, which involve activating only half the 
total number of elements in the array (64 elements centred on the geometric centre of 
the transducer). 
Table 15 - Expected focal intensities with ALL elements activated (Figure 51 to Figure 55) (TAP 3 W 
cm-2, element width 0.43 mm, kerf 0.1 mm, phase resolution 0.044 rads)  
Distance of focus 
from array centre 
(mm) 
Focal 
intensity     
(W cm-2) 
Max grating 
lobe 
(W/cm-2) 
Grating lobe as a fraction 
of Focal Intensity           
(%) 
0 795.4 74.69 9.39 
20 659.3 65.03 9.86 
35 432.1 59.32 13.73 
37.5 392.6 67.55 17.21 
45 290.3 64.75 22.30 
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5.3.1.8.2: Half Elements 
 
Figure 56 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=0, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, HALF elements activated (Sim No.53) 
 
Figure 57 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=15, kerf = 0.1 mm, α = 7.5 
Np m-1MHz-1 TAP =3 W cm-2, HALF elements activated (Sim No.59) 
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Figure 58 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=17.5, kerf = 0.1 mm, α = 
7.5 Np m-1 MHz-1 TAP =3 W cm-2, HALF elements activated (Sim No.60) 
 
Figure 59 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=20, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, HALF elements activated (Sim No.61) 
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Figure 60 - Acoustic Intensity (W m-2), element width 0.43 mm, Focus at x=25, kerf = 0.1 mm, α = 7.5 
Np m-1 MHz-1 TAP =3 W cm-2, HALF elements activated (Sim No.62) 
Table 16 - Expected focal intensities with HALF elements activated (Figure 56 to Figure 60) (TAP 3 
W cm-2, element width 0.43 mm, kerf 0.1 mm, phase resolution 0.044 rads) 
 
From the above two sets of results (see Table 15 & Table 16) it can be seen that the 
more the focus is steered away from the geometric centre of the transducer the 
greater the grating lobes become. Interestingly, it can also be seen here that the ratios 
of these grating lobes to the main (focal) lobe are actually less for the case in which all 
the elements are activated, with focal points outside the length of the (active) 
transducer (the ‘extreme’ foci) compared to the greater ratios of grating to main lobes 
Distance of 
focus from 
array centre 
(mm) 
Focal Intensity    
(W cm-2) 
Max grating lobe 
(W cm-2) 
Grating lobe as  
fraction of focal 
intensity (%) 
0 256.9 6.495 2.53 
15 219.2 62.85 28.67 
17.5 207.8 71.95 34.62 
20 194.8 72.66 37.30 
25 166.8 71.13 42.64 
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when only half the elements are activated, even with focal points within the length of 
the (active) transducer. For this reason, and especially when steering to the ‘extreme‘ 
focal points at and beyond the length of the transducer, it is recommended that all 
elements are activated. When focal point are required in the central ‘two-quarters’ of 
the transducer however it would be advantageous to use dynamic apertures (focused 
on the centre of the aperture) instead of steering the focus such as to allow vertical 
lesions to be created (perpendicular to the transducer) rather than those created at an 
angle which would result from using phased excitation signals to steer the focus if 
more elements were used. These vertical lesions would facilitate the targeting and 
treatment planning as the volume covered would be easier to estimate compared to 
creating a comprehensive treatment plan using only angled lesions. 
The heating patterns resulting from the above intensity fields are investigated in the 
‘steering simulations’ subsection in the next chapter of this thesis (see Section 6.3.2). 
Please refer to this later section to observe the heating effects cause by the intensity 
fields presented above. 
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5.4: Chapter Conclusion 
To conclude, in this fifth chapter the theory used to create a suitable simulation model 
capable of calculating acoustic pressure and intensity fields based on Huygen’s 
principle, has been defined.  
The relevant equations used in the custom written MATLAB code were introduced and 
briefly explained. Using this simulation model numerous parameters affecting the 
output of the transducer have been investigated. These have included initial tests to 
find a suitable and useable grid size for the simulations to be computed, a 
characterisation of the expected pressure fields, tests for performance optimisation 
and finally the expected acoustic intensities that the designed transducer will be 
capable of producing. These tests have included simulating the activation of both half 
and all of the total number of elements of the designed array. Steering of the focal 
point has also been considered and simulated. 
  
137 
 
 
Chapter 6:        
           
                
Bio-Heat Transfer Simulations 
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6.1: Chapter Introduction 
In this chapter the theory and model used in the simulation of the target tissue 
temperature rise, resulting from the acoustic intensity fields simulated previously will 
be explained. The results from the performed simulations will then be presented, using 
the intensity fields theoretically created by the selected transducer geometry 
(performed in MATLAB, see Chapter 5). By this method the resulting temperature 
distribution in the simulated target tissue volume will be calculated and discussed. 
A ‘Thermal Dose’ model [4] will be introduced to allow the accurate comparison of 
differing heating regimes, caused by different simulation parameters being used as 
inputs. This model will greatly facilitate comparisons between different transducer 
parameters as well as steering of the focus and other factors that require investigation 
before a safe and effective design can be finalised. The simulation results presented 
here were computed using the COMSOL Multiphysics simulation package. 
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6.2: Simulation Theory 
Building on the theory presented in the previous chapter (see Chapter 5) the 
mechanism for the rise in tissue temperature will be briefly described here. 
It has already been shown that the acoustic intensity field for the proposed transducer 
can be calculated. The heat deposition within a tissue exposed to such an intensity 
field can be calculated by computing the BHTE, which for Cartesian coordinates can be 
written as follows [2] [87] [88]. 
 |$|& = 	} ~|
x$|x +	|
x$|x +	|
x$|x − )$ − $% +   
           {6.1} 
Where ‘’ is the specific heat of the tissue, ‘K’ is the thermal conductivity, ‘T’ is the 
temperature, ‘w’ is the blood perfusion rate, ‘’ is the specific heat of the blood, ‘Ta’ is 
the arterial blood temperature, ‘qmet’ is the metabolic heat and all other symbols are as 
stated previously. 
Here we assume the total heat deposited is equal to the absorption (or attenuation) of 
the acoustic energy within the tissue in question. This gives us the relationship [89]. 
   , ,  = 2, ,      {6.2} 
We can then use this to replace the metabolic heat term ‘qmet’ in the BHTE as the heat 
produced by metabolism is negligible compared to that produced by the absorption of 
the incident acoustic energy. Thus the BHTE becomes 
 |$|& = 	} ~|
x$|x +	|
x$|x +	|
x$|x − )$ − $% + , ,  
          {6.1a} 
The COMSOL Multiphysics software package was used to solve the above equation, 
using the resultant acoustic intensity distribution for all points obtained from the 
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custom-written MATLAB code mentioned previously. With a suitable mesh size 
(determined by the frequency of the acoustic waves involved and the maximum 
available computational power) the time-dependent temperature rise was obtained. In 
addition a model for calculating the ‘Thermal Dose’ (TD) was employed (using 
COMSOL) according to the equation presented below. 
&'( =			$ = 	 "'( &  
           {6.3} 
Where ‘R’ equals 0.25 for 37°C < T < 43°C or 0.5 for T ≥ 43°C and ‘t0’ & ‘tf’ are the initial 
and final times respectively [4]. 
The above provides a datum to measure the effect of differing heating regimes, thus 
allowing them to be quantifiably compared. For reference, the plot below (see Figure 
61) shows a visual representation of the above relationship. Please note however that 
the temperature-time combinations shown by the plot assume the temperature has 
been held constant for the entire time period. This will not be the case for the heating 
effects caused by HIFU sonications as the (tissue) temperature will be time-dependent, 
increasing as more energy is deposited by incoming sonications. 
 
Figure 61 - Plot showing relationship of Time to Temperature in 'Thermal Dose' (TD) model     
 (cell necrosis predicted above line shown) 
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As a general rule of thumb, once tissue temperature reaches 65 °C the tissue can said 
to be necrosed. This can be seen by comparing the time-dependent temperature rise 
with the TD value. The TD (or ‘ t43‘) value is measured in ‘equivalent minutes’, 
equivalent to tissue held at 43 °C. It is generally accepted that tissue is destroyed once 
the dose reaches 240 of these ‘equivalent minutes’. This value will be used as the 
threshold in determining the feasibility of tissue ablation in the simulations following 
(see Section 6.3). 
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6.3: COMSOL Simulations 
As stated in the ‘Theory’ section, presented earlier, the COMSOL Multiphysics software 
package was used to simulate the expected time-dependent temperature rise and 
equivalent thermal dose given the intensity fields obtained from the pressure field 
simulations performed using MATLAB. As COMSOL is processor and RAM intensive, 
models of interest were simulated using a relatively coarse mesh. Once areas of 
interest were identified the simulations were re-performed, using a mesh size 
matching the mesh size used in the MATLAB pressure field simulations, thus allowing 
more accurate results to be observed. This was particularly important for the contour 
plots of equivalent thermal dose and was achieved by reducing the total simulation 
area and focusing on a smaller area, containing the regions of interest. This allowed 
solutions to be obtained without the PC being used running out of resources or errors 
being caused in the simulation results. A number of these simulations performed 
overnight as the timescales involved in converging on a solution were suitably large. 
Many simulations have been performed while learning to use COMSOL and during the 
fine-tuning of the model such that it produced reliable, repeatable results. The number 
of simulations performed easily exceeds seventy individual tests and as such only the 
simulations pertinent to the narrative of this thesis will be included, with references 
being made to those omitted as deemed appropriate. 
As the minimum element width and spacing has been set according to manufacturing 
constraints subsequent simulations will involve intensity fields produced by a 
transducer array with element width 0.43 mm and inter-element spacing of 0.1 mm. 
Additionally the phase resolution will be set to 0.044 rads (2 ns time delay equivalent) 
as described in the previous section of this thesis. 
The parameters used in these simulations have been listed earlier (see Table 5) and so 
will not be listed here again. A time step size of 0.01 s was used in all COMSOL 
simulations. 
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6.3.1: TAP vs. Exposure Time Simulations 
In the course of discussions with manufacturer Imasonic it has become necessary to 
define the exposure conditions for treatment sonications using the designed device. As 
the transducer will heat up while active it has been suggested (and accepted) that two 
thermocouples will be fixed to the back of the transducer, allowing operation to be 
halted if a certain maximum temperature is reached that would cause irreparable 
damage to the transducer. Furthermore to allow Imasonic to produce a detailed 
technical specification of permitted exposure regimes, a number of simulations have 
been performed. These simulations were performed for the cases of TAP output 
ranging from 1 W to 5 W in steps of 1 W, with an attenuation coefficient of 7.5 Np m-1 
MHz-1. Using COMSOL the time at which the equivalent thermal dose is greater than 
240 mins [4] was recorded, thus allowing an approximation of the maximum necessary 
sonication periods required to ablate the target tissue. These results have been 
tabulated, for the case of all elements being active (see Table 17 & Table 18) and for half 
elements being active (see Table 19 & Table 20). Additionally the temperature 
distribution plots are presented for the time at which the thermal dose exceeds the 
threshold value of 240 equivalent minutes (accurate to at least 0.1 seconds, ‘HiDef’ 
simulations additionally are accurate to 0.01s) for each TAP value (1 W to 5 W). These 
plots will also include the ‘extreme’ focus (x=25 mm for half elements and x=45 mm 
for all elements) as well as the geometrically centred focus (x=0) to allow the effects of 
both the minimum and maximum steering angles to be observed at all TAP values. The 
results of these simulations will be tabulated (see Table 17 to Table 20) following the 
relevant plots (see Figure 62 to Figure 81 & Figure 84 to Figure 102) and will include at 
least 1 and 2 second values for all cases (in addition to the time at which a thermal 
dosage of 240 equivalent minutes is exceeded) to allow some comparison between 
different TAP values at similar points in the simulated treatment time. The first two 
plots (see Figure 62 and Figure 63) have been enlarged to allow labels to be seen more 
clearly. 
144 
 
6.3.1.1: All Elements 
 
Figure 62 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 1.8 seconds - focus 
at x=0, ALL elements activated 
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Figure 63 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 1.75 seconds - focus 
at x=0, ALL elements activated (HiDef) 
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Figure 64 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 4.8 seconds - focus 
at x=45, ALL elements activated 
 
Figure 65 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 4.77 seconds - focus 
at x=45, ALL elements activated (HiDef) 
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Figure 66 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 0.7 seconds - focus 
at x=0, ALL elements activated 
 
Figure 67 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 0.65 seconds - focus 
at x=0, ALL elements activated (HiDef) 
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Figure 68 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 1.8 seconds - focus 
at x=45, ALL elements activated 
 
Figure 69 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 1.76 seconds - focus 
at x=45, ALL elements activated (HiDef) 
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Figure 70 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.4 seconds - focus 
at x=0, ALL elements activated 
 
Figure 71 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.38 seconds - focus 
at x=0, ALL elements activated (HiDef) 
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Figure 72 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.1 seconds - focus 
at x=45, ALL elements activated 
 
Figure 73 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.01 seconds - focus 
at x=45, ALL elements activated (HiDef) 
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Figure 74 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.3 seconds - focus 
at x=0, ALL elements activated 
 
Figure 75 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.26 seconds - focus 
at x=0, ALL elements activated (HiDef) 
152 
 
 
Figure 76 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.7 seconds - focus 
at x=45, ALL elements activated 
 
Figure 77 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.69 seconds - focus 
at x=45, ALL elements activated (HiDef) 
153 
 
 
Figure 78 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.21 seconds - focus 
at x=0, ALL elements activated 
 
Figure 79 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.2 seconds - focus 
at x=0, ALL elements activated (HiDef) 
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Figure 80 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.55 seconds - focus 
at x=45, ALL elements activated 
 
Figure 81 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.53 seconds - focus 
at x=45, ALL elements activated (HiDef) 
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Focus x=0: 
Table 17 - Exposure time vs. TAP, results for the case of ALL elements being active, with a focus of 
x=0 mm (Figure 62 to Figure 79, see legend(s) for relevant plots) 
TAP     
(W cm-2) 
Time 
(s) 
Focal temp 
(°C) 
Focal TD    
(mins) 
Lobe temp 
(°C) 
Lobe TD 
(mins) 
1 1 51.89 2.33 39.35 <0.0001 
 1.75 58.07 248.66 40.33 0.0006 
 2 59.83 935.12 40.61 0.0012 
2 0.65 59.64 270.13 40.58 0.0001 
 1 66.82 60279 41.71 0.0015 
 2 82.64 7.82x109 44.21 0.0713 
3 0.38 60.59 313.15 38.24 <0.0001 
 1 81.70 1.86x109 44.06 0.0153 
 2 105.45 8.47x1016 47.81 1.3905 
4 0.26 61.04 305.36 38.27 <0.0001 
 1 96.59 7.08x1013 46.41 0.0872 
 2 128.27 1.09x1024 51.41 33.2131 
5 0.2 61.72 333.25 40.42 <0.0001 
 1 111.48 3.13x1018 50.95 0.6957 
 2 143.57 1.9586x1030 61.09 847.4314 
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Focus x=45: 
Table 18 - Exposure time vs. TAP, results for the case of ALL elements being active, with an ‘extreme’ 
focus of x=45 mm (Figure 64 to Figure 81, see legend(s) for relevant plots) 
TAP     
(W cm-2) 
Time 
(s) 
Focal temp 
(°C) 
Focal TD 
(mins) 
Lobe temp 
(°C) 
Lobe TD 
(mins) 
1 1 44.42 0.02 38.95 <0.0001 
 2 48.47 0.76 41.22 0.0011 
 3 51.84 6.43 42.47 0.0107 
 4 54.70 54.75 44.22 0.0473 
 4.77 56.67 243.15 45.46 0.1086 
2 1 51.51 1.659 42.83 0.0012 
 1.76 58.16 247.17 44.80 0.0284 
 2 59.97 942.22 45.46 0.0515 
3 1 58.84 235.76 43.77 0.0189 
 1.01 58.99 262.45 44.00 0.0194 
 2 71.45 2.73x106 49.69 1.0978 
4 0.69 59.47 246.37 42.91 0.0064 
 1 66.08 31406 44.65 0.0527 
 2 82.92 8.48x109 53.92 15.0070 
5 0.53 60.20 286.31 43.11 0.0045 
 1 73.33 5.02x106 46.56 0.2572 
 2 94.40 2.98x1013 58.15 2.04x109 
Generally with all elements being activated it can be observed that a focus of x=0 mm 
(see Table 17 & Figure 82) allows the threshold thermal dose to be reached much more 
rapidly than in the case of an ‘extreme’ focus at x=45 mm (see Table 18 & Figure 82) 
even at low powers (approximately 2 seconds at TAP 1 W cm-2 and less than 1 second 
at 2 W cm-2 and above). Also the grating lobes are much reduced when focusing on the 
geometric centre at x=0 mm. Hence the treatment plan, once formulated, will have to 
take into account this discrepancy and adjust exposure times accordingly such that all 
of the focal points within the target volume will receive the same thermal dose, taking 
into account the beam steering angle. 
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Figure 82 - Graph of TAP against time taken to reach the TD threshold limit at the focal point (ALL 
elements activated) 
In all cases presented the maximum thermal dose in non-focal areas was observed to 
be less than 0.11 equivalent minutes (See Figure 83, Table 17 & Table 18) with a 
maximum lobe temperature of less than 45 °C at the time at which the focal thermal 
dose threshold of 240 equivalent minutes was exceeded. Please note the 
corresponding graph for the ‘natural’ focus (x=0 mm) has been omitted as values were 
low enough to be considered insignificant. 
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Figure 83 - TAP against TD at the grating lobe for the case of the extreme focus at x=45 mm (ALL 
elements activated) 
In the case of the ‘extreme’ focus of x=45 mm it can be seen there is a sharp rise in the 
equivalent thermal dose in certain cases, as can be seen when looking at the 1 and 2 
second TD values for 3, 4 and 5 W/cm2 (TAP). This is not a major concern as the 
sonications will be halted before these times, as the thermal dose at the focus will 
have already been reached. However this effect will be more important for the case of 
half elements being activated as expected exposure times would be longer and 
therefore it is more probable that non-focal TD levels may rise. This will be relevant 
when defining maximum exposure times. The results above, for all elements have 
been included to allow a meaningful comparison to the case of half elements and also 
to give an impression of how the transducer performance differs when all elements 
are activated and targeted on a single focal point. 
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6.3.1.2: Half Elements 
 
Figure 84 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 4.7 seconds - focus 
at x=0, HALF elements activated 
 
Figure 85 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 4.77 seconds - focus 
at x=0, HALF elements activated (HiDef) 
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Figure 86 - Surface and contour Temperature plots (°C) for TAP = 1 W cm-2 after 7.1 seconds - focus 
at x=25, HALF elements activated 
 
 
 
 
[Note – The ‘HiDef’ simulation here failed due to hardware limitations of the PC used]  
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Figure 87 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 1.8 seconds - focus 
at x=0, HALF elements activated 
 
Figure 88 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 1.8 seconds - focus 
at x=0, HALF elements activated (HiDef) 
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Figure 89 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 2.7 seconds - focus 
at x=25, HALF elements activated 
 
Figure 90 - Surface and contour Temperature plots (°C) for TAP = 2 W cm-2 after 2.73 seconds - focus 
at x=25, HALF elements activated (HiDef) 
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Figure 91 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.1 seconds - focus 
at x=0, HALF elements activated 
 
Figure 92 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.05 seconds - focus 
at x=0, HALF elements activated (HiDef) 
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Figure 93 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.6 seconds - focus 
at x=25, HALF elements activated 
 
Figure 94 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.59 seconds - focus 
at x=25, HALF elements activated (HiDef) 
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Figure 95 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.75 seconds - focus 
at x=0, HALF elements activated 
 
Figure 96 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 0.73 seconds - focus 
at x=0, HALF elements activated (HiDef) 
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Figure 97 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 1.1 seconds - focus 
at x=25, HALF elements activated 
 
Figure 98 - Surface and contour Temperature plots (°C) for TAP = 4 W cm-2 after 1.11 seconds - focus 
at x=25, HALF elements activated (HiDef) 
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Figure 99 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.55 seconds - focus 
at x=0, HALF elements activated 
 
Figure 100 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.56 seconds - 
focus at x=0, HALF elements activated 
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Figure 101 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.85 seconds - 
focus at x=25, HALF elements activated 
 
Figure 102 - Surface and contour Temperature plots (°C) for TAP = 5 W cm-2 after 0.84 seconds - 
focus at x=25, HALF elements activated (HiDef) 
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Focus x=0: 
Table 19 - Exposure time vs. TAP, results for the case of HALF elements being active, with a focus of 
x=0 mm (Figure 84, Figure 85 & Figure 87 to Figure 100, see legend(s) for relevant plots) 
TAP     
(W cm-2) 
Time 
(s) 
Focal temp 
(°C) 
Focal TD 
(mins) 
Lobe temp 
(°C) 
Lobe TD 
(mins) 
1 1 44.23 0.01 37.38 <0.0001 
 2 48.36 0.40 37.60 <0.0001 
 3 51.79 6.13 37.78 <0.0001 
 4 54.70 53.81 37.93 <0.0001 
 4.77 56.70 243.46 38.07 <0.0001 
2 1 51.11 1.20 37.74 <0.0001 
 1.8 58.21 246.59 38.12 <0.0001 
 2 59.74 770.45 38.20 <0.0001 
3 1 58.30 150.87 38.12 <0.0001 
 1.05 59.04 254.76 38.16 <0.0001 
 2 71.12 2.17x106 38.80 <0.0001 
4 0.73 59.62 263.67 38.19 <0.0001 
 1 65.36 19431 38.49 <0.0001 
 2 82.49 6.15x109 39.40 0.0002 
5 0.56 60.21 306.73 38.22 <0.0001 
 1 72.45 2.67x106 38.87 <0.0001 
 2 93.86 1.93x1013 39.99 0.0003 
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Focus x=25: 
Table 20 - Exposure time vs. TAP, results for the case of HALF elements being active, with an 
‘extreme’ focus of x=25 mm (Figure 86 & Figure 89 to Figure 102, see legend(s) for relevant plots) 
TAP 
(W/cm-2) 
Time 
(s) 
Focal temp 
(°C) 
TD 
(mins) 
Lobe temp 
(°C) 
TD 
(mins) 
1 2 45.52 0.10 41.03 0.0020 
 4 50.29 3.80 44.69 0.0485 
 6 54.034 60.33 46.87 0.4706 
 7 55.70 213.11 47.83 1.2004 
 7.1 55.86 242.01 47.92 1.3494 
2 1 47.20 0.07 41.83 0.0030 
 2 53.70 12.00 44.91 0.0714 
 2.73 57.59 241.62 46.75 0.4355 
3 1 52.30 2.60 44.25 0.0227 
 1.59 58.37 245.93 48.11 0.3203 
 2 62.05 3833.40 50.28 1.4466 
4 1 57.42 79.68 46.68 0.1072 
 1.11 59.05 259.79 47.44 0.2173 
 2 70.40 1.23x106 52.82 23.1510 
5 0.84 59.40 247.24 47.61 0.1672 
 1 62.51 2474.60 49.08 0.5986 
 2 78.73 4.22x108 56.77 471.1324 
As with the case in which all elements are excited (see Section 6.3.1.1) simulations 
were performed to allow a more accurate thermal dose pattern to be observed, In this 
case only half the total elements were excited. The tables presented (see Table 19 & 
Table 20) show the results of these tests, performed to further define the time at which 
each power level causes the thermal dose to exceed the threshold of 240 equivalent 
minutes. As with the case of all elements being excited, the central focus at x=0 mm 
allows the target thermal dose to be achieved more quickly and with lower lobe 
temperatures than the ‘extreme focus at x=25 mm (see Figure 103). Additionally it can 
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again be seen grating lobe levels are reduced when the focus is central, at x=0 mm (see 
Table 19 & Table 20). 
 
Figure 103 - Graph of TAP against time taken to reach the TD threshold limit at the focal point 
(HALF elements activated) 
In all cases the thermal dose in non-focal areas was observed to be less than 1.35 
equivalent minutes (see Figure 104, Table 19 & Table 20) with a corresponding maximum 
lobe temperature of 47.9 °C at the time at which the focal thermal dose threshold of 
240 equivalent minutes was exceeded. As previously the corresponding graph for the 
‘natural’ focus (x=0 mm) has been omitted as values were low enough to be 
considered insignificant. 
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Figure 104 - TAP against TD at the grating lobe for the case of the extreme focus at x=25 mm (HALF 
elements activated) 
From the results of both cases (all and half elements being activated) it can be said 
that even though TD values were marginally higher, using half the elements of the 
array would be feasible and would allow the focal thermal dose threshold to be 
exceeded while avoiding permanent damage to the surrounding tissue. Even though 
the TD deposited at the non-focal grating lobe decreases with increasing TAP (see 
Figure 104) the values are low enough that the actual TAP used seems significant only in 
determining the total sonication time, with higher values allowing shorter sonication 
periods to be used. The exposure time in this regard will be investigated in the 
following section (see Section 6.3.1.3). Having said this it would be preferable to use a 
TAP of 2 W cm-1 or higher to reduce the lobe TD by a factor of three (see Figure 104 & 
Table 20) 
6.3.1.3: TAP vs. Exposure Time Specification 
From the simulation results presented previously (see Section 6.3.1.2) the following 
information has been officially added to the technical specification for the transducer 
to be manufactured by Imasonic (see Table 21). These times are based on the 
maximum times necessary when activating only half the total elements and focusing at 
the ‘extreme’ focus (x=25 mm for half elements) hence they represent the absolute 
maximum necessary sonication/exposure times of any case. 
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It should be noted here that actual exposure times will likely be much smaller (for 
example when activating all elements or focusing at a distance of less than 45 mm 
from the centre of the transducer) which will have no adverse effects on the 
transducer as the ON time will be reduced, while the OFF time will remain as shown 
(see Table 21) to allow extra cooling time, therefore decreasing the probability of 
damage to the device. 
Table 21 - Table showing allowable continuous transducer activation time periods, as suggested by 
manufacturer IMASONIC 
TAP at 
transducer 
(W cm-2) 
ON time      
(s) 
OFF time   
(s) 
1 7.3 2 
2 2.9 2 
3 1.7 2 
4 1.2 5 
5 0.9 5 
The above OFF times (see Table 21) should not interfere with any treatment plan used 
as during the scanning phase (between HIFU sonications) the plate in which the HIFU 
and possible diagnostic transducers are held has to rotate to scan the target volume. 
This process will take approximately 5 seconds and so could interleave with the HIFU 
treatment times for each sonication period, as shown above.  
6.3.2: Steering Simulations 
In the following simulations the effect of steering angle on exposure time (to reach 240 
equivalent minutes thermal dosage) will be investigated. A mid-range TAP value of 3 W 
cm-2 will be used, and the focus will be varied from x=0 mm to x=45 mm (for all 
elements, see Figure 105 to Figure 122) and x=0 mm to x=25 mm (for half elements, see 
Figure 125 to Figure 138) in steps of 10 mm, and once at the edge of the length of the 
transducer array. As previously, plots will be given for the point at which thermal dose 
at the focus exceeds 240 equivalent minutes. 
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6.3.2.1: All Elements 
 
Figure 105 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.4 seconds - focus 
at x=0, ALL elements activated 
 
Figure 106 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.38 seconds - 
focus at x=0, ALL elements activated (HiDef) 
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Figure 107 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.5 seconds - focus 
at x=10, ALL elements activated 
 
Figure 108 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.39 seconds - 
focus at x=10, ALL elements activated (HiDef) 
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Figure 109 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.5 seconds - focus 
at x=20, ALL elements activated 
 
Figure 110 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.46 seconds - 
focus at x=20, ALL elements activated (HiDef) 
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Figure 111 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.6 seconds - focus 
at x=30, ALL elements activated 
 
Figure 112 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.59 seconds - 
focus at x=30, ALL elements activated (HiDef) 
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Figure 113 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.75 seconds - 
focus at x=35, ALL elements activated 
 
Figure 114 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.68 seconds - 
focus at x=35, ALL elements activated (HiDef) 
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Figure 115 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.8 seconds - focus 
at x=37.5, ALL elements activated 
 
Figure 116 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.75 seconds - 
focus at x=37.5, ALL elements activated 
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Figure 117 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.85 seconds - 
focus at x=40, ALL elements activated 
 
Figure 118 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.82 seconds - 
focus at x=40, ALL elements activated (HiDef) 
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Figure 119 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.0 seconds - focus 
at x=42.5, ALL elements activated 
 
Figure 120 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 0.9 seconds - focus 
at x=42.5, ALL elements activated (HiDef) 
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Figure 121 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.1 seconds - focus 
at x=45, ALL elements activated 
 
Figure 122 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.01 seconds - 
focus at x=45, ALL elements activated (HiDef) 
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Table 22 - Effect of steering the focal point (ALL elements) on the resulting thermal dose (TD) (Figure 
105 to Figure 122) 
Focus at 
(mm) 
Time 
(s) 
Focal 
temp (°C) 
Focal TD     
(mins) 
Lobe 
temp (°C) 
Lobe TD     
(mins) 
0 0.38 60.59 313.15 38.24 <0.0001 
 1 81.70 1.86x109 44.06 0.01528 
 2 105.45 8.47x1016 47.81 1.3905 
10 0.39 60.30 266.36 38.23 <0.0001 
 1 80.44 7.69x108 39.29 0.01964 
 2 103.54 2.31x1016 47.51 1.0566 
20 0.45 60.06 250.74 40.64 <0.0001 
 1 76.16 4.09x107 43.18 0.0181 
 2 97.22 2.39x1014 46.51 0.9547 
30 0.59 60.03 311.52 40.64 <0.0001 
 1 69.75 4.23x105 42.17 0.0082 
 2 87.79 2.80x1011 45.02 0.9161 
35 0.68 59.50 247.09 40.55 0.0020 
 1 66.15 35955 41.60 0.0155 
 2 82.40 6.20x109 48.95 0.8151 
37.5 0.75 59.49 270.04 42.92 0.0047 
 1 64.29 9419.22 44.18 0.0180 
 2 79.63 9.04x108 46.36 0.9186 
40 0.87 59.26 247.68 42.86 0.0076 
 1 62.46 2832.80 43.70 0.0142 
 2 76.92 1.34x108 47.51 0.7432 
42.5 0.91 59.16 252.62 42.83 0.0167 
 1 60.63 762.79 43.22 0.0254 
 2 74.16 1.88x107 50.69 1.3529 
45 1 58.84 235.76 43.77 0.0189 
 1.01 58.99 262.45 44.00 0.0194 
 2 71.45 2.73x106 49.69 1.0978 
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Figure 123 - Graph of time to focal TD threshold against beam steering point (ALL elements activated) 
From these results (see Table 22 & Figure 123) it can be seen that the threshold thermal 
dose of 240 mins was reached in under one second in all cases except from the 
extreme focus at x=45, for which the threshold was exceed at 1.01 seconds. The 
maximum temperature outside of the focus was under 43 °C in all simulations and was 
the lowest at the ‘natural’ focus of x=0 mm where the temperature rose just over 1.2 
°C above normal human body temperature. In all cases thermal dose outside the focus 
did not exceed 0.02 equivalent minutes (see Figure 124). 
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Figure 124 - Graph of TD developed at the non-focal lobe against the beam steering point (ALL 
elements activated) 
From these results we can draw the conclusion that ablation would be feasible at all 
points simulated using a TAP of 3 W, with all of the transducer elements being excited 
to create the desired focus. Also all times to a TD of 240 mins were less than 1.7 s, the 
limit of allowable continuous transducer activation period for 3 W TAP at the 
transducer (see Table 21). In the following section (see Section 6.3.2.2) these 
simulations will be performed using half the elements of the array. 
 
 
186 
 
6.3.2.2: Half Elements 
 
Figure 125 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.1 seconds - focus 
at x=0, HALF elements activated 
 
Figure 126 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.05 seconds - 
focus at x=0, HALF elements activated (HiDef) 
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Figure 127 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.15 seconds - 
focus at x=10, HALF elements activated 
 
Figure 128 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.11 seconds - 
focus at x=10, HALF elements activated (HiDef) 
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Figure 129 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.24 seconds - 
focus at x=15, HALF elements activated 
 
Figure 130 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.22 seconds - 
focus at x=15, HALF elements activated (HiDef) 
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Figure 131 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.3 seconds - focus 
at x=17.5, HALF elements activated 
 
Figure 132 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.29 seconds - 
focus at x=17.5, HALF elements activated (HiDef) 
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Figure 133 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.35 seconds - 
focus at x=20, HALF elements activated 
 
Figure 134 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.38 seconds - 
focus at x=20, HALF elements activated (HiDef) 
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Figure 135 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.5 seconds - focus 
at x=22.5, HALF elements activated 
 
Figure 136 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.47 seconds - 
focus at x=22.5, HALF elements activated (HiDef) 
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Figure 137 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.6 seconds - focus 
at x=25, HALF elements activated 
 
Figure 138 - Surface and contour Temperature plots (°C) for TAP = 3 W cm-2 after 1.59 seconds - 
focus at x=25, HALF elements activated (HiDef) 
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Table 23 - Effect of steering the focal point (HALF elements) on the resulting thermal dose (TD) 
(Figure 125 to Figure 138) 
Focus at 
(mm) 
Time    
(s) 
Focal temp 
(°C) 
Focal TD      
(mins) 
Lobe temp 
(°C) 
Lobe TD     
(mins) 
0 1 58.30 150.87 38.12 <0.0001 
 1.05 59.04 254.76 38.16 <0.0001 
 2 71.12 2.17x106 38.80 <0.0001 
10 1 57.27 87.41 40.23 <0.001 
 1.15 58.82 244.33 40.44 0.0012 
 2 69.54 6.15x105 42.14 0.0230 
15 1 56.33 32.47 42.83 0.0149 
 1.23 58.62 247.59 43.82 0.0461 
 2 68.38 1.2212x105 47.27 0.7708 
17.5 1 55.15 18.65 43.69 0.0311 
 1.29 58.73 253.27 45.01 0.1046 
 2 66.34 71552 50.90 1.6132 
20 1 54.25 10.02 43.36 0.2458 
 1.38 58.69 259.54 47.27 0.1276 
 2 64.98 28318 50.25 1.4240 
22.5 1 53.30 5.63 43.04 0.0149 
 1.47 58.47 248.52 44.91 0.1163 
 2 63.54 10452 49.57 0.7470 
25 1 52.30 2.60 44.25 0.02270 
 1.59 58.37 245.93 48.11 0.3203 
 2 62.05 3833.41 50.28 1.4466 
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Figure 139 - Graph of time to focal TD threshold against beam steering point (HALF elements 
activated) 
From the results of these simulations (see Table 23 & Figure 139) it can be observed that 
the thermal dose threshold was exceeded between 1 and 1.6 seconds for all cases, 
within the limit set by manufacturers Imasonic (see Table 21).. The further away from 
the geometric centre the beam was steered the longer time was required to exceed 
the focal TD threshold. The maximum temperature outside of the focus was under 
48.2 °C in all simulations and was the lowest when directed at the ‘natural’ focus of 
x=0 mm where the simulated temperature at the lobe rose just over 1.1 °C above 
normal human body temperature. In all cases thermal dose outside the focus did not 
exceed 0.35 equivalent minutes (see Figure 140). 
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Figure 140 - Graph of TD developed at the non-focal lobe against the beam steering point (HALF 
elements activated) 
From these results we can again draw the conclusion that ablation would be feasible at 
all points simulated using a TAP of 3 W, with just half of the transducer elements being 
excited to create the desired focus. An interesting point of note here is the anomalous 
result of the TD at the grating lobe when the beam is steered to x=22.5 mm (see Figure 
140). Here the TD decreased, rather than increased as in the case of all elements (see 
Figure 124). The simulation data for this point was checked and retested a number of 
times with the same result. However, whether this was due to a limitation in the 
simulation mesh size, or due to a property of the interaction of the acoustic waves 
themselves, it can be said that the TD levels at non-focal points are well within safe 
levels and as such this outlying point cannot be said to affect the efficacy of the 
transducer design or treatment plan. 
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6.4: Chapter Conclusion 
To conclude, in this chapter the theory used to simulate the time-dependent tissue 
temperature rise using acoustic intensity fields obtained earlier, has been defined. 
Using this theory the BHTE was computed using suitable software with the effects of 
acoustic power input and exposure time being thoroughly investigated, with a thermal 
dose model being used to compare the surgical affectivity of differing heating regimes. 
Steering of the focal point has also been considered and simulated. The result of these 
simulations have shown that enough energy was delivered at the focus to ablate tissue 
whilst not causing permanent damage in non-focal areas. Overall this has resulted in a 
novel design that is both compatible with the existing EIM device and theoretically 
capable of ablating tissue within the defined volume, as described in the problem 
definition specified previously (see Section 4.2). Results have been discussed with 
emphasis on the ability of the designed transducer to perform as a surgical instrument. 
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Chapter 7:        
           
                
Conclusions & Future Work 
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7.1: Chapter Introduction 
In this brief final chapter conclusions from the work described in previous chapters will 
be drawn. These conclusions will be based on the achievement of the goals set out in 
the original project proposal (see Appendix B) which has been included as a 
supplement to this thesis. 
Additionally suggestions for the direction of future work will be outlined. These will 
include topics that would have been considered had time constraints allowed and 
other useful avenues of research, such as research into adaptation of the designed 
device for cancers that affect tissues other than the breast. 
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7.2: Project Conclusions 
To summarise, the work described in this thesis has shown that the incorporation of a 
surgical HIFU device into the existing EIM system developed at the University of Sussex 
is indeed feasible, thus fulfilling the research aim (see Section 1.6.1: Aims).  
It has been shown that modification of the existing electrode plate would allow 
sufficient space to fit a suitably powerful HIFU transducer, capable of targeted tissue 
ablation within a known volume, namely that of human breast tissue. The research 
objectives have therefore also been satisfied in that the research questions posed have 
been effectively answered (see Section 1.6.2: Objectives & Appendix B: Original Project 
Proposal). Referring to the first two questions, the feasibility study has indeed shown 
that HIFU can be used as a surgical tool in combination with EIM to provide diagnosis 
and targeted treatment. It has also been shown how a suitably powerful HIFU 
transducer can be incorporated into the existing EIM system, designed by the BMEng 
group at the University of Sussex, allowing the region of interest to be effectively 
targeted by the designed device via mechanical movement of the EIM electrode plate 
and electronic steering of the focal point using a phased array. This study has included 
the factors that must be considered when designing such a device, with simulations 
used to investigate the effect of these factors and of the surgical   of the HIFU device as 
a whole. 
The benefits of HIFU over existing comparable treatments was one of the driving 
forces of the investigations described in this thesis. Ablation using radiofrequency has 
the drawback of requiring direct contact with the treatment area, thus cannot be 
termed truly non-invasive. Although technological advances may allow progressively 
smaller electrodes to be used, this techniques would still require insertion of some 
type of device into the patients’ body. The same is true for laser, microwave and 
cryoablation. Even though these techniques may be performed laparoscopically or 
percutaneously, an incision, regardless of the size, would still be required for the 
treatment of breast cancer in current surgical environments. Moreover radiation based 
ablation techniques such as brachytherapy and hadron therapy however safe could 
have negative psychological implications to patients due to the negative public opinion 
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of radiation. Given a choice it is likely patients would favour ‘acoustic therapy’ over a 
technique based on radiation. For these reasons the development of HIFU treatments 
seems to provide true progress, minimising treatment time and greatly improving 
patient comfort during the treatment process. Furthermore incorporating HIFU as a 
treatment device into a system capable of performing a non-invasive diagnosis of 
breast cancer seems to be a progressive step in creating an ‘all-in-one’ device for 
breast cancer treatment. The main body of work described in previous chapters has 
focused on this goal. 
Using current fabrication methods HIFU transducers generally have many features in 
common with one another, such as using a piezoelectric element and incorporating a 
matching layer to minimise the losses arising when acoustic waves propagate through 
more than one medium with differing acoustic impedances. Using an element 
thickness of half a wavelength and a matching layer with a thickness equal to a quarter 
wavelength in the piezoelectric material is optimal to minimise these losses. The 
designed transducer follows this principle. 
Focusing of the HIFU beam was one of the most important factors to consider in the 
HIFU transducer design. To allow maximum coverage in the scanned volume of the 
EIM system, using a spherical type array was deemed impractical due to the difficulty 
in moving the device to surgically advantageous positions relative to the treatment 
region. Using an annular truncated array, as commonly used in transrectal devices for 
the treatment of prostate cancer was also not implemented due to the absence of a 
need to vary the focal depth using control of annular phased elements. This 
requirement was met by the mechanical movement of the electrode plate in the EIM 
system. Using a lens or lenses to focus the beam was an option, however using a lens 
causes a loss in the power output of the transducer and therefore decreases the 
intensity of the focal point. As the space available, and therefore the maximum power 
output of the transducer, was limited, a lens was deemed unsuitable and was not 
included as part of the design. In place of a lens the transducer elements themselves 
were designed with a linear concave geometry, causing propagated ultrasound to 
focus naturally along one axis, or rather along a line. Using the phasing of individual 
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elements allows this line to be focused into a point and using the vertical translation of 
the electrode plate allows the target focal depth to be varied. This is the technique 
employed by the transducer described in this thesis. 
With a transducer geometry and operation of focus decided, the remaining 
characteristics of the transducer were considered. Assuming a maximum focal depth of 
4 cm it was shown that the optimal operating frequency of the transducer would be 
approximately 3.5 MHz. Simulations were performed using these values and were 
carried out to fully explore the feasibility of the project and to optimise design 
parameters to meet the necessary criteria of surgical ablation. 
Using a custom-written MATLAB code based on Huygen’s principle investigations 
showed the most efficient spacing of sub-elements was equal to one-sixth of a 
wavelength in the piezoelectric material. As the attenuation coefficient of breast tissue 
in different patients will vary, the effect of altering the value was investigated, 
resulting in 7.5 Np m-1 MHz-1 being used for the majority of simulations performed. 
Compared to similar studies this would allow the focal intensity to be underestimated, 
allowing a suitable ‘safety factor’ and ensuring ablation at the focus would be possible. 
Element width and kerf were initially optimised to reduce or prevent grating lobes but 
were later modified following discussions with transducer manufacturer Imasonic. 
Eventually these two parameters were selected as a compromise between 
manufacturing limitations and optimal values found from simulation. Following further 
simulations, this resulted in an element width and kerf of 0.43 mm and 0.1 mm 
respectively to be used.  
The expected focal intensities and magnitude of grating lobes were investigated and 
used as inputs in the Pennes Bio-Heat Transfer Equation computed using the COMSOL 
Multiphysics software package. Using a thermal dose model, simulations showed that 
it would indeed be feasible to ablate tissue in a reasonable timeframe using the 
acoustic power value limitations advised on by the transducer manufacturers, in 
accordance with the proprietary piezoelectric materials available. Simulations involving 
steering the focus were then carried out and proved steering to be feasible in terms of 
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focused tissue heating, with heating of surrounding tissue outside the focal area falling 
within acceptable limits, leading to no permanent cell damage. 
To conclude, not only has feasibility been proven but a design has been developed, up 
to the stage of plausible manufacture. This design is based on the numerous 
simulations performed to allow the optimisation of a small but powerful device, 
capable of steering a suitably focused point along the major axis of the device. 
Combined with the mechanical, stepper motor controlled height and rotation of the 
EIM electrode plate, this transducer would allow ablation of tissue at any surgically 
useful point in the scanned volume. This focus has been proven capable of depositing 
enough energy, in the form of heat from attenuated acoustic waves, such that 
targeted tissue will be ablated via coagulative necrosis at the cellular level. Once 
necrosed, these cells would be naturally absorbed by cellular phagocytosis, resulting 
over time in the disappearance of the palpable lump that would likely be present 
immediately following treatment. While the presence of this lump may be a 
psychological factor involved in prospective patients’ decision to undergo HIFU 
surgery, it is an inconvenience that would allow invasive surgery to be completely 
avoided. This is one of, if not the major benefit of undergoing a non-invasive surgical 
procedure such as FUS. It should also be noted that anaesthesia is rarely necessary 
during HIFU procedures as mentioned in a number of the publications reviewed, 
furthering the move away from the necessity of major surgical operations for the 
treatment breast cancer. Some patients may favour conventional surgery, such as a 
mastectomy, over HIFU treatment due to the persistence of the resulting palpable 
lump but nonetheless the option of avoiding this type of surgery altogether will almost 
certainly lead a large number prospective patients to choose the non-invasive HIFU 
option. The exact proportions of patients making this choice may vary from country to 
country and culture to culture, and it remains to be seen where this balance may lie. 
Further investigations and interviews with prospective patients would help to 
illuminate the general consensus on this matter, as would consultations with practicing 
oncologists prior to the mainstream introduction of this type of treatment. 
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7.3: Future Work 
For various reasons a number of investigated research areas had to be omitted from 
this thesis. In this section these areas and some additional topics not covered in the 
body of this thesis will be described, with suggestions made for useful further 
developments. 
7.3.1: Prototype Manufacture & Test 
The next logical step for the work described in this thesis would be the manufacture of 
a prototype device. Primarily this would allow simulation findings to be verified in 
vitro, thus allowing adjustment of the model to reflect ‘real world’ results if and where 
necessary. Originally it was intended the project would reach this prototype stage but 
due to unfortunate external pressures and suspension of funding this could not be 
achieved. 
In anticipation of prototype fabrication a specialised manufacturer was contacted 
resulting in the modification of certain simulation parameters reflecting the limitations 
of manufacture and manufacturing technology. It is possible however that as the 
technology for creating suitable materials and devices that these limitation may be 
lifted or at least relaxed allowing for a reappraisal of the feasibility study performed, 
paving the way for development of a more advanced device. 
Once a prototype has been manufactured and laboratory tested progress toward 
medical trials could begin. It seems fair to assume that, given suitable approval, the 
device described could eventually be used in clinical trials. Following this path to 
successful completion it is hoped that the designed device, or a development 
henceforth could be usefully adopted into the treatment of breast cancer patients. At 
the least the use of the device or similar could become a viable option to patients 
facing conventional treatment and invasive surgery. 
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7.3.2: Driving Electronics & Circuitry 
To operate the designed HIFU transducer a system capable of driving current to the 
elements of the array must be developed. This in itself warrants a separate research 
project similar in magnitude to that described in this thesis. An overview of the 
requirements of such a system is given below in addition to a block diagram showing a 
basic system layout (see Figure 141, [90]). 
 
Figure 141 - General layout of HIFU array driving circuitry 
 
• 128 Channels 
• Sine wave input 
• Variable power: Electrical power of 0.27 W to 1 W per channel (advantageous if 
this could go higher / with small a resolution as possible (3W TAP = 0.5522 W 
per element at 59 % efficiency)) 
• Delay line(s) for phase shift between 0 and 2π (approx. 0 to 286 ns at 3.5 MHz) 
for each channel, resolution of 2 ns (lower if possible) 
The development of driving circuitry may originally have been included as part of this 
thesis, but as project funding was withdrawn the work required to continue was 
omitted in favour of the main narrative, the design of the HIFU transducer and 
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simulation of surgical efficacy. It is highly recommended that this design work and 
fabrication of a completed design be undertaken as the ‘next step’ following on from 
the work presented in this thesis. This, along with the manufacture of the designed 
transducer, would allow trials to begin, at which stage results could be compared to 
simulations and the simulation model validated or adapted using the test data. 
7.3.3: Two Media Simulations 
As mentioned in a previously, the simulations performed involved the propagation of 
ultrasound through a single, homogenous media. This allowed the parameters 
involved in the design of the selected transducer to be characterised and optimised. 
However, once integrated into the existing EIM system and put to use, more than one 
media would be present, most notably the saline bath within the scanned volume into 
which a patient’s breast would be placed prior to scanning or treatment taking place. 
Although saline in-between the transducer and the tissue to be treated would affect 
the resulting ultrasound beam properties, this should be kept to a minimum, as by 
design the breast being scanned may be compressed by the electrode plate of the EIM 
system, pushing the saline out to the sides of the breast, to locations where treatment 
should not be necessary. To what extent this occurs would vary patient to patient. 
Nevertheless it would be advantageous to model this second media and investigate 
the effect this would have on acoustic intensity and focal steering that would affect 
the resulting heat deposition within the tissue in question. This would allow for a more 
accurate treatment regime to be planned and as such would increase the overall 
usefulness of the simulation work presented in terms of use for treatment planning 
and targeting. 
Furthermore the tissue was modelled as homogenous, having a constant acoustic 
impedance throughout the simulated volume. In reality breast tissue is far from 
homogenous. Fatty tissues, muscle and blood vessels have different acoustic 
impedance and would affect the propagation of ultrasound and would therefore alter 
the path to the focus in different ways. Additionally blood vessels may cause a small 
amount of heat to be carried away from the focus, especially with longer sonications, 
and as a result less energy would be deposited than reported in the simulations 
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described earlier, although it is generally agreed that, as mentioned previously, for 
short exposure times this effect can be ignored. To ensure this is indeed the case 
further investigation is warranted 
To make accurate estimations more difficult there is also the problem that individual 
patient’s breast tissue will differ from one another, making precise, non-generic 
simulations difficult. Using a method such as diagnostic ultrasound it may be possible 
to develop a model that would take into account the composition of a patient’s breast 
prior to treatment, by identifying the volume and type of each tissue present to create 
personalised treatment plans. This would be a useful topic to consider in surgical 
planning and future development of the device. 
7.3.4: Dual Mode Transducers 
An interesting topic worthy of consideration is the use of ‘dual-mode’ transducers, 
examples of which have been described in the literature review presented earlier (see 
Section 2.3.1). This type of transducer could be used to supplement the diagnostic part 
of the EIM scanning procedure, in addition providing accurate location information on 
the cancerous tissue within the scanned volume. 
This dual mode could operate in various ways, such as interleaving diagnostic 
sonications with those intended for the ablation of cancerous tissue. Progress could be 
monitored during treatment, offering advantages in terms of in-treatment supervision 
and feedback. 
Alternatively, with the development of signal processing it may be possible to both 
monitor and treat the target tissue simultaneously. This may allow treatment to be 
monitored in real-time. As ultrasound devices are far more accessible in terms of cost, 
this offers the possibility of a machine capable of real-time treatment feedback, for the 
fraction of the cost involved with MR machines and imaging. To develop similar 
monitoring capabilities using ultrasound alone would vastly increase the practicality of 
device adoption and could well tip the balance in favour of comparatively inexpensive 
yet highly effective surgical EIM-HIFU devices, thus making valuable progress towards 
a widely accepted all-in-one device for the treatment of breast cancer. 
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It is also worth noting here that there is a current project researching the possibility of 
combining a diagnostic ultrasound with the EIM system at the University of Sussex. 
This project combines diagnostic ultrasound with EIM and has been named Combined 
Electrical Impedance Mammography with Ultrasound (CEIMUS). This work is out of the 
scope of the current research, but nevertheless offers an interesting avenue of 
research that could help further develop a truly all in one device, capable of detection, 
diagnosis and treatment of breast cancer. 
7.3.5 Application to Other Cancer Types 
Treatment of breast cancer has been the main focus of this thesis. While the device 
was designed to treat breast cancer alone, this does not deny the possibility of 
treatment of other types of cancer. Most notably the treatment of testicular cancer 
may be possible, with a few adaptions of the EIM device. HIFU has been successfully 
used to treat many different cancers as has been described in the literature review. 
The challenge here would be to develop an EIM system capable of scanning volumes of 
tissue other than the breast, from which point a suitable HIFU transducer could well be 
designed to complement the detection and diagnosis with a treatment modality that 
requires little or no anaesthesia. The treatment of other types of cancer, along with 
the other suggestions described in this final thesis section, could easily form the basis 
of a new and novel research project. It is the hope of the author that such a project be 
taken on and the ideas and approaches described herein be developed to the point 
that breast cancer surgery may truly become an outpatient procedure. 
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Appendix A: MATLAB Simulation Code 
In this appendix a sample of the custom-written MATLAB code is given, for reference. 
It should be noted that the code was adapted & modified for the various simulations 
presented in this thesis and as such underwent many changes as the project evolved. 
The sample below simulates a ‘mini-array’ comprising only sixteen elements and so 
compared to the simulations shown previously, that simulated a minimum of 64 
elements, would produce a much less powerful and less defined focus. It has been 
included as a characteristic example. 
Additional parameters used in sample include the following: 
• ‘Kerf’ (Gap between elements) = 0.05 mm 
• Element Width = 0.32 mm 
• No. elements simulated = 16  
• Focus at 1 mm (positive x-direction) 
[CODE BEGINS] 
r=0.05; 
c=1500; 
freq=3500000; 
lambda=c/freq; 
  
kerf=0.00005; 
elemwidth=0.00032; 
numelem=16; 
elempitch=elemwidth+kerf; 
%numelem=fix((0.07/(elempitch))/2); 
  
 A=((r*sin(((28.955*2*pi))/360))*elemwidth)*numelem; 
 S=((r*sin(((28.955*2*pi))/360))*elemwidth); 
  
maxacousticpower=3; 
W=A*10000*maxacousticpower; 
  
k=(2*pi)/lambda; 
att=5*(freq/1000000); 
rho=998; 
n=lambda/5; 
  
alphaT=(28.96*2*pi)/360; 
  
circ=r*alphaT; 
minsize=(lambda/2); 
nmin=circ/minsize; 
intn=ceil(nmin); 
alphastep=alphaT/intn; 
  
subS=S/intn; 
constant=(sqrt(((2*W*rho)/(c*A))))*(freq)*subS; 
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startalpha=(-14.48)*(2*pi)/(360); 
endalpha=(14.48)*(2*pi)/(360); 
  
alpha=[startalpha:alphastep:endalpha]; 
  
% origin at focus (x=a,y=b) - ie directly 'in front of'/above centre 
of (centre) element 
a=0; 
b=0; 
  
focusx=0.001; 
focusy=0.01; 
focusz=0; 
  
elemxc=0; 
elemyc=0; 
elemzc=-0.05; 
  
% decimal places to round phi (rads) to 
dp=(1/0.044);  
  
subelemx=a+(r*sin(alpha));        
        % 'subelemx' is the x co-ords of the sub-elements 
        % & 'a'&'b' are the co-ords of the centre of the arc 
subelemz=b+(-r*cos(alpha));    
  
[Y,Z]=meshgrid(-0.05:n:0.05,-0.045:n:0.02);    % 'n' is grid 'step' 
size 
% distance for each sub element to every point in the x,z grid 
% how big is the array 
[r,c]=size(Y);           
Y1d=reshape(Y,r*c,1);    
Z1d=reshape(Z,r*c,1);   
  
  
%Element 1  
% loop through each subelemx 
elemxc1=0; 
elemyc1=0; 
elemzc1=-0.05; 
  
phi1=round((((sqrt(((elemxc1-focusx)^2)+((elemyc1-
focusy)^2)+((elemzc1-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi1=exp(1i*phi1); 
for sCnt1=1:length(subelemx);      
    dist1(:,sCnt1)=sqrt(((subelemx(sCnt1)).^2) +((Z1d-
subelemz(sCnt1)).^2)+((Y1d-elemyc1).^2));   
end                              
% aY1d and Z1d are the points within the grid 
    attd1 = exp(-att.*dist1);      
    ejkd1 = exp(-1i.*k.*dist1);    
    Texp1 = (ephi1.*attd1.*ejkd1);  
    Texpd1 = (Texp1./dist1); 
    ATTexpd1 = sum(Texpd1,2); 
     
pmatrix1=reshape(ATTexpd1,(size((Y),1)),(size((Y),2))); 
pmatrix1s=pmatrix1; 
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clear pmatrix1 
clear dist1 
clear attd1 
clear ejkd1 
clear Texp1 
clear Texpd1 
clear ATTexpd1 
clear sCnt1 
clear phi1 
clear ephi1 
clear elemyc1 
clear elemxc1 
clear elemzc1 
  
  
%Element 2% 
  
elemxc2=0; 
elemyc2=1*elempitch; 
elemzc2=-0.05; 
  
phi2=round((((sqrt(((elemxc2-focusx)^2)+((elemyc2-
focusy)^2)+((elemzc2-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi2=exp(1i*phi2); 
for sCnt2=1:length(subelemx)      
    dist2(:,sCnt2)=sqrt(((subelemx(sCnt2)).^2) +((Z1d-
subelemz(sCnt2)).^2)+((Y1d-elemyc2).^2));   
end                              
    attd2 = exp(-att.*dist2);      
    ejkd2 = exp(-1i.*k.*dist2);    
    Texp2 = (ephi2.*attd2.*ejkd2);  
    Texpd2 = (Texp2./dist2); 
    ATTexpd2 = sum(Texpd2,2); 
     
pmatrix2=reshape(ATTexpd2,(size((Y),1)),(size((Y),2))); 
pmatrix2s=pmatrix1s+pmatrix2; 
  
clear pmatrix1s 
clear pmatrix2 
clear dist2 
clear attd2 
clear ejkd2 
clear Texp2 
clear Texpd2 
clear ATTexpd2 
clear sCnt2 
clear phi2 
clear ephi2 
clear elemyc2 
clear elemxc2 
clear elemzc2 
  
  
% %Element 3% 
  
elemxc3=0; 
elemyc3=-1*elempitch; 
elemzc3=-0.05; 
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phi3=round((((sqrt(((elemxc3-focusx)^2)+((elemyc3-
focusy)^2)+((elemzc3-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi3=exp(1i*phi3); 
for sCnt3=1:length(subelemx)      
    dist3(:,sCnt3)=sqrt( ((subelemx(sCnt3)).^2) +((Z1d-
subelemz(sCnt3)).^2)+((Y1d-elemyc3).^2) );   
end                              
    attd3 = exp(-att.*dist3);      
    ejkd3 = exp(-1i.*k.*dist3);    
    Texp3 = (ephi3.*attd3.*ejkd3);  
    Texpd3 = (Texp3./dist3); 
    ATTexpd3 = sum(Texpd3,2); 
     
pmatrix3=reshape(ATTexpd3,(size((Y),1)),(size((Y),2))); 
pmatrix3s=pmatrix2s+pmatrix3; 
  
clear pmatrix2s 
clear pmatrix3 
clear dist3 
clear attd3 
clear ejkd3 
clear Texp3 
clear Texpd3 
clear ATTexpd3 
clear sCnt3 
clear phi3 
clear ephi3 
clear elemyc3 
clear elemxc3 
clear elemzc3 
  
  
% %Element 4% 
  
elemxc4=0; 
elemyc4=2*elempitch; 
elemzc4=-0.05; 
  
phi4=round((((sqrt(((elemxc4-focusx)^2)+((elemyc4-
focusy)^2)+((elemzc4-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi4=exp(1i*phi4); 
for sCnt4=1:length(subelemx)      
    dist4(:,sCnt4)=sqrt( ((subelemx(sCnt4)).^2) +((Z1d-
subelemz(sCnt4)).^2)+((Y1d-elemyc4).^2) );   
end                              
    attd4 = exp(-att.*dist4);      
    ejkd4 = exp(-1i.*k.*dist4);    
    Texp4 = (ephi4.*attd4.*ejkd4);  
    Texpd4 = (Texp4./dist4); 
    ATTexpd4 = sum(Texpd4,2); 
  
pmatrix4=reshape(ATTexpd4,(size((Y),1)),(size((Y),2))); 
pmatrix4s=pmatrix3s+pmatrix4; 
  
clear pmatrix3s 
clear pmatrix4 
clear dist4 
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clear attd4 
clear ejkd4 
clear Texp4 
clear Texpd4 
clear ATTexpd4 
clear sCnt4 
clear phi4 
clear ephi4 
clear elemyc4 
clear elemxc4 
clear elemzc4 
  
  
% %Element 5% 
  
elemxc5=0; 
elemyc5=-2*elempitch; 
elemzc5=-0.05; 
  
phi5=round((((sqrt(((elemxc5-focusx)^2)+((elemyc5-
focusy)^2)+((elemzc5-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi5=exp(1i*phi5); 
for sCnt5=1:length(subelemx)      
    dist5(:,sCnt5)=sqrt( ((subelemx(sCnt5)).^2) +((Z1d-
subelemz(sCnt5)).^2)+((Y1d-elemyc5).^2) );   
end                              
    attd5 = exp(-att.*dist5);      
    ejkd5 = exp(-1i.*k.*dist5);    
    Texp5 = (ephi5.*attd5.*ejkd5);  
    Texpd5 = (Texp5./dist5); 
    ATTexpd5 = sum(Texpd5,2); 
     
pmatrix5=reshape(ATTexpd5,(size((Y),1)),(size((Y),2))); 
pmatrix5s=pmatrix4s+pmatrix5; 
  
clear pmatrix4s 
clear pmatrix5 
clear dist5 
clear attd5 
clear ejkd5 
clear Texp5 
clear Texpd5 
clear ATTexpd5 
clear sCnt5 
clear phi5 
clear ephi5 
clear elemyc5 
clear elemxc5 
clear elemzc5 
  
  
% %Element 6% 
  
elemxc6=0; 
elemyc6=3*elempitch; 
elemzc6=-0.05; 
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phi6=round((((sqrt(((elemxc6-focusx)^2)+((elemyc6-
focusy)^2)+((elemzc6-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi6=exp(1i*phi6); 
for sCnt6=1:length(subelemx)      
    dist6(:,sCnt6)=sqrt( ((subelemx(sCnt6)).^2) +((Z1d-
subelemz(sCnt6)).^2)+((Y1d-elemyc6).^2) );   
end                              
    attd6 = exp(-att.*dist6);      
    ejkd6 = exp(-1i.*k.*dist6);    
    Texp6 = (ephi6.*attd6.*ejkd6);  
    Texpd6 = (Texp6./dist6); 
    ATTexpd6 = sum(Texpd6,2); 
  
pmatrix6=reshape(ATTexpd6,(size((Y),1)),(size((Y),2))); 
pmatrix6s=pmatrix5s+pmatrix6; 
  
clear pmatrix5s 
clear pmatrix6 
clear dist6 
clear attd6 
clear ejkd6 
clear Texp6 
clear Texpd6 
clear ATTexpd6 
clear sCnt6 
clear phi6 
clear ephi6 
clear elemyc6 
clear elemxc6 
clear elemzc6 
  
  
% %Element 7% 
  
elemxc7=0; 
elemyc7=-3*elempitch; 
elemzc7=-0.05; 
  
phi7=round((((sqrt(((elemxc7-focusx)^2)+((elemyc7-
focusy)^2)+((elemzc7-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi7=exp(1i*phi7); 
for sCnt7=1:length(subelemx)      
    dist7(:,sCnt7)=sqrt( ((subelemx(sCnt7)).^2) +((Z1d-
subelemz(sCnt7)).^2)+((Y1d-elemyc7).^2) );   
end                              
    attd7 = exp(-att.*dist7);      
    ejkd7 = exp(-1i.*k.*dist7);    
    Texp7 = (ephi7.*attd7.*ejkd7);  
    Texpd7 = (Texp7./dist7); 
    ATTexpd7 = sum(Texpd7,2); 
     
pmatrix7=reshape(ATTexpd7,(size((Y),1)),(size((Y),2))); 
pmatrix7s=pmatrix6s+pmatrix7; 
  
clear pmatrix6s 
clear pmatrix7 
clear dist7 
clear attd7 
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clear ejkd7 
clear Texp7 
clear Texpd7 
clear ATTexpd7 
clear sCnt7 
clear phi7 
clear ephi7 
clear elemyc7 
clear elemxc7 
clear elemzc7 
  
  
% %Element 8% 
  
elemxc8=0; 
elemyc8=4*elempitch; 
elemzc8=-0.05; 
  
phi8=round((((sqrt(((elemxc8-focusx)^2)+((elemyc8-
focusy)^2)+((elemzc8-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi8=exp(1i*phi8); 
for sCnt8=1:length(subelemx)      
    dist8(:,sCnt8)=sqrt( ((subelemx(sCnt8)).^2) +((Z1d-
subelemz(sCnt8)).^2)+((Y1d-elemyc8).^2) );   
end                              
    attd8 = exp(-att.*dist8);      
    ejkd8 = exp(-1i.*k.*dist8);    
    Texp8 = (ephi8.*attd8.*ejkd8);  
    Texpd8 = (Texp8./dist8); 
    ATTexpd8 = sum(Texpd8,2); 
     
pmatrix8=reshape(ATTexpd8,(size((Y),1)),(size((Y),2))); 
pmatrix8s=pmatrix7s+pmatrix8; 
  
clear pmatrix7s 
clear pmatrix8 
clear dist8 
clear attd8 
clear ejkd8 
clear Texp8 
clear Texpd8 
clear ATTexpd8 
clear sCnt8 
clear phi8 
clear ephi8 
clear elemyc8 
clear elemxc8 
clear elemzc8 
  
 
% %Element 9% 
  
elemxc9=0; 
elemyc9=-4*elempitch; 
elemzc9=-0.05; 
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phi9=round((((sqrt(((elemxc9-focusx)^2)+((elemyc9-
focusy)^2)+((elemzc9-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi9=exp(1i*phi9); 
for sCnt9=1:length(subelemx)      
    dist9(:,sCnt9)=sqrt( ((subelemx(sCnt9)).^2) +((Z1d-
subelemz(sCnt9)).^2)+((Y1d-elemyc9).^2) );   
end                              
    attd9 = exp(-att.*dist9);      
    ejkd9 = exp(-1i.*k.*dist9);    
    Texp9 = (ephi9.*attd9.*ejkd9);  
    Texpd9 = (Texp9./dist9); 
    ATTexpd9 = sum(Texpd9,2); 
     
pmatrix9=reshape(ATTexpd9,(size((Y),1)),(size((Y),2))); 
pmatrix9s=pmatrix8s+pmatrix9; 
  
clear pmatrix8s 
clear pmatrix9 
clear dist9 
clear attd9 
clear ejkd9 
clear Texp9 
clear Texpd9 
clear ATTexpd9 
clear sCnt9 
clear phi9 
clear ephi9 
clear elemyc9 
clear elemxc9 
clear elemzc9 
  
  
% %Element 10% 
  
elemxc10=0; 
elemyc10=5*elempitch; 
elemzc10=-0.05; 
  
phi10=round((((sqrt(((elemxc10-focusx)^2)+((elemyc10-
focusy)^2)+((elemzc10-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi10=exp(1i*phi10); 
for sCnt10=1:length(subelemx)      
    dist10(:,sCnt10)=sqrt( ((subelemx(sCnt10)).^2) +((Z1d-
subelemz(sCnt10)).^2)+((Y1d-elemyc10).^2) );   
end                              
    attd10 = exp(-att.*dist10);      
    ejkd10 = exp(-1i.*k.*dist10);    
    Texp10 = (ephi10.*attd10.*ejkd10);  
    Texpd10 = (Texp10./dist10); 
    ATTexpd10 = sum(Texpd10,2); 
     
pmatrix10=reshape(ATTexpd10,(size((Y),1)),(size((Y),2))); 
pmatrix10s=pmatrix9s+pmatrix10; 
  
clear pmatrix9s 
clear pmatrix10 
clear dist10 
clear attd10 
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clear ejkd10 
clear Texp10 
clear Texpd10 
clear ATTexpd10 
clear sCnt10 
clear phi10 
clear ephi10 
clear elemyc10 
clear elemxc10 
clear elemzc10 
  
  
% %Element 11% 
  
elemxc11=0; 
elemyc11=-5*elempitch; 
elemzc11=-0.05; 
  
 phi11=round((((sqrt(((elemxc11-focusx)^2)+((elemyc11-
focusy)^2)+((elemzc11-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi11=exp(1i*phi11); 
for sCnt11=1:length(subelemx)      
    dist11(:,sCnt11)=sqrt( ((subelemx(sCnt11)).^2) +((Z1d-
subelemz(sCnt11)).^2)+((Y1d-elemyc11).^2) );   
end                              
    attd11 = exp(-att.*dist11);      
    ejkd11 = exp(-1i.*k.*dist11);    
    Texp11 = (ephi11.*attd11.*ejkd11);  
    Texpd11 = (Texp11./dist11); 
    ATTexpd11 = sum(Texpd11,2); 
     
pmatrix11=reshape(ATTexpd11,(size((Y),1)),(size((Y),2))); 
pmatrix11s=pmatrix10s+pmatrix11; 
  
clear pmatrix10s 
clear pmatrix11 
clear dist11 
clear attd11 
clear ejkd11 
clear Texp11 
clear Texpd11 
clear ATTexpd11 
clear sCnt11 
clear phi11 
clear ephi11 
clear elemyc11 
clear elemxc11 
clear elemzc11 
  
  
% %Element 12% 
  
elemxc12=0; 
elemyc12=6*elempitch; 
elemzc12=-0.05; 
phi12=round((((sqrt(((elemxc12-focusx)^2)+((elemyc12-
focusy)^2)+((elemzc12-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi12=exp(1i*phi12); 
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for sCnt12=1:length(subelemx)      
    dist12(:,sCnt12)=sqrt( ((subelemx(sCnt12)).^2) +((Z1d-
subelemz(sCnt12)).^2)+((Y1d-elemyc12).^2) );   
end                              
    attd12 = exp(-att.*dist12);      
    ejkd12 = exp(-1i.*k.*dist12);    
    Texp12 = (ephi12.*attd12.*ejkd12);  
    Texpd12 = (Texp12./dist12); 
    ATTexpd12 = sum(Texpd12,2); 
     
pmatrix12=reshape(ATTexpd12,(size((Y),1)),(size((Y),2))); 
pmatrix12s=pmatrix11s+pmatrix12; 
  
clear pmatrix11s 
clear pmatrix12 
clear dist12 
clear attd12 
clear ejkd12 
clear Texp12 
clear Texpd12 
clear ATTexpd12 
clear sCnt12 
clear phi12 
clear ephi12 
clear elemyc12 
clear elemxc12 
clear elemzc12 
  
  
% %Element 13% 
  
elemxc13=0; 
elemyc13=-6*elempitch; 
elemzc13=-0.05; 
  
phi13=round((((sqrt(((elemxc13-focusx)^2)+((elemyc13-
focusy)^2)+((elemzc13-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi13=exp(1i*phi13); 
for sCnt13=1:length(subelemx)      
    dist13(:,sCnt13)=sqrt( ((subelemx(sCnt13)).^2) +((Z1d-
subelemz(sCnt13)).^2)+((Y1d-elemyc13).^2) );   
end                              
    attd13 = exp(-att.*dist13);      
    ejkd13 = exp(-1i.*k.*dist13);    
    Texp13 = (ephi13.*attd13.*ejkd13);  
    Texpd13 = (Texp13./dist13); 
    ATTexpd13 = sum(Texpd13,2); 
     
pmatrix13=reshape(ATTexpd13,(size((Y),1)),(size((Y),2))); 
pmatrix13s=pmatrix12s+pmatrix13; 
  
clear pmatrix12s 
clear pmatrix13 
clear dist13 
clear attd13 
clear ejkd13 
clear Texp13 
clear Texpd13 
clear ATTexpd13 
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clear sCnt13 
clear phi13 
clear ephi13 
clear elemyc13 
clear elemxc13 
clear elemzc13 
  
  
% %Element 14% 
  
elemxc14=0; 
elemyc14=7*elempitch; 
elemzc14=-0.05; 
  
phi14=round((((sqrt(((elemxc14-focusx)^2)+((elemyc14-
focusy)^2)+((elemzc14-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi14=exp(1i*phi14); 
for sCnt14=1:length(subelemx)      
    dist14(:,sCnt14)=sqrt( ((subelemx(sCnt14)).^2) +((Z1d-
subelemz(sCnt14)).^2)+((Y1d-elemyc14).^2) );   
end                              
    attd14 = exp(-att.*dist14);      
    ejkd14 = exp(-1i.*k.*dist14);    
    Texp14 = (ephi14.*attd14.*ejkd14);  
    Texpd14 = (Texp14./dist14); 
    ATTexpd14 = sum(Texpd14,2); 
     
pmatrix14=reshape(ATTexpd14,(size((Y),1)),(size((Y),2))); 
pmatrix14s=pmatrix13s+pmatrix14; 
  
clear pmatrix13s 
clear pmatrix14 
clear dist14 
clear attd14 
clear ejkd14 
clear Texp14 
clear Texpd14 
clear ATTexpd14 
clear sCnt14 
clear phi14 
clear ephi14 
clear elemyc14 
clear elemxc14 
clear elemzc14 
  
  
% %Element 15% 
 
elemxc15=0; 
elemyc15=-7*elempitch; 
elemzc15=-0.05; 
  
phi15=round((((sqrt(((elemxc15-focusx)^2)+((elemyc15-
focusy)^2)+((elemzc15-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi15=exp(1i*phi15); 
for sCnt15=1:length(subelemx)      
    dist15(:,sCnt15)=sqrt( ((subelemx(sCnt15)).^2) +((Z1d-
subelemz(sCnt15)).^2)+((Y1d-elemyc15).^2) );   
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end                              
    attd15 = exp(-att.*dist15);      
    ejkd15 = exp(-1i.*k.*dist15);    
    Texp15 = (ephi15.*attd15.*ejkd15);  
    Texpd15 = (Texp15./dist15); 
    ATTexpd15 = sum(Texpd15,2); 
     
pmatrix15=reshape(ATTexpd15,(size((Y),1)),(size((Y),2))); 
pmatrix15s=pmatrix14s+pmatrix15; 
  
clear pmatrix14s 
clear pmatrix15 
clear dist15 
clear attd15 
clear ejkd15 
clear Texp15 
clear Texpd15 
clear ATTexpd15 
clear sCnt15 
clear phi15 
clear ephi15 
clear elemyc15 
clear elemxc15 
clear elemzc15 
  
  
% %Element 16% 
  
elemxc16=0; 
elemyc16=8*elempitch; 
elemzc16=-0.05; 
   
phi16=round((((sqrt(((elemxc16-focusx)^2)+((elemyc16-
focusy)^2)+((elemzc16-focusz)^2)))-(sqrt(((elemxc-focusx)^2+((elemyc-
focusy)^2)+((elemzc-focusz)^2)))))*((2*pi)/lambda))*dp)/dp 
ephi16=exp(1i*phi16); 
for sCnt16=1:length(subelemx)      
    dist16(:,sCnt16)=sqrt( ((subelemx(sCnt16)).^2) +((Z1d-
subelemz(sCnt16)).^2)+((Y1d-elemyc16).^2) );   
end                              
    attd16 = exp(-att.*dist16);      
    ejkd16 = exp(-1i.*k.*dist16);    
    Texp16 = (ephi16.*attd16.*ejkd16);  
    Texpd16 = (Texp16./dist16); 
    ATTexpd16 = sum(Texpd16,2); 
     
pmatrix16=reshape(ATTexpd16,(size((Y),1)),(size((Y),2))); 
pmatrix16s=pmatrix15s+pmatrix16; 
  
clear pmatrix15s 
clear pmatrix16 
clear dist16 
clear attd16 
clear ejkd16 
clear Texp16 
clear Texpd16 
clear ATTexpd16 
clear sCnt16 
clear phi16 
clear ephi16 
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clear elemyc16 
clear elemxc16 
clear elemzc16 
 
clear Y1d 
clear Z1d 
  
figure(1); 
 [C,h] = contour(Y,Z,abs((pmatrix16s)*constant),10); 
 clabel(C,h) 
  
figure(2); 
 mesh(Y,Z,abs((pmatrix16s)*constant)) 
  
pmatrixabs=(abs(pmatrix16s))*constant; 
Imatrixabs=((pmatrixabs).^2)/(2*rho*c); 
  
figure(3); 
 [C,h] = contour(Y,Z,Imatrixabs,10); 
 clabel(C,h) 
  
figure(4); 
 mesh(Y,Z,Imatrixabs); 
    
normI=Imatrixabs./(max(max(Imatrixabs))); 
v1=0.1:0.1:1.0; 
    
figure(5); 
 [C,h] = contour(Y,Z,normI,v1); 
 clabel(C,h) 
   
lognormI=10*log10(normI); 
v2=[-3,-6,-9,-12,-15,-18,-21]; 
   
figure(6); 
 [C,h] = contour(Y,Z,lognormI,v2); 
 clabel(C,h) 
  
v3=[-21:-1]; 
  
figure(7); 
 [C,h] = contour(Y,Z,lognormI,v3); 
 clabel(C,h) 
  
Q=2*att*Imatrixabs; % For Export 
 
 
[CODE ENDS] 
  
227 
 
Appendix B: Original Project Proposal 
Development of a medical imaging-based technology for cancer 
treatment 
The research project proposed is the integration of a therapeutic high intensity 
focused ultrasound (HIFU) transducer array into an existing electrical impedance 
modelling (EIM) non-invasive medical imaging device. The resulting system therefore 
will allow dual modalities of diagnosis and treatment to be available using a single 
device. 
Background & Rationale 
HIFU involves bringing ultrasonic waves into a tight focus at a targeted spot within the 
body. As ultrasonic waves are attenuated in tissue, the loss in power is converted into 
heat. This allows ablation of internal structures caused by coagulative necrosis of the 
tissue when heated to temperatures in excess of 65 degrees Celsius. A major 
advantage of using HIFU is that the overlying skin and tissue remains unharmed, as 
ablation will only occur at the focal spot or point. This fact has led to the use of HIFU 
being referred to as a ‘trackless scalpel’. 
In recent years the use of HIFU for the treatment of various ailments has been given 
much attention. Although the concepts and theory of using HIFU as a surgical tool have 
existed for decades it is only recently that the supporting technology has evolved 
sufficiently to effectively use such a device. In the last few years the use of HIFU to 
treat prostate cancer has been given particular attention and is now an approved 
treatment methodology in countries around the world including, but not limited to 
China, where it is understood that the largest number of clinical trials have taken 
place. 
Breast cancer, amongst others, has the potential to be efficiently treated using a HIFU 
device. This is because the breast is easily accessible from outside the body and also 
contains no pockets of air that would negatively affect the propagation of ultrasound 
through tissue (such as are present in the lungs). 
The use of EIM for early detection of breast cancer has been under investigation by 
numerous groups worldwide, but to the authors knowledge none of these groups have 
incorporated a suitable treatment methodology to allow diagnosis and treatment to be 
performed using the same device. The bio-medical engineering (BMEng) group, 
currently based at the University of Sussex, are working towards this goal. Therefore it 
can be seen that the research proposed here would have a greatly beneficial effect on 
obtaining this goal and progressing towards a system allowing early detection and 
destruction of breast cancer 
Research Questions 
The questions this research project aims to answer are numerous. To simplify, these 
questions can be broadly split into the following. 
• Can EIM be used in conjunction with HIFU to provide both diagnosis and 
targeted treatment? 
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• What factors must be considered when designing and manufacturing a HIFU 
transducer? (Including, but in no way limited to the phasing of array elements, 
allowing electronic steering)  
• How can a HIFU transducer be integrated into the existing EIM system designed 
by the BMEng group at the University of Sussex? 
• How can the resulting device be made viable for treatment of human patients? 
Methods 
Much of the methodology for the proposed research can be inferred from the 
questions above. More specifically research will begin with an extensive literature 
review of current groups working in the field of HIFU and tumour ablation and of 
existing texts on the theory of ultrasonics and interaction with tissue. Following this 
suitable transducer designs will be created and a simulation methodology will be 
employed to model the pressure fields and resulting heat deposition caused by the 
propagation of ultrasound into tissue. Once satisfactory simulation has been 
completed a prototype will be manufactured using the created designs in conjunction 
with advice from the preferred manufacturers. The prototype, once manufactured, will 
then undergo extensive testing largely using phantoms that represent human tissue. 
The prototype will then be evaluated and modified as necessary, with improvement 
being made as and when they are required. Eventually the finished HIFU/EIM device 
will be tested in medical trials, following sufficient approval from the relevant bodies. 
Ethical Considerations 
As the existing EIM system has been created largely using external funding 
confidentiality is an issue here. All parties consulted during this research project should 
be asked to sign non-disclosure agreements (NDAs) prior to any sensitive information 
being divulged. In addition to this how the HIFU treatment will be tested should be 
considered, especially in terms of acceptability to patients when considering all 
available treatment options. 
Timescales 
The timescales involved in a project such as has been proposed here are largely 
dependent on existing deadlines and on-going work presently being carried out by the 
BMEng group at the University of Sussex. That being said, the first working prototype 
HIFU transducer will aim to be manufactured and initially tested within 4 weeks of the 
start of July 2011. 
